
<html lang="en"     class="pb-page"  data-request-id="83dfb1c2-3271-40a6-ab67-d3e63ea55671"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.9b01912;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2020.63.issue-3;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders" /></meta><meta name="dc.Creator" content="Zhicheng  Xie" /></meta><meta name="dc.Creator" content="Bing  Wu" /></meta><meta name="dc.Creator" content="Yingqiang  Liu" /></meta><meta name="dc.Creator" content="Wenming  Ren" /></meta><meta name="dc.Creator" content="Linjiang  Tong" /></meta><meta name="dc.Creator" content="Caigui  Xiang" /></meta><meta name="dc.Creator" content="Aihuan  Wei" /></meta><meta name="dc.Creator" content="Yuanzhuo  Gao" /></meta><meta name="dc.Creator" content="Limin  Zeng" /></meta><meta name="dc.Creator" content="Hua  Xie" /></meta><meta name="dc.Creator" content="Wei  Tang" /></meta><meta name="dc.Creator" content="Youhong  Hu" /></meta><meta name="dc.Description" content="Colony-stimulating factor 1 receptor (CSF-1R) is involved in inflammatory disorders as well as in many types of cancer. Based on high-throughput screening and docking results, we performed a detail..." /></meta><meta name="Description" content="Colony-stimulating factor 1 receptor (CSF-1R) is involved in inflammatory disorders as well as in many types of cancer. Based on high-throughput screening and docking results, we performed a detail..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 14, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01912" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01912" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01912" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01912" /></link>
        
    
    

<title>Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01912" /></meta><meta property="og:title" content="Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0017.jpeg" /></meta><meta property="og:description" content="Colony-stimulating factor 1 receptor (CSF-1R) is involved in inflammatory disorders as well as in many types of cancer. Based on high-throughput screening and docking results, we performed a detailed structure–activity-relationship study, leading to the discovery of a new series of compounds with nanomolar IC50 values against CSF-1R without the inhibition of fibroblast growth factor receptors. One of the most promising hits, compound 29, potently inhibited CSF-1R kinase with an IC50 value of 0.7 nM, while it showed no inhibition to the same family member FMS-like tyrosine kinase 3. Compound 29 displayed excellent anti-inflammatory effects against RAW264.7 macrophages indicated by significant inhibition against the activation of the CSF-1R pathway with low cytotoxicity. In addition, compound 29 exhibited strong in vivo anti-inflammatory efficacy alongside favorable drug characteristics. This novel compound 29 may serve as a new drug candidate with promising applications in inflammatory disorders." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01912"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01912">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01912&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01912&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01912&amp;href=/doi/10.1021/acs.jmedchem.9b01912" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1397-1414</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01931" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02067" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an <i>o</i>-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhicheng Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhicheng Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhicheng++Xie">Zhicheng Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bing Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bing Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bing++Wu">Bing Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yingqiang Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yingqiang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yingqiang++Liu">Yingqiang Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenming Ren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenming Ren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenming++Ren">Wenming Ren</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Linjiang Tong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linjiang Tong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linjiang++Tong">Linjiang Tong</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Caigui Xiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caigui Xiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caigui++Xiang">Caigui Xiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aihuan Wei</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aihuan Wei</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aihuan++Wei">Aihuan Wei</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuanzhuo Gao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuanzhuo Gao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuanzhuo++Gao">Yuanzhuo Gao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Limin Zeng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Limin Zeng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Limin++Zeng">Limin Zeng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hua Xie</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hua Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#543c2c3d3114273d39397a35377a373a"><span class="__cf_email__" data-cfemail="e38b9b8a86a3908a8e8ecd8280cd808d">[email protected]</span></a> (H.X.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hua++Xie">Hua Xie</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Tang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Tang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3b4f5a555c4c5e527b48525656155a58155855"><span class="__cf_email__" data-cfemail="e79386898090828ea7948e8a8ac98684c98489">[email protected]</span></a> (W.T.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Tang">Wei Tang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Youhong Hu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Youhong Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</div><div class="loa-info-affiliations-info">University of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#3b4253534e7b48525656155a58155855"><span class="__cf_email__" data-cfemail="5e2736362b1e2d373333703f3d703d30">[email protected]</span></a>. Phone: +86-21-50806600-3526 (Y.H.).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Youhong++Hu">Youhong Hu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1770-6272" title="Orcid link">http://orcid.org/0000-0003-1770-6272</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01912&amp;href=/doi/10.1021%2Facs.jmedchem.9b01912" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1397–1414</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 14, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 November 2019</li><li><span class="item_label"><b>Published</b> online</span>14 January 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 February 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01912" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01912</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1397%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhicheng%2BXie%252C%2BBing%2BWu%252C%2BYingqiang%2BLiu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D3%26contentID%3Dacs.jmedchem.9b01912%26title%3DNovel%2BClass%2Bof%2BColony-Stimulating%2BFactor%2B1%2BReceptor%2BKinase%2BInhibitors%2BBased%2Bon%2Ban%2Bo-Aminopyridyl%2BAlkynyl%2BScaffold%2Bas%2BPotential%2BTreatment%2Bfor%2BInflammatory%2BDisorders%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1414%26publicationDate%3DFebruary%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01912"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1724</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01912" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Class of Colony-Stimulating Factor 1 Receptor Kinase Inhibitors Based on an o-Aminopyridyl Alkynyl Scaffold as Potential Treatment for Inflammatory Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhicheng&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Bing&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Yingqiang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Wenming&quot;,&quot;last_name&quot;:&quot;Ren&quot;},{&quot;first_name&quot;:&quot;Linjiang&quot;,&quot;last_name&quot;:&quot;Tong&quot;},{&quot;first_name&quot;:&quot;Caigui&quot;,&quot;last_name&quot;:&quot;Xiang&quot;},{&quot;first_name&quot;:&quot;Aihuan&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Yuanzhuo&quot;,&quot;last_name&quot;:&quot;Gao&quot;},{&quot;first_name&quot;:&quot;Limin&quot;,&quot;last_name&quot;:&quot;Zeng&quot;},{&quot;first_name&quot;:&quot;Hua&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Tang&quot;},{&quot;first_name&quot;:&quot;Youhong&quot;,&quot;last_name&quot;:&quot;Hu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;1397-1414&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01912&quot;},&quot;abstract&quot;:&quot;Colony-stimulating factor 1 receptor (CSF-1R) is involved in inflammatory disorders as well as in many types of cancer. Based on high-throughput screening and docking results, we performed a detailed structure–activity-relationship study, leading to the discovery of a new series of compounds with nanomolar IC50 values against CSF-1R without the inhibition of fibroblast growth factor receptors. One of the most promising hits, compound 29, potently inhibited CSF-1R kinase with an IC50 value of 0.7 nM, while it showed no inhibition to the same family member FMS-like tyrosine kinase 3. Compound 29 displayed excellent anti-inflammatory effects against RAW264.7 macrophages indicated by significant inhibition against the activation of the CSF-1R pathway with low cytotoxicity. In addition, compound 29 exhibited strong in vivo anti-inflammatory efficacy alongside favorable drug characteristics. This novel compound 29 may serve as a new drug candidate with promising applications in inflammatory disorders.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01912&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01912" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01912&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01912" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01912&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01912" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01912&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01912&amp;href=/doi/10.1021/acs.jmedchem.9b01912" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01912" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01912" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01912%26sid%3Dliteratum%253Aachs%26pmid%3D31934767%26genre%3Darticle%26aulast%3DXie%26date%3D2020%26atitle%3DNovel%2BClass%2Bof%2BColony-Stimulating%2BFactor%2B1%2BReceptor%2BKinase%2BInhibitors%2BBased%2Bon%2Ban%2Bo-Aminopyridyl%2BAlkynyl%2BScaffold%2Bas%2BPotential%2BTreatment%2Bfor%2BInflammatory%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D3%26spage%3D1397%26epage%3D1414%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/jmcmar.2020.63.issue-3/20200213/jmcmar.2020.63.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Colony-stimulating factor 1 receptor (CSF-1R) is involved in inflammatory disorders as well as in many types of cancer. Based on high-throughput screening and docking results, we performed a detailed structure–activity-relationship study, leading to the discovery of a new series of compounds with nanomolar IC<sub>50</sub> values against CSF-1R without the inhibition of fibroblast growth factor receptors. One of the most promising hits, compound <b>29</b>, potently inhibited CSF-1R kinase with an IC<sub>50</sub> value of 0.7 nM, while it showed no inhibition to the same family member FMS-like tyrosine kinase 3. Compound <b>29</b> displayed excellent anti-inflammatory effects against RAW264.7 macrophages indicated by significant inhibition against the activation of the CSF-1R pathway with low cytotoxicity. In addition, compound <b>29</b> exhibited strong in vivo anti-inflammatory efficacy alongside favorable drug characteristics. This novel compound <b>29</b> may serve as a new drug candidate with promising applications in inflammatory disorders.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A macrophage colony-stimulating factor-1 receptor (CSF-1R, also known as FMS)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> is a class III receptor tyrosine kinase family, which also includes FMS-like tyrosine kinase 3 (FLT-3), stem cell factor receptor (KIT), and platelet-derived growth factor receptor (PDGFR) α and β. CSF-1R is primarily expressed in macrophage lineages including monocytes, tissue macrophages, dendritic cells, and osteoclasts.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> It plays an important role in signal transduction through CSF-1/CSF-1R for the differentiation, survival, proliferation, adhesion, and migration of monocyte/macrophage lineage cells.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, CSF-1/CSF-1R axis overactivation through downstream pathways such as PI3K/AKT/NF-κB, PKC/NF-κB, and ROS/RAS/RAF/MAPK<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3−6)</a> may lead to aberrant expression of pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), among others. The augmentation of these pro-inflammatory cytokines can promote the pathogenesis of various types of cancer, bone disorders, and inflammatory diseases. Various groups have shown that CSF-1R inhibition has the potential to prevent erosions, reduce symptoms of rheumatoid arthritis (RA) and bone osteolysis,<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> and slow the progression of amyotrophic lateral sclerosis.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Moreover, recent research has demonstrated that elimination of microglia through CSF-1R inhibition could curtail plaque formation in an Alzheimer’s disease in vivo model.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These experiments and others identify CSF-1R as a suitable target for macrophage-induced inflammatory disease. Thus, suppression of the CSF-1/CSF-1R axis through CSF-1R selective small-molecule inhibitors is of great promise in anti-inflammation therapy.</div><div class="NLM_p">A number of small-molecule CSF-1R inhibitors have been reported to date.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For instance, PLX3397 (<b>1</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> an oral tyrosine kinase inhibitor of CSF-1R, KIT, and mutant FLT-3 was approved by the U.S. Food and Drug Administration (FDA) in 2019 as an orphan drug for the treatment of pigmented villonodular synovitis (PVNS or dt-GCT). In addition to PLX3397, BLZ-945 (<b>2</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> ARRY-382 (<b>3</b>),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> JNJ-40346527 (<b>4</b>),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> PLX7486 (<b>5</b>, structure undisclosed),<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and DCC-3014 (<b>6</b>, structure undisclosed)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> are currently under clinical development (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). However, most of the CSF-1R small-molecule inhibitors in development unfortunately exhibit poor kinase selectivity. In particular, it has been difficult for the field to distinguish homologous kinases such as FLT-3, KIT, PDGF-α/β, and so forth. Recent research demonstrates that the simultaneous inhibition of FLT-3 and KIT could result in profound side effects including myelosuppression and hair depigmentation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Therefore, there is large demand to develop novel CSF-1R inhibitors exhibiting favorable chemical scaffolding and compound properties for inflammatory disease therapy. Herein, we report potent and selective CSF-1R inhibitors with an <i>o</i>-aminopyridylene scaffold that do not inhibit FLT-3.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative chemical structure of CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our previously developed diarylenes-based multitargeted kinase inhibitor <b>7</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> exhibited potent activity against fibroblast growth factor receptors (FGFRs) and moderated inhibitory activity against CSF-1R. Removal of the <i>N</i>-methylpiperazine tail produced a novel CSF-1R inhibitor displaying excellent selectivity to CSF-1R over FGFRs. Following this identification, structure–activity relationship (SAR) studies adjusted “head”, “gate”, “linker”, and “tail” moieties, leading to the discovery of a novel, highly potent, and selective CSF-1R kinase inhibitor without FGFR and FLT-3 inhibition, compound <b>29</b>. In addition, <b>29</b> also displayed promising pharmacokinetic (PK) properties and excellent anti-inflammatory efficacy in both in vitro assays using RAW264.7 macrophages and in vivo investigations utilizing LPS-induced mouse models of inflammation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of the designed compounds <b>8–22</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) is outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Commercially available halogenated heteroaromatic compounds (<b>38</b>) were reacted with ethynyltrimethylsilane through Sonogashira cross-coupling reaction to give the intermediates (<b>39</b>). Compounds <b>41</b> were prepared in high yields by the condensation reaction between 4-substituted-3-halogenobenzoic acids (<b>40</b>) with the corresponding anilines. The coupling of <b>41</b> with <b>39</b> gave the final products (<b>8–15</b>) and intermediates (<b>42</b>). Compound <b>42</b> was subsequently used in a Suzuki reaction with the boric acid ester to produce the designed molecules (<b>16–22</b>). To explore the SAR of R<sub>2</sub> moiety (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), an efficient synthetic route was designed as shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Methyl 3-iodo-4-methylbenzoate (<b>43</b>) was coupled with 5-bromo-3-((trimethylsilyl)ethynyl) pyridin-2-amine (<b>39i</b>) at room temperature to generate the intermediate, which was further coupled with the related boric acid ester to produce the key intermediate (<b>44</b>). The designed molecules (<b>23–33</b>) were readily prepared by hydrolysis of methyl ester (<b>44</b>) and then followed by condensation with the different substituted anilines. Compounds <b>34–37</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) were prepared as illustrated in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. The amides <b>48a–c</b> were obtained by a condensation reaction with <b>46</b> and <b>47</b>. The designed linear molecule <b>34</b> and reversed amide compound <b>35</b> were obtained through a Sonogashira cross-coupling reaction and a Suzuki reaction starting from the intermediates <b>48a</b> and <b>48b</b> with <b>39i</b> and 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, respectively. The amide bond of <b>48c</b> was further methylated or reduced to give the intermediates <b>49</b> and <b>50</b>, which is followed by two-step Pd-catalyzed cross-coupling reaction to provide the final compounds <b>36</b> and <b>37</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>8–22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagent and conditions: (a) X = Br: trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, MeCN/Et<sub>3</sub>N (4:1, v/v), 80 °C, 4 h; X = I: ethynyltrimethyl-silane, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, rt, 6 h; (b) HATU, DIPEA, DMF, rt, 4 h; (c) X = Br: Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, 80 °C, 4 h; X = I: Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, rt, 4 h; (d) 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, toulene/EtOH/H<sub>2</sub>O (2/1/1, v/v/v), microwave irradiation, 100 °C, 20 min.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>23–33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagent and conditions: (a) <b>39i</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, rt, 5 h; (b) 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, Pd(OAc)<sub>2</sub>, X-phos, K<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (4/1, v/v), 90 °C, 6 h; (c) LiOH·H<sub>2</sub>O, THF/MeOH/H<sub>2</sub>O (4/1/1, v/v/v), rt, 12 h; (d) the substituted phenylamines, HATU, DIPEA, DMF, rt, 4 h.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>34–37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagent and conditions: (a) HATU, DIPEA, DMF, rt, 4 h; (b) MeI, NaH, THF, 0 °C to rt, 5 h; (c) BF<sub>3</sub>·THF (1 M), THF, rt, 12 h; (d) <b>39i</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, rt, 4 h; (e) 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, THF/EtOH/H<sub>2</sub>O (2/1/1, v/v/v), microwave irradiation, 100 °C, 20 min.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Exploration Focused on the Het. Moiety<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0012.gif" alt="" id="GRAPHIC-d7e745-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0013.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">All IC<sub>50</sub> values (mean ± SD) against CSF-1R kinase were obtained from inhibition ratios at different concentrations (0.1–1000 nM) from two independent experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration Focused on the Substitution (R<sub>1</sub>) Moiety<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0014.gif" alt="" id="GRAPHIC-d7e766-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">CSF-1R (IC<sub>50</sub>, nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">–CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">2.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="left">16.1 ± 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">–CH(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">–OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">263.0 ± 59.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">–F</td><td class="colsep0 rowsep0" align="left">160.3 ± 22.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">–Cl</td><td class="colsep0 rowsep0" align="left">6.5 ± 2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">–CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLX3397</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">14.0 ± 2.9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All IC<sub>50</sub> values (mean ± SD) against CSF-1R kinase were obtained from inhibition ratios at different concentrations (0.1–1000 nM) from two independent experiments performed in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR Exploration Focused on the Substitution (R<sub>2</sub>) Moiety<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0015.gif" alt="" id="GRAPHIC-d7e888-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">CSF-1R (IC<sub>50</sub>, nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3,5-(OCH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">–H</td><td class="colsep0 rowsep0" align="char" char="±">6.5 ± 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">2-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">20.2 ± 4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">3-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="char" char="±">318.0 ± 54.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="char" char="±">1.3 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">3.0 ± 0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">2,4-(Cl)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">5.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">3,4-(Cl)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="±">10.8 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLX3397</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">17.3 ± 1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">All IC<sub>50</sub> values (mean ± SD) against CSF-1R kinase were obtained from inhibition ratios at different concentrations (0.1–1000 nM) from two independent experiments performed in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR Exploration Focused on the Linker Moiety<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0016.gif" alt="" id="GRAPHIC-d7e1074-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd.</th><th class="colsep0 rowsep0" align="center">linker</th><th class="colsep0 rowsep0" align="center">CSF-1R (IC<sub>50</sub>, nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">5-CONH–</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">4-CONH–</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">5-NHCO–</td><td class="colsep0 rowsep0" align="left">7.2 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">5-CON(CH<sub>3</sub>)–</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">5-CH<sub>2</sub>NH–</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PLX3397</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12.0 ± 1.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">All IC<sub>50</sub> values (mean ± SD) against CSF-1R kinase were obtained from inhibition ratios at different concentrations (0.1–1000 nM) from two independent experiments performed in duplicate.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67623" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67623" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Design Rationale and SAR</h3><div class="NLM_p">Through screening of our in-house kinase inhibitor library, we identified a number of compounds that displayed CSF-1R kinase inhibition including compounds <b>7</b> and <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), which exhibited moderate suppression of CSF-1R with an IC<sub>50</sub> value of 46.0 ± 17.3 and 23.4 ± 8.7 nM, respectively. Interestingly, differences in molecular structure revealed that FGFR inhibition activity (compound <b>7</b>, FGFR1 IC<sub>50</sub> = 1.2 ± 0.4 nM; compound <b>8</b>, FGFR1-4 IC<sub>50</sub> > 1000 nM) could be eliminated through removal of a trifluoromethyl group and a <i>N</i>-methylpiperazine tail. To identify structure-dependent differential binding modalities, we conducted preliminary computational investigations (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The docking results of <b>7</b> and <b>8</b> with FGFR1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B,C) indicate potential binding with the inactive DFG-out conformation (represented by Phe642) of FGFR1 utilizing a type II binding mode. The trifluoromethyl group and <i>N</i>-methylpiperazine tail present in compound <b>7</b> likely form interactions crucial for FGFR1 kinase binding (e.g., multihalogen bonds with Ile546 and Ile639, a cation−π interaction with His621, electrostatic interactions with His621 and Cys619, water-bridged hydrogen bonds between the <i>N</i>-methylpiperazine motif and backbone carbonyl oxygen atom of Ile620 and His621, among others) that are not present in compound <b>8</b> because of the removal of key pharmacophores integral to FGFR binding (<b>8</b>, FGFR1-4 IC<sub>50</sub> > 1000 nM). Compounds <b>7</b> and <b>8</b> were then docked into CSF-1R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D–F) to determine the factors contributing to compound <b>8</b>’s increased CSF-1R potency poststructural modification from <b>7</b>. Although both <b>7</b> and <b>8</b> fit the DFG-out conformation of CSF-1R as represented by Phe797 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D,F), the large <i>N</i>-methylpiperazine group present in compound <b>7</b> sterically repulsed the JM (juxtamembrane) domain (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>E) while <b>8</b> recruited the JM domain and formed novel contacts (represented by a π–π stacking with Trp550) with JM residues upon binding to CSF-1R (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>F). Consistent with prior research, unlike compound <b>7</b> which acts as a conventional type II inhibitor, <b>8</b> binds to an autoinhibited CSF-1R and engages the JM region on a more physiologically common full-length CSF-1R protein state, leading to increased potency and reduced secondary kinase cross-reactivity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As a novel-type II inhibitor, <b>8</b> exhibited excellent selectivity to CSF-1R over FGFRs (CSF-1R IC<sub>50</sub> = 23.4 ± 8.7 nM; FGFR1-4 IC<sub>50</sub> > 1000 nM). Consequently, compound <b>8</b> was chosen as a lead compound for further SAR study.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Development schematic of novel <i>o</i>-aminopyridylene scaffold-based CSF-1R selective inhibitor <b>29</b> by structural modification of the previously designed FGFR inhibitor <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding mode analysis of compounds <b>7</b> and <b>8</b> to FGFR and CSF-1R kinases. (A) Crystal structure of CSF-1R kinase domain with PLX3397 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>). (B) Molecular docking of compound <b>7</b> into FGFR1 kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a>). (C) Molecular docking of compound <b>8</b> into FGFR1 kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a>). (D) Molecular docking of compound <b>7</b> into CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a>). (E) Structure illustration of compound <b>7</b> displaces the JM domain of CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a>). (F) Structure illustration of compound <b>8</b> recruits the JM domain of CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Based on the type II kinase inhibitor-binding element hybrid design strategy,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> we initiated the SAR investigation by varying the “head”, “gate”, “linker”, and “tail” moieties. First, as a hinge-binding element, the isoquinoline introduced low atomic economic efficiency and unfavorable drug characteristics because of its large rigid planar conjugated system. Therefore, we first explored the effect of “head” (Het.) moiety and synthesized a series of compounds with varying aromatic heterocycles (Het). The biochemical potency of newly synthesized compounds against CSF-1R was measured and is displayed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The isoquinoline in <b>8</b> was replaced with the dominant fragment imidazo[1,2-<i>b</i>]pyridazine in Ponatinib and a ring-opening pyridine, leading to compound <b>9</b> and monocyclic compound <b>10</b>, respectively. However, compound <b>10</b> lost more than 9-fold activity against CSF-1R in comparison with <b>8</b>. The binding modes of PLX3397 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A) and <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C) suggest that the introduction of an amino group can serve as a hydrogen bond donor and form an extra hydrogen bond with a Glu664 backbone carbonyl in the hinge domain, as in the binding mode of PLX3397. The instillation of a −NH<sub>2</sub> group in the ortho-position of a pyridine N atom (<b>11</b>, IC<sub>50</sub> = 28.5 ± 9.3 nM) could thus significantly increase potency to that of compound <b>8</b>. Structural differences between compound <b>8</b>, <b>11</b>, and PLX3397 revealed an extra binding pocket in the 5-position outwardly extending from the <i>o</i>-aminopyridine ring. With this in mind, we hybridized compound <b>11</b> and PLX3397 to create compound <b>12</b>, which yielded improvements in activity. Docking studies to CSF-1R identified plausible binding modes of compound <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A): “head” <i>o</i>-aminopyridine forms double hydrogen bonds with the hinge regions that are integral to high potency. The middle benzene ring passes through the “gate” area and allows the molecule to fit in a hydrophobic pocket. As a “linker”, the amide motif then forms critical hydrogen bonds with the conserved DFG-motif (Asp796, Phe797, Gly798) and Glu633 in the c-helix of CSF-1R. Finally, the “tail” of compound <b>12</b> (a benzene ring) binds to the receptor through establishing a π–π stacking interaction with a Trp550 residue in the JM domain. Subsequently, we discuss the detailed SAR based on compound <b>12</b> binding modalities.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic illustration of the SAR exploration rationale. (A) Binding mode study of compound <b>12</b> in CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>); (B) binding mode study of compound <b>16</b> in CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A series of compounds with different substituent groups to replace the 5-chloro of Het. in compound <b>12</b> were synthesized to understand the importance of this substituent in the “head” (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). As shown in the binding mode of <b>12</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), the substituent at the 5-position of <i>o</i>-aminopyridine ring was bound in a relatively large hydrophilic pocket, and the introduction of polar groups with heteroatoms or heterocycle could increase potency because of the electronic fit or the extra π–π stacking with Tyr665. Interestingly, changing the Cl atom to a carbonyl group (<b>13–15</b>) remarkably increased the potency against CSF-1R. Further increasing the size and polarity of the substituent with a <i>N</i>-methylpyrazolyl group (<b>16</b>) resulted in the increasing potency of compound <b>16</b> for the inhibition of CSF-1R with an IC<sub>50</sub> value of 2.6 ± 0.4 nM. Based on the results discussed above, the SAR on “head” (Het.) moiety indicates binding in a suitable hydrophilic pocket of CSF-1R that is closed to the solvent-exposed areas. Moreover, the molecular docking results of compound <b>16</b> displayed that the <i>N</i>-methylpyrazolyl group increased its receptor binding affinity because of the extra π–π stacking interactions forming between its arene π-system with the benzene ring of Try665 and a π–anion interaction with the carboxyl negative charge center of Asp670 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><div class="NLM_p">Because <b>16</b> exhibited potent inhibitory efficacy against CSF-1R, we maintained the “head” moiety with 5-<i>N</i>-methylpyrazolyl-2-aminopyridine and further explored the “Gate” (R<sub>1</sub>) moiety (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>17</b> to <b>22</b> were initially synthesized to elucidate the steric and electronic effects present at this position. It was found that methyl group replacement with hydrogen (<b>17</b>) and isopropyl (<b>18</b>) decreased potency, with dramatic loss in activity upon isopropyl introduction. This finding indicates that optimal R<sub>1</sub> group sizing is crucial for potency. Subsequently, substituent variations at this position with differing electronic effects (MeO in <b>19</b>, F in <b>20</b>, and CF<sub>3</sub> in <b>22</b>) substantially decreased activity. A Cl group addition (compound <b>21</b>) yielded similar potencies to compound <b>16</b>. These results indicate that the R<sub>1</sub> substituent binds in a specific hydrophobic binding pocket with steric and electronic requirements. The importance of this methyl in maintaining high potency against the CSF-1R kinase was found by docking compound <b>16</b> into CSF-1R, as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. The methyl group of <b>16</b> was bound in a specifically sized hydrophobic pocket formed by Val596, Ala614, Lys616 and the gatekeeper Thr663 via extensive van der Waals forces, and hydrophobic interactions with the receptor. More importantly, computational analysis hypothesized approximate orthogonal conformations between the two aromatic systems of <b>16</b> fixed by this methyl group, which aided CSF-1R binding (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Given the outstanding potency of inhibitor <b>16</b>, the R<sub>1</sub> moiety (methyl group) was further fixed in the follow SAR investigation.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Molecular modeling analysis of the binding mode of compound <b>16</b> in CSF-1R kinase. (A) Binding mode study of <b>16</b> in CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>); (B) Approximate orthogonal conformation of the diarylethyne system was controlled by the methyl group in the middle benzene ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Computational studies suggest that the substituted benzene ring “tail” stabilizes the auto-inhibited CSF-1R state by forming interactions directly with the JM domain (represented by a π–π stacking interaction with JM-Trp550), which is crucial for potency and selectivity improvement. To maintain this key interaction, differential substituent effects were introduced into the aniline ring (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). 3,5-Dimethoxyl groups were first removed to yield compound <b>23</b>, which also exhibited potency to CSF-1R. Then, we investigated the potential impact of phenyl ring substituents by introducing electronic effects (MeO, Cl, CF<sub>3</sub>) at the 2-, 3-, and 4- positions of the benzene ring (<b>24–31</b>). Ortho-substitution with electron-donating group MeO yielded lowered activity as compared to <b>23</b>, whereas the meta- and para-substitution patterns of methoxyl groups (<b>25</b> and <b>26</b>) improved potency against CSF-1R. A similar phenomenon was observed with the substitution patterns of Cl (<b>27–29</b>). These findings suggest that the 3- or 4- positions might optimally suppress the kinase function of CSF-1R, with the 4-chloro substitution (<b>29</b>) exhibiting the highest potency (IC<sub>50</sub> = 0.7 nM). In addition, CF<sub>3</sub> substitution at the 3- or 4- position maintained CSF-1R potency. Further investigating di-substitutional effects at favorable meta- and para-positions (<b>33</b>) did not display synergistic effects. These findings indicate that benzene ring electron density plays a minor role in potency, whereas benzene ring spatial orientation to JM-Trp550 contributes greatly to activity through π–π interactions, which requires suitable orientations between the benzene and indole rings of JM-Trp550. The steric hindrance of ortho-substituent groups may disrupt the optimal orientation between the two aromatic rings to lead the potency loss. Thus, the mono-substitution at meta- or para-position is more favorable, especially the <i>para</i>-chloro substitution (<b>29</b>) is optimal.</div><div class="NLM_p">Finally, we explored the “linker” moiety by fixing the “head”, “gate”, and “tail” as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Changing the amide from the 5-position to the 4-position to yield a linear molecule (<b>34</b>) resulted in total loss of inhibitory potency because of its high rigidity and steric resistance upon binding to the target protein. Furthermore, a reversed amide counterpart of the linker in <b>29</b> (<b>35</b>) resulted in decreasing activity to CSF-1R. Amide blockage by methylation of −NH (<b>36</b>) and carbonyl saturation (<b>37</b>) also led to total loss of potency. These results indicate that the 5-amine linker is crucial for CSF-1R activity because of the key hydrogen bonding established between the amide −NH and carbonyl moieties with the DFG-motif and Glu633 in the c-helix of CSF-1R.</div><div class="NLM_p">To better understand the interaction between the synthesized compounds and CSF-1R kinase, molecular docking of the highest potent compound <b>29</b> into the ATP binding site of CSF-1R kinase (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>) was performed. The binding model is depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. Serving as a desirable hinge binding element, the 5-(<i>N</i>-methyl)pyrazol-2-amino pyridine formed double hydrogen bonds with the hinge region (the nitrogen of pyridine with amino hydrogen atom of Cys666 and 2-amino hydrogen of pyridine with the carbonyl oxygen atom of Glu664). Beyond this, the aromatic system formed a π–π stacking interaction with the benzene ring of Tyr665 and the <i>N</i>-methyl pyrazol, which could enhance the binding affinity through a π–anion interaction with the negatively charged carboxyl center of Asp670. Thus, this “head” motif likely plays a key role in CSF-1R interactions. The alkynyl linker connects the hinge-binding element with the back-pocket moiety because of its favorable overall orientation, while the middle phenyl ring of <b>29</b> binds in a hydrophobic pocket to form a π–cation interaction with the positively charged center of Lys616. Furthermore, the methyl group of the phenyl ring extended to another relatively small hydrophobic sub-pocket, which may have optimized molecular conformations, resulting in the observed increased inhibitory activity against CSF-1R. The amide linker, which can form two typical hydrogen bonds with Asp796 in the DFG motif and Glu633 in the c-helix, was critical for the binding. Therefore, the modification (as shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) of this amide linker could destroy the forming of these crucial hydrogen bonds, leading to the significant loss of activity. Furthermore, we identified a π–π stacking interaction between the terminal phenyl ring with a Trp550 residue in the JM domain of suitable conformation, which required a suitable spatial conformation of these two aromatic rings. Because of the steric effect, the ortho-substituent groups (represented by <b>24</b> and <b>27</b>) are unfavorable for this spatial requirement, whereas, the <i>para</i>-chloro substitution (<b>29</b>) was optimal and exhibited the highest potency.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding mode study of inhibitor <b>29</b> in CSF1R kinase (generated from PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Selectivity Profiling of Compound <b>29</b></h3><div class="NLM_p">The inhibitory activities of <b>29</b> against the other protein kinases, especially the other members of the class III growth factor receptor family, that is, FLT-3, KIT, PDGF-α and β, were also evaluated utilizing our in-house kinase assays (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). The results showed that <b>29</b> potently inhibited the activity of KIT (inhibition rate = 70.4% at 10 nM) and PDGFR-α (inhibition rate = 54.6% at 10 nM). This result is not surprising, considering that KIT and PDGFRα/β kinases belong to the class III receptor tyrosine kinase family with highly conserved ATP binding pockets. Interestingly, <b>29</b> exhibited no inhibition against FLT-3, FGFR1-4, EGFR, ErbB2/4, and so forth. kinases at 1 μM concentration, which could greatly reduce the potential toxic effects induced by the simultaneous inhibition of FLT-3 and KIT as previously mentioned.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity Profiling of Compound <b>29</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">% inhibition ratio @ conc.</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">% inhibition ratio @ conc.</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinases</th><th class="colsep0 rowsep0" align="center" char=".">1000 nM</th><th class="colsep0 rowsep0" align="center" char=".">100 nM</th><th class="colsep0 rowsep0" align="center">10 nM</th><th class="colsep0 rowsep0" align="center">kinases</th><th class="colsep0 rowsep0" align="center" char=".">1000 nM</th><th class="colsep0 rowsep0" align="center" char=".">100 nM</th><th class="colsep0 rowsep0" align="center">10 nM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR1</td><td class="colsep0 rowsep0" align="char" char=".">89.80</td><td class="colsep0 rowsep0" align="char" char=".">78.50</td><td class="colsep0 rowsep0" align="left">36.20</td><td class="colsep0 rowsep0" align="left">ErbB2</td><td class="colsep0 rowsep0" align="char" char=".">9.50</td><td class="colsep0 rowsep0" align="char" char=".">8.80</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR2</td><td class="colsep0 rowsep0" align="char" char=".">95.50</td><td class="colsep0 rowsep0" align="char" char=".">83.60</td><td class="colsep0 rowsep0" align="left">23.20</td><td class="colsep0 rowsep0" align="left">ErbB4</td><td class="colsep0 rowsep0" align="char" char=".">1.60</td><td class="colsep0 rowsep0" align="char" char=".">6.60</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR3</td><td class="colsep0 rowsep0" align="char" char=".">100.00</td><td class="colsep0 rowsep0" align="char" char=".">69.40</td><td class="colsep0 rowsep0" align="left">27.30</td><td class="colsep0 rowsep0" align="left">IGF1R</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-α</td><td class="colsep0 rowsep0" align="char" char=".">92.60</td><td class="colsep0 rowsep0" align="char" char=".">83.90</td><td class="colsep0 rowsep0" align="left">54.60</td><td class="colsep0 rowsep0" align="left">IR</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">2.10</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-β</td><td class="colsep0 rowsep0" align="char" char=".">87.90</td><td class="colsep0 rowsep0" align="char" char=".">70.50</td><td class="colsep0 rowsep0" align="left">14.70</td><td class="colsep0 rowsep0" align="left">FGFR1</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RET</td><td class="colsep0 rowsep0" align="char" char=".">96.60</td><td class="colsep0 rowsep0" align="char" char=".">77.60</td><td class="colsep0 rowsep0" align="left">42.70</td><td class="colsep0 rowsep0" align="left">FGFR2</td><td class="colsep0 rowsep0" align="char" char=".">20.70</td><td class="colsep0 rowsep0" align="char" char=".">16.20</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">c-Kit</td><td class="colsep0 rowsep0" align="char" char=".">98.20</td><td class="colsep0 rowsep0" align="char" char=".">100.00</td><td class="colsep0 rowsep0" align="left">70.40</td><td class="colsep0 rowsep0" align="left">FGFR3</td><td class="colsep0 rowsep0" align="char" char=".">2.30</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Flt-3</td><td class="colsep0 rowsep0" align="char" char=".">5.90</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">FGFR4</td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">BTK</td><td class="colsep0 rowsep0" align="char" char=".">8.00</td><td class="colsep0 rowsep0" align="char" char=".">0.00</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Src</td><td class="colsep0 rowsep0" align="char" char=".">72.80</td><td class="colsep0 rowsep0" align="char" char=".">61.70</td><td class="colsep0 rowsep0" align="left">1.50</td><td class="colsep0 rowsep0" align="left">FAK</td><td class="colsep0 rowsep0" align="char" char=".">10.80</td><td class="colsep0 rowsep0" align="char" char=".">14.70</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Abl</td><td class="colsep0 rowsep0" align="char" char=".">98.30</td><td class="colsep0 rowsep0" align="char" char=".">82.10</td><td class="colsep0 rowsep0" align="left">0.00</td><td class="colsep0 rowsep0" align="left">ITK</td><td class="colsep0 rowsep0" align="char" char=".">7.40</td><td class="colsep0 rowsep0" align="char" char=".">4.20</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EphA2</td><td class="colsep0 rowsep0" align="char" char=".">92.30</td><td class="colsep0 rowsep0" align="char" char=".">31.40</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">ACK1</td><td class="colsep0 rowsep0" align="char" char=".">30.90</td><td class="colsep0 rowsep0" align="char" char=".">10.30</td><td class="colsep0 rowsep0" align="left">N.T.<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">N.T. = not test.</p></div></div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Cellular Evaluation of Compound <b>29</b></h3><div class="NLM_p">In light of its strong potency and reasonable target selectivity, <b>29</b> was selected as a representative molecule for further cellular evaluation. We first investigated the CSF-1R-mediated signaling pathway suppression by compound <b>29</b> in RAW264.7 cells, which harbors high kinase levels (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). We found dose-dependent inhibition of CSF-1R and the downstream mediator, Akt, in the presence of compound <b>29</b> with significant inhibition starting at 10 nM.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cellular effects of compound <b>29</b> in the RAW264.7 cell line. (A) Compound <b>29</b> inhibited phosphorylation of CSF-1R and its downstream signaling pathway in RAW264.7 cells as determined by Western blot analysis. (B) Compound <b>29</b> exhibited potent activity on LPS-induced TNF-α and IL-6 release in RAW264.7 cells. Blk: Blank. Data are given as the mean ± standard error of the mean (SEM). Statistical analysis is performed by one-way analysis of variance (ANOVA). *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to LPS. #<i>P</i> < 0.05, ##<i>P</i> < 0.01, and ###<i>P</i> < 0.001 compared to Blk. (C) Cytotoxicity of compound <b>29</b> (CC<sub>50</sub> = 66.01 μM) and PLX3397 (CC<sub>50</sub> = 20.52 μM) over RAW264.7 macrophages was determined by Cell Counting Kit-8 (CCK-8).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">CSF-1/CSF-1R signaling-mediated elevated expression of TNF-α, IL-6, and other proinflammatory cytokines contributes greatly to the pathogenesis in inflammatory diseases. Signaling interruptions with CSF-1R inhibitors have shown therapeutic effects in several inflammatory disorders by reducing the expression of TNF-α, IL-6, and other proinflammatory cytokines. Therefore, the potential anti-inflammation effects of compound <b>29</b> were investigated by measuring its capacity to suppress the release of TNF-α and IL-6 in macrophages (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Compound <b>29</b> suppressed TNF-α (IC<sub>50</sub> = 110 nM) and IL-6 (IC<sub>50</sub> = 130 nM) production in RAW264.7 macrophages with low toxicity (CC<sub>50</sub> = 66.01 μM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C), which is a stark improvement to that of PLX3397 (CC<sub>50</sub> = 20.52 μM; TNF-α IC<sub>50</sub> = 400 nM; IL-6 IC<sub>50</sub> = 430 nM), indicating excellent anti-inflammatory effects in vitro.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo PK Evaluation of Compound <b>29</b></h3><div class="NLM_p">The preliminary in vivo PK properties of <b>29</b> were investigated in Sprague-Dawley (SD) rats, following intravenous (i.v.) and oral (p.o.) administration (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The results demonstrated that <b>29</b> exhibited favorable drug characteristics with acceptable bioavailability (<i>F</i> = 34.8%), moderate half-life (<i>t</i><sub>1/2</sub> = 2.21 h), and drug exposure (AUC<sub>0–<i>t</i></sub> = 634.02 h·ng/mL) using 5 mg/kg oral administration. These PK properties indicate that <b>29</b> is suitable for oral administration. In addition, the blockade effect of <b>29</b> on the hERG channel was evaluated using the Qpatch Automatic Patch-Clamp assays; compound <b>29</b> exhibited low hERG-potassium-ion-channel inhibition with an IC<sub>50</sub> value of >40 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_001.pdf" class="ext-link">Figure S1</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. PK Profile of Compound <b>29</b> in Rats<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–<i>t</i></sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center">CL<sub>_obs</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">MRT<sub>INF_obs</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss_obs</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p.o.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5 mg/Kg</td><td class="colsep0 rowsep0" align="left">2.21</td><td class="colsep0 rowsep0" align="left">4.00</td><td class="colsep0 rowsep0" align="left">165.60</td><td class="colsep0 rowsep0" align="left">634.02</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5.42</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">34.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">i.v.</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2 mg/Kg</td><td class="colsep0 rowsep0" align="left">3.33</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">728.93</td><td class="colsep0 rowsep0" align="left">45.98</td><td class="colsep0 rowsep0" align="left">2.30</td><td class="colsep0 rowsep0" align="left">6.34</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Determined using LC/MS/MS. AUC<sub>0–<i>t</i></sub>: the area under the concentration time curve; MRT: mean residence time; <i>t</i><sub>1/2</sub>: elimination half-life; <i>T</i><sub>max</sub>: the peak time; <i>C</i><sub>max</sub>: the peak concentration; CL: clearance; <i>V</i><sub>ss</sub>: steady-state distribution volume; <i>F</i>: absolute bioavailability.</p></div></div></div><div class="NLM_p">We finally evaluated the in vivo anti-inflammation efficacy of <b>29</b> in LPS-induced mouse models of inflammation (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). LPS injection in mice resulted in elevation of inflammatory cytokines, including TNF-α and IL-6, which peak at 1.5 and 3 h postinjection, respectively.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The compound <b>29</b> was orally administered 4 h prior to LPS injection. Treatment with compound <b>29</b> prominently reduced serum TNF-α and IL-6 concentration as compared with vehicle controls. Therefore, the results indicate that CSF-1R inhibition by compound <b>29</b> can effectively attenuate inflammation and has the potential to treat inflammatory diseases.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Inflammation cytokine concentrations in serum of the LPS-induced mice model. The mice were orally administrated with PLX3397 (40 mg/kg), compound <b>29</b> (20 and 40 mg/kg) at 4 h before intraperitoneal injection with LPS (<i>n</i> = 6, female). The concentration of cytokines in serum was detected at 1.5 h for TNF-α and 3 h for IL-6 by ELISA assay. Data are given as mean ± SEM. Statistical analysis is performed by one-way analysis of variance (ANOVA). *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to vehicle. #<i>P</i> < 0.05, ##<i>P</i> < 0.01, and ###<i>P</i> < 0.001 compared to normal.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53175" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53175" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we started SAR exploration of a novel type II kinase inhibitor <b>8</b>, which identified novel <i>o</i>-aminopyridyl alkynyl scaffold-based CSF-1R selective inhibitors targeting the autoinhibited-state CSF-1R kinase without FGFR inhibition. Based on the inhibitor-binding element hybrid design strategy, we initiated the detailed SAR investigation by varying the “head”, “gate”, “linker”, and “tail” moieties, leading to the discovery of a series of potent CSF-1R inhibitors. The instillation of a −NH<sub>2</sub> group in the ortho-position of a pyridine (head) of this scaffold forms an extra hydrogen bond with a Glu664 backbone carbonyl in the hinge domain of CSF-1R and can increase potency against CSF-1R significantly. One of the most promising compounds <b>29</b> had the highest kinase inhibitor potency against CSF-1R (IC<sub>50</sub> = 0.7 ± 0.1 nM). Further kinome-screen data revealed that <b>29</b> displayed a good relative selectivity profile, which is the loss of FLT-3 potency. The effects of <b>29</b> on LPS-stimulated RAW-264.7 macrophage cells were evaluated in vitro, which exhibited low cellular toxicity and potent inhibition of the CSF-1R-mediated signaling pathways, resulting a significant suppression of the release of the inflammatory cytokines. In addition, compound <b>29</b> displayed acceptable PK properties in rats without the inhibition of hERG. Furthermore, compound <b>29</b> potent in vivo anti-inflammatory effects make it a promising candidate as potential treatment for inflammatory disorders. Further preclinical evaluation of compound <b>29</b> is currently being conducting.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Methods for Chemistry</h3><div class="NLM_p">Unless otherwise noted, all reagents and solvents employed were purchased commercially and used as received. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen (N<sub>2</sub>) atmosphere. All reactions were conducted in microwave vials or flasks containing a Teflon-coated magnetic stirrer. Microwave irradiation experiments were performed in a CEM-Discover Lab-Mate mono-mode microwave apparatus equipped with an Intelli-VentTM pressure control system and a vertically focused IR temperature sensor. Reactions were monitored by thin-layer chromatography (TLC) on precoated TLC glass plates (silica gel GF254, 0.2 ± 0.03 mm thickness). TLC glass plates were developed in a covered chamber and were visualized with ultraviolet light using a 254 nm fluorescent indicator. Flash column chromatography was carried out on silica gel (200–300 mesh). All NMR spectra were recorded on a Bruker 400 (<sup>1</sup>H: 400 MHz, <sup>13</sup>C NMR: 101 MHz, <sup>19</sup>F: 376 MHz), Bruker 500 (<sup>1</sup>H: 500 MHz, <sup>13</sup>C NMR: 126 MHz, <sup>19</sup>F: 471 MHz), or Bruker 600 (<sup>1</sup>H: 500 MHz, <sup>13</sup>C NMR: 151 MHz) spectrometer and referenced to the deuterium solvent (chloroform-<i>d</i>, MeOH-<i>d</i><sub>4</sub> or DMSO-<i>d</i><sub>6</sub>). Chemical shifts (δ) were expressed in parts per million (ppm) relative to an internal standard (TMS), and coupling constants were given in Hz. Data for NMR spectra were reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, br s = broad singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, m = multiplet), coupling constant (Hz), and integration. Low-resolution mass spectral data were measured on an Agilent 1200 series LC–MS spectrometer, and high-resolution mass spectral (HRMS) data were measured on Micromass Ultra Q-Tof. The purity of all final compounds (>95%) was determined on an Agilent 1200 series LC system (Agilent ChemStation Rev.B.03.01; column, ZORBAX Eclipse XD B-C18, 4.6 mm × 150 mm, 5 μm; flow rate, 1.0 mL/min; UV wavelength, maximal absorbance at 254 nm; temperature, ambient; and injection volume, 5 μL; mobile phase, solvent A: H<sub>2</sub>O (with 0.1% HCOOH) and solvent B: MeOH). The gradient elution for compounds <b>7–11</b>, <b>13–16</b>, <b>18–25</b>, <b>27–32</b>, and <b>35–37</b>: 0–5 min, B: 50–50%; 5–10 min, B: 50–75%; 10–18 min, B: 75–75%; 18–19 min, B: 75–95%; 19–22 min, B: 95–95%; 22–23 min, B: 95–50%; 23–25 min, B: 50–50%; for compounds <b>12</b>, <b>17</b>, <b>26</b> and <b>33–34</b>: 0–20 min, MeOH/H<sub>2</sub>O (0.1% HCOOH) (75/25, v/v) (see Table S1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(3,5-Dimethoxyphenyl)-3-(isoquinolin-4-ylethynyl)-4-methylbenzamide (<b>8</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>8–15, 42a–d</i></b><i>and</i><b><i>42f</i></b>. To a solution of <b>41a</b> (100 mg, 0.25 mmol) in dry MeCN (20 mL) were added <b>39a</b> (76 mg, 0.34 mmol), CsF (95 mg, 0.63 mmol), and Et<sub>3</sub>N (105 μL, 0.76 mmol) at rt under a N<sub>2</sub> atmosphere. The mixture was stirred at rt for 6 h. The resulting solution was poured into water and extracted with EtOAc. The organic layer was washed with brine and dried with Na<sub>2</sub>SO<sub>4</sub> to give the crude product, which was purified by flash column chromatography (SiO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 25:1) to give <b>8</b> as a white solid (91 mg, yield 85%); mp 177–178 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.26 (s, 1H), 9.39 (s, 1H), 8.84 (s, 1H), 8.36 (d, <i>J</i> = 8.5 Hz, 1H), 8.28 (s, 1H), 8.25 (s, 1H), 8.00 (t, <i>J</i> = 7.6 Hz, 1H), 7.94 (d, <i>J</i> = 8.0 Hz, 1H), 7.83 (t, <i>J</i> = 7.5 Hz, 1H), 7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.11 (d, <i>J</i> = 2.0 Hz, 2H), 6.28 (s, 1H), 3.75 (s, 6H), 2.67 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.46, 160.37, 152.66, 146.27, 143.51, 140.73, 134.41, 132.78, 132.10, 130.90, 129.97, 128.53, 128.50, 128.44, 127.43, 124.23, 121.84, 114.70, 98.58, 95.82, 94.63, 88.85, 55.11, 20.61. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>27</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 423.1703; found, 423.1723. HPLC analysis: 22.78 min, 98.92% purity.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>N</i>-(3,5-Dimethoxyphenyl)-3-(imidazo[1,2-<i>b</i>]pyridazin-3-ylethynyl)-4-methylbenzamide (<b>9</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 76%); mp 95–96 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.26 (s, 1H), 8.73 (dd, <i>J</i> = 4.4, 1.4 Hz, 1H), 8.27 (dd, <i>J</i> = 9.2, 1.5 Hz, 1H), 8.24 (s, 1H), 8.18 (d, <i>J</i> = 1.8 Hz, 1H), 7.92 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.53 (d, <i>J</i> = 8.1 Hz, 1H), 7.40 (dd, <i>J</i> = 9.2, 4.4 Hz, 1H), 7.11 (d, <i>J</i> = 2.2 Hz, 2H), 6.27 (t, <i>J</i> = 2.2 Hz, 1H), 3.74 (s, 6H), 2.60 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.39, 160.38, 145.10, 143.25, 140.79, 139.67, 138.26, 132.67, 130.12, 130.03, 128.49, 126.14, 121.70, 119.11, 111.74, 98.54, 96.50, 95.83, 81.08, 55.14, 20.40. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>24</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 413.1608; found, 413.1604. HPLC analysis: 16.76 min, 98.41% purity.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-(3,5-Dimethoxyphenyl)-4-methyl-3-(pyridin-3-ylethynyl)benzamide (<b>10</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 81%); mp 111–113 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.22 (s, 1H), 8.82 (s, 1H), 8.62 (s, 1H), 8.16 (s, 1H), 8.04 (d, <i>J</i> = 7.5 Hz, 1H), 7.91 (d, <i>J</i> = 7.5 Hz, 1H), 7.51 (t, <i>J</i> = 8.1 Hz, 2H), 7.10 (s, 2H), 6.27 (s, 1H), 3.74 (s, 6H), 2.56 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.41, 160.38, 151.61, 149.25, 143.67, 140.76, 138.60, 132.66, 130.67, 129.97, 128.55, 123.75, 121.62, 119.32, 98.51, 95.81, 90.64, 90.46, 55.13, 20.38. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>23</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 373.1547; found, 375.1543. HPLC analysis: 16.86 min, 99.18% purity.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-((2-Aminopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-methylbenzamide (<b>11</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 85%); mp 179–180 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.19 (s, 1H), 8.23 (d, <i>J</i> = 1.8 Hz, 1H), 8.01 (s, 1H), 7.85 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.65 (dd, <i>J</i> = 7.5, 1.4 Hz, 1H), 7.47 (d, <i>J</i> = 8.1 Hz, 1H), 7.10 (t, <i>J</i> = 2.2 Hz, 2H), 6.61 (dd, <i>J</i> = 7.4, 4.9 Hz, 1H), 6.32 (s, 2H), 6.27 (t, <i>J</i> = 2.2 Hz, 1H), 3.74 (s, 6H), 2.54 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.65, 160.38, 159.43, 148.51, 143.10, 140.70, 139.97, 132.59, 130.87, 129.66, 127.78, 122.52, 112.36, 98.49, 98.40, 95.73, 92.70, 90.03, 55.12, 20.51. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>23</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 388.1656; found, 388.1653. HPLC analysis: 11.94 min, 98.18% purity.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-((2-Amino-5-chloropyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-methylbenzamide (<b>12</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 82%); mp 195–197 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.20 (s, 1H), 8.25 (s, 1H), 8.03 (s, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.76 (s, 1H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 7.09 (d, <i>J</i> = 2.0 Hz, 2H), 6.61 (s, 2H), 6.26 (s, 1H), 3.73 (s, 6H), 2.53 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.67, 160.34, 158.08, 147.66, 146.55, 143.32, 140.73, 139.58, 138.77, 132.63, 131.11, 129.60, 127.98, 122.07, 98.49, 95.71, 93.64, 88.47, 55.08, 20.42. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>23</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 422.1266; found, 422.1265. HPLC analysis: 15.27 min, 100.00% purity.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 6-Amino-5-((5-((3,5-dimethoxyphenyl)carbamoyl)-2-methylphenyl)ethynyl)nicotinamide (<b>13</b>)</h4><div class="NLM_p last">It is obtained as a light yellow solid (yield 72%); mp 253–254 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.23 (s, 1H), 8.53 (d, <i>J</i> = 2.3 Hz, 1H), 8.29 (d, <i>J</i> = 1.8 Hz, 1H), 8.12 (d, <i>J</i> = 2.3 Hz, 1H), 7.88–7.82 (m, 2H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.21 (s, 1H), 7.10 (d, <i>J</i> = 2.2 Hz, 2H), 6.93 (s, 2H), 6.27 (t, <i>J</i> = 2.2 Hz, 1H), 3.74 (s, 6H), 2.56 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 166.06, 164.79, 160.75, 160.38, 149.24, 143.20, 140.83, 139.26, 132.67, 131.14, 129.64, 127.88, 122.36, 118.09, 99.97, 98.50, 95.73, 92.73, 89.30, 55.13, 20.50. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>24</sub>H<sub>22</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>: calcd, 431.1714; found, 431.1718. HPLC analysis: 13.21 min, 96.15% purity.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Amino-5-((5-((3,5-dimethoxyphenyl)carbamoyl)-2-methylphenyl)ethynyl)-<i>N</i>-methylnicotinamide (<b>14</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 80%); mp 262–265 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.20 (s, 1H), 8.49 (d, <i>J</i> = 2.3 Hz, 1H), 8.30–8.26 (m, 2H), 8.08 (d, <i>J</i> = 2.2 Hz, 1H), 7.86 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.09 (d, <i>J</i> = 2.1 Hz, 2H), 6.91 (s, 2H), 6.27 (t, <i>J</i> = 2.0 Hz, 1H), 3.74 (s, 6H), 2.75 (d, <i>J</i> = 4.4 Hz, 3H), 2.56 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.75, 164.70, 160.61, 160.37, 148.62, 143.16, 140.78, 138.69, 132.67, 131.10, 129.62, 127.84, 122.32, 118.41, 100.01, 98.49, 95.73, 92.75, 89.25, 55.11, 26.00, 20.48. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup>: calcd, 445.1871; found, 445.1866. HPLC analysis: 14.05 min, 97.75% purity.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 6-Amino-5-((5-((3,5-dimethoxyphenyl)carbamoyl)-2-methylphenyl)ethynyl)nicotinate (<b>15</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 78%); mp 231–232 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.19 (s, 1H), 8.56 (s, 1H), 8.29 (s, 1H), 8.05 (d, <i>J</i> = 2.0 Hz, 1H), 7.86 (dd, <i>J</i> = 1.6, 8.1 Hz, 1H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.29 (s, 2H), 7.10 (s, 1H), 7.09 (s, 1H), 6.27 (s, 1H), 3.80 (s, 3H), 3.74 (s, 6H), 2.55 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.94, 164.75, 161.67, 160.37, 150.82, 143.31, 140.78, 140.35, 132.65, 131.25, 129.60, 127.96, 122.18, 113.73, 100.63, 98.49, 95.72, 93.06, 88.52, 55.11, 51.67, 20.47. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> [M + H]<sup>+</sup>: calcd, 446.1711; found, 446.1713. HPLC analysis: 18.44 min, 99.46% purity.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-methylbenzamide (<b>16</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>16–22</i></b>. To a solution of <b>42a</b> (80 mg, 0.17 mmol) in toluene/EtOH/H<sub>2</sub>O (2 mL, 2:1:1, v/v/v) were added 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (71 mg, 0.34 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (19 mg, 0.017 mmol), and K<sub>2</sub>CO<sub>3</sub> (59 mg, 0.43 mmol) at rt. After stirring for 5 min under a N<sub>2</sub> atmosphere, the mixture was irradiated at 100 °C for 20 min. The mixture was poured into water and extracted with EtOAc. The organic layer was separated, washed with brine, dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was further purified by flash column chromatography (SiO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 20:1:0.02) to afford compound <b>16</b> as a light yellow solid (80 mg, yield 85%); mp 230–231 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.20 (s, 1H), 8.27 (d, <i>J</i> = 2.3 Hz, 1H), 8.24 (d, <i>J</i> = 1.9 Hz, 1H), 8.08 (s, 1H), 7.89–7.83 (m, 2H), 7.83 (s, 1H), 7.48 (d, <i>J</i> = 8.1 Hz, 1H), 7.10 (d, <i>J</i> = 2.2 Hz, 2H), 6.29 (s, 2H), 6.27 (t, <i>J</i> = 2.2 Hz, 1H), 3.84 (s, 3H), 3.74 (s, 6H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.72, 160.36, 157.83, 145.25, 143.10, 140.78, 136.30, 135.34, 132.64, 130.93, 129.64, 127.77, 126.82, 122.47, 118.70, 117.61, 101.10, 98.50, 95.73, 92.84, 89.92, 55.11, 38.62, 20.55. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>27</sub>H<sub>25</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 468.2030; found, 468.2028. HPLC analysis: 14.11 min, 99.65% purity.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl) benzamide (<b>17</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 77%); mp 221–222 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.30 (s, 1H), 8.26 (d, <i>J</i> = 2.2 Hz, 1H), 8.23 (s, 1H), 8.07 (s, 1H), 7.93 (d, <i>J</i> = 7.9 Hz, 1H), 7.89–7.83 (m, 2H), 7.81 (s, 1H), 7.58 (t, <i>J</i> = 7.8 Hz, 1H), 7.10 (t, <i>J</i> = 2.1 Hz, 2H), 6.44 (s, 2H), 6.28 (t, <i>J</i> = 2.1 Hz, 1H), 3.83 (s, 3H), 3.72 (d, <i>J</i> = 10.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.92, 160.40, 157.94, 145.12, 140.75, 136.48, 135.36, 134.22, 130.53, 128.82, 127.80, 126.80, 122.74, 118.72, 117.47, 100.86, 98.52, 98.43, 95.81, 94.05, 86.26, 55.15, 38.67. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 454.1874; found, 454.1869. HPLC analysis: 2.93 min, 99.16% purity.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-isopropylbenzamide (<b>18</b>)</h4><div class="NLM_p last">It is obtained as a bright yellow solid (yield 80%); mp 216–217 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.22 (s, 1H), 8.28 (s, 1H), 8.25 (s, 1H), 8.09 (s, 1H), 7.91 (d, <i>J</i> = 7.9 Hz, 1H), 7.83 (s, 2H), 7.54 (d, <i>J</i> = 8.1 Hz, 1H), 7.11 (s, 2H), 6.28 (d, <i>J</i> = 6.4 Hz, 3H), 3.85 (s, 3H), 3.74 (s, 6H), 3.62–3.52 (m, 1H), 1.31 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.87, 160.41, 157.87, 153.00, 145.29, 140.85, 136.26, 135.41, 132.79, 131.54, 128.28, 126.90, 125.30, 121.40, 118.71, 117.66, 101.19, 98.47, 95.73, 92.59, 89.56, 55.14, 38.64, 31.33, 22.81. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>29</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 496.2343; found, 496.2343. HPLC analysis: 16.51 min, 99.31% purity.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-methoxybenzamide (<b>19</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 75%); mp 229–230 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.13 (s, 1H), 8.27 (d, <i>J</i> = 2.4 Hz, 1H), 8.22 (d, <i>J</i> = 2.3 Hz, 1H), 8.08 (s, 1H), 8.01 (dd, <i>J</i> = 8.8, 2.3 Hz, 1H), 7.83 (d, <i>J</i> = 0.6 Hz, 1H), 7.79 (d, <i>J</i> = 2.4 Hz, 1H), 7.26 (d, <i>J</i> = 8.9 Hz, 1H), 7.10 (s, 1H), 7.09 (s, 1H), 6.30 (s, 2H), 6.26 (t, <i>J</i> = 2.3 Hz, 1H), 3.98 (s, 3H), 3.84 (s, 3H), 3.74 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.26, 161.82, 160.37, 157.97, 154.39, 145.16, 140.92, 135.40, 135.28, 131.87, 130.29, 127.06, 126.85, 118.75, 117.60, 111.12, 101.24, 98.44, 95.64, 91.14, 90.04, 56.34, 55.13, 38.67. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>27</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub> [M + H]<sup>+</sup>: calcd, 484.1908; found, 484.0693. HPLC analysis: 22.50 min, 100.00% purity.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-fluorobenzamide (<b>20</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 88%); mp 236–238 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.28 (s, 1H), 8.39 (d, <i>J</i> = 6.9 Hz, 1H), 8.29 (s, 1H), 8.09 (s, 1H), 8.03–7.97 (m, 1H), 7.83 (d, <i>J</i> = 2.8 Hz, 2H), 7.51 (t, <i>J</i> = 9.4 Hz, 1H), 7.07 (s, 2H), 6.40 (s, 2H), 6.28 (s, 1H), 3.84 (s, 3H), 3.74 (s, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.88, 162.23 (d, <i>J</i> = 254.5 Hz), 160.38, 157.99, 145.72, 140.61, 136.25, 135.35, 133.22, 131.59 (d, <i>J</i> = 2.9 Hz), 130.42 (d, <i>J</i> = 9.1 Hz), 126.85, 118.59, 117.57, 115.77 (d, <i>J</i> = 21.6 Hz), 110.98 (d, <i>J</i> = 16.2 Hz), 100.27, 98.55, 95.86, 91.15 (d, <i>J</i> = 2.3 Hz), 87.27, 55.12, 38.61. <sup>19</sup>F NMR (376 MHz, DMSO-<i>d</i><sub>6</sub>): δ −106.42 to −106.54 (m). HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>22</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 472.1780; found, 472.1776. HPLC analysis: 14.02 min, 98.35% purity.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-chloro-<i>N</i>-(3,5-dimethoxyphenyl)benzamide (<b>21</b>)</h4><div class="NLM_p last">It is obtained as a light yellow solid (yield 75%); mp 229–230 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.34 (s, 1H), 8.39 (d, <i>J</i> = 2.0 Hz, 1H), 8.31 (d, <i>J</i> = 2.1 Hz, 1H), 8.10 (s, 1H), 7.94 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.85 (d, <i>J</i> = 2.2 Hz, 1H), 7.83 (s, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 1H), 7.08 (s, 2H), 6.39 (s, 2H), 6.29 (s, 1H), 3.84 (s, 3H), 3.74 (s, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.41, 158.92, 158.05, 145.98, 140.46, 137.21, 136.26, 135.38, 133.94, 132.52, 129.42, 129.19, 126.91, 122.26, 118.59, 117.66, 98.55, 98.46, 95.92, 91.36, 90.90, 55.16, 38.66. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>22</sub>ClN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 488.1484; found, 488.1484. HPLC analysis: 15.57 min, 97.94% purity.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-(trifluoromethyl)benzamide (<b>22</b>)</h4><div class="NLM_p last">It is obtained as a bright yellow solid (yield 83%); mp 223–224 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.49 (s, 1H), 8.50 (s, 1H), 8.32 (s, 1H), 8.10 (s, 1H), 8.07 (d, <i>J</i> = 8.0 Hz, 1H), 7.99 (d, <i>J</i> = 8.1 Hz, 1H), 7.82 (s, 1H), 7.76 (s, 1H), 7.09 (s, 2H), 6.40 (s, 2H), 6.31 (s, 1H), 3.85 (s, 3H), 3.75 (s, 6H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 163.83, 160.43, 158.03, 146.29, 140.37, 138.79, 136.34, 135.32, 133.15, 131.22 (q, <i>J</i> = 29.8 Hz), 127.86, 126.92, 126.43 (q, <i>J</i> = 4.5 Hz), 123.40 (q, <i>J</i> = 273.4 Hz), 120.63, 118.47, 117.71, 99.97, 98.62, 96.11, 91.74, 89.99, 55.15, 38.59. <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>): δ −60.95 (s). HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>27</sub>H<sub>22</sub>F<sub>3</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup>: calcd, 522.1748; found, 522.1745. HPLC analysis: 16.56 min, 98.15% purity.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-methyl-<i>N</i>-phenylbenzamide (<b>23</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>23–33, 38f–g, 41a–g</i></b>, <i>and</i><b><i>48a–c</i></b>. To a solution of <b>45</b> (100 mg, 0.30 mmol) in DMF (3 mL) were added HATU (148 mg, 0.39 mmol) and DIPEA (149 μL, 0.90 mmol) at rt, and after stirring for 30 min, aniline (30 μL, 0.33 mmol) was added, and the mixture was stirred at rt for 4 h. The resulting solution was poured into water and extracted with EtOAc. The organic layer was washed with water and brine and dried with Na<sub>2</sub>SO<sub>4</sub>. The resultant crude material was purified by flash column chromatography (SiO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH, 20:1:0.02) to give <b>23</b> as a yellow solid (116 mg, yield 95%); mp 95–96 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.29 (s, 1H), 8.32–8.24 (m, 2H), 8.08 (s, 1H), 7.90–7.85 (m, 2H), 7.83 (s, 1H), 7.79 (d, <i>J</i> = 7.7 Hz, 2H), 7.49 (d, <i>J</i> = 8.0 Hz, 1H), 7.36 (t, <i>J</i> = 7.9 Hz, 2H), 7.11 (t, <i>J</i> = 7.4 Hz, 1H), 6.31 (s, 2H), 3.84 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.70, 157.85, 145.26, 143.04, 139.12, 136.32, 135.36, 132.71, 131.00, 129.64, 128.62, 127.80, 126.83, 123.69, 122.49, 120.35, 118.72, 117.62, 101.13, 92.88, 89.91, 38.62, 20.55. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>21</sub>N<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 408.1819; found, 408.1820. HPLC analysis: 13.18 min, 98.93% purity.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(2-methoxyphenyl)-4-methylbenzamide (<b>24</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 90%); mp 107–108 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.48 (s, 1H), 8.30–8.23 (m, 2H), 8.08 (s, 1H), 7.87 (t, <i>J</i> = 6.5 Hz, 2H), 7.83 (s, 1H), 7.75 (d, <i>J</i> = 7.3 Hz, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.19 (t, <i>J</i> = 7.3 Hz, 1H), 7.10 (d, <i>J</i> = 7.8 Hz, 1H), 6.98 (t, <i>J</i> = 7.6 Hz, 1H), 6.31 (s, 2H), 3.84 (br s, 6H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.23, 157.84, 151.62, 145.25, 143.06, 136.33, 135.35, 132.28, 130.91, 129.71, 127.56, 126.83, 126.71, 125.84, 124.56, 122.58, 120.19, 118.71, 117.61, 111.44, 101.13, 92.84, 89.90, 55.71, 38.61, 20.53. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>: calcd, 438.1925; found, 438.1923. HPLC analysis: 14.03 min, 98.47% purity.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3-methoxyphenyl)-4-methylbenzamide (<b>25</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 86%); mp 232–233 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.26 (s, 1H), 8.28 (s, 1H), 8.27 (s, 1H), 8.08 (s, 1H), 7.86 (t, <i>J</i> = 10.0 Hz, 3H), 7.48 (d, <i>J</i> = 8.5 Hz, 2H), 7.41 (d, <i>J</i> = 8.1 Hz, 1H), 7.26 (t, <i>J</i> = 8.1 Hz, 1H), 6.69 (d, <i>J</i> = 6.9 Hz, 1H), 6.32 (s, 2H), 3.85 (s, 3H), 3.76 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.74, 159.45, 157.87, 145.28, 143.10, 140.33, 136.34, 135.38, 132.71, 131.00, 129.66, 129.41, 127.82, 126.84, 122.51, 118.75, 117.66, 112.57, 109.18, 106.07, 101.17, 92.91, 89.94, 55.01, 38.62, 20.56. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>: calcd, 438.1925; found, 438.1925. HPLC analysis: 13.60 min, 98.64% purity.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(4-methoxyphenyl)-4-methylbenzamide (<b>26</b>)</h4><div class="NLM_p last">It is obtained as a light yellow solid (yield 91%); mp 180–182 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.17 (s, 1H), 8.27 (d, <i>J</i> = 1.9 Hz, 1H), 8.24 (s, 1H), 8.09 (s, 1H), 7.86 (d, <i>J</i> = 8.1 Hz, 2H), 7.83 (s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 2H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 6.93 (d, <i>J</i> = 8.9 Hz, 2H), 6.31 (s, 2H), 3.84 (s, 3H), 3.75 (s, 3H), 2.56 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.21, 157.81, 155.54, 145.22, 142.82, 136.28, 135.33, 132.76, 132.14, 130.87, 129.59, 127.67, 126.81, 122.42, 121.92, 118.69, 117.61, 113.73, 101.13, 92.90, 89.81, 55.16, 38.60, 20.50. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>23</sub>N<sub>5</sub>O<sub>2</sub> [M + H]<sup>+</sup>: calcd, 438.1925; found, 438.1925. HPLC analysis: 3.16 min, 99.72% purity.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(2-chlorophenyl)-4-methylbenzamide (<b>27</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 75%); mp 175–176 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.12 (s, 1H), 8.28–8.26 (m, 2H), 8.09 (s, 1H), 7.91 (dd, <i>J</i> = 1.2, 7.7 Hz, 2H), 7.86 (d, <i>J</i> = 2.0 Hz, 1H), 7.83 (s, 1H), 7.59–7.55 (m, 2H), 7.50 (d, <i>J</i> = 8.1 Hz, 1H), 7.40 (t, <i>J</i> = 7.6 Hz, 1H), 7.31 (t, <i>J</i> = 7.6 Hz, 1H), 6.31 (s, 2H), 3.84 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.58, 157.81, 145.25, 143.34, 136.31, 135.33, 135.01, 131.71, 131.06, 129.72, 129.56, 128.50, 127.72, 127.51, 127.47, 126.81, 122.61, 118.68, 117.62, 101.08, 92.75, 89.92, 38.59, 20.54. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>20</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 442.1429; found, 442.1426. HPLC analysis: 14.08 min, 98.06% purity.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3-chlorophenyl)-4-methylbenzamide (<b>28</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 85%); mp 204–206 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.45 (s, 1H), 8.27 (d, <i>J</i> = 2.3 Hz, 1H), 8.26 (d, <i>J</i> = 1.7 Hz, 1H), 8.08 (s, 1H), 7.98 (t, <i>J</i> = 1.9 Hz, 1H), 7.89–7.85 (m, 2H), 7.83 (s, 1H), 7.73 (dd, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.50 (d, <i>J</i> = 8.0 Hz, 1H), 7.39 (t, <i>J</i> = 8.1 Hz, 1H), 7.17 (dd, <i>J</i> = 7.9, 1.8 Hz, 1H), 6.31 (s, 2H), 3.84 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.97, 157.85, 145.29, 143.37, 140.61, 136.32, 135.35, 132.94, 132.30, 131.02, 130.35, 129.72, 127.84, 126.83, 123.37, 122.57, 119.68, 118.70, 118.60, 117.62, 101.07, 92.77, 90.01, 38.62, 20.57. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>20</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 442.1429; found, 442.1429. HPLC analysis: 15.62 min, 96.20% purity.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(4-chlorophenyl)-4-methylbenzamide (<b>29</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 90%); mp 225–226 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.40 (s, 1H), 8.27 (d, <i>J</i> = 2.4 Hz, 1H), 8.25 (d, <i>J</i> = 1.8 Hz, 1H), 8.08 (s, 1H), 7.87 (dd, <i>J</i> = 8.1, 1.8 Hz, 1H), 7.85 (d, <i>J</i> = 2.4 Hz, 1H), 7.84–7.80 (m, 3H), 7.49 (d, <i>J</i> = 8.1 Hz, 1H), 7.44–7.39 (m, 2H), 6.29 (s, 2H), 3.84 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.78, 157.82, 145.26, 143.21, 138.08, 136.30, 135.33, 132.42, 130.98, 129.67, 128.52, 127.79, 127.27, 126.80, 122.52, 121.81, 118.69, 117.61, 101.07, 92.78, 89.96, 38.59, 20.53. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>20</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 442.1429; found, 442.1425. HPLC analysis: 15.48 min, 99.00% purity.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-methyl-<i>N</i>-(3-(trifluoromethyl)phenyl)benzamide (<b>30</b>)</h4><div class="NLM_p last">It is obtained as a deep yellow solid (yield 85%); mp 206–208 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.63 (s, 1H), 8.30 (d, <i>J</i> = 1.8 Hz, 1H), 8.27 (d, <i>J</i> = 2.4 Hz, 1H), 8.26 (s, 1H), 8.09 (d, <i>J</i> = 9.3 Hz, 2H), 7.91 (dd, <i>J</i> = 8.0, 1.9 Hz, 1H), 7.86 (d, <i>J</i> = 2.4 Hz, 1H), 7.82 (d, <i>J</i> = 0.6 Hz, 2H), 7.61 (t, <i>J</i> = 8.0 Hz, 1H), 7.51 (d, <i>J</i> = 8.1 Hz, 1H), 7.46 (d, <i>J</i> = 7.8 Hz, 1H), 6.30 (s, 2H), 3.85 (s, 3H), 2.58 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.21, 157.84, 145.28, 143.43, 142.87, 136.32, 135.34, 132.26, 131.12, 129.75, 129.70, 129.61, 127.93, 126.81, 125.90 (q, <i>J</i> = 3.8 Hz), 124.39 (q, <i>J</i> = 271.3 Hz), 123.57 (q, <i>J</i> = 32.0 Hz), 122.56, 120.14, 118.69, 117.61, 101.06, 92.75, 90.02, 38.60, 20.56. <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>): δ −61.28. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 476.1693; found, 476.1693. HPLC analysis: 16.28 min, 96.39% purity.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-methyl-<i>N</i>-(4-(trifluoromethyl)phenyl)benzamide (<b>31</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 90%); mp 239–240 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.66 (s, 1H), 8.29 (d, <i>J</i> = 1.4 Hz, 1H), 8.27 (d, <i>J</i> = 2.2 Hz, 1H), 8.08 (s, 1H), 8.03 (d, <i>J</i> = 8.5 Hz, 2H), 7.90 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.85 (d, <i>J</i> = 2.2 Hz, 1H), 7.82 (s, 1H), 7.73 (d, <i>J</i> = 8.6 Hz, 2H), 7.50 (d, <i>J</i> = 8.0 Hz, 1H), 6.30 (s, 2H), 3.84 (s, 3H), 2.58 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.09, 157.84, 145.29, 143.43, 139.95, 136.31, 135.34, 132.17, 131.05, 129.86, 129.74, 129.33 (q, <i>J</i> = 31.5 Hz), 127.87, 126.82, 124.16 (q, <i>J</i> = 272.2 Hz), 123.76, 122.57, 119.93 (q, <i>J</i> = 3.7 Hz), 118.70, 117.62, 116.36 (q, <i>J</i> = 4.1 Hz), 101.07, 92.76, 90.00, 38.60, 20.56. <sup>19</sup>F NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>): δ −60.31. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>20</sub>F<sub>3</sub>N<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 476.1693; found, 476.1694. HPLC analysis: 16.85 min, 98.52% purity.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(2,4-dichlorophenyl)-4-methylbenzamide (<b>32</b>)</h4><div class="NLM_p last">It is obtained as a light yellow solid (yield 75%); mp 196–198 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.18 (s, 1H), 8.27 (d, <i>J</i> = 1.9 Hz, 2H), 8.08 (s, 1H), 7.90 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.85 (d, <i>J</i> = 2.4 Hz, 1H), 7.75 (d, <i>J</i> = 2.3 Hz, 1H), 7.61 (d, <i>J</i> = 8.6 Hz, 1H), 7.54–7.45 (m, 2H), 6.30 (s, 2H), 3.84 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.66, 157.83, 145.28, 143.53, 136.33, 135.34, 134.25, 131.46, 131.11, 130.82, 130.57, 129.76, 129.60, 129.07, 127.77, 127.65, 126.82, 122.65, 118.69, 117.61, 101.06, 92.71, 89.99, 38.61, 20.58. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 476.1040; found, 476.1035. HPLC analysis: 16.58 min, 97.87% purity.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(3,4-dichlorophenyl)-4-methylbenzamide (<b>33</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 82%); mp 108–111 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.59 (s, 1H), 8.27 (s, 2H), 8.18 (s, 1H), 8.08 (s, 1H), 7.92–7.84 (m, 2H), 7.84–7.74 (m, 2H), 7.63 (d, <i>J</i> = 8.8 Hz, 1H), 7.50 (d, <i>J</i> = 7.5 Hz, 1H), 6.31 (s, 2H), 3.84 (s, 3H), 2.57 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 165.02, 157.84, 145.30, 143.51, 139.29, 136.32, 135.34, 132.04, 131.05, 130.84, 130.57, 129.75, 127.86, 126.82, 125.11, 122.59, 121.42, 120.23, 118.69, 117.62, 101.04, 92.72, 90.04, 38.61, 20.56. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 476.1040; found, 476.1042. HPLC analysis: 9.59 min, 98.70% purity.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(4-chlorophenyl)-3-methylbenzamide (<b>34</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>34–37</i></b>. Step 1: The cross-coupling product was prepared in 69% yield from <b>48a</b> and <b>39i</b> according to the procedure in the preparation of <b>8</b>. Step 2: According to the general procedure in the preparation of <b>16</b>, the title compound (<b>34</b>) was prepared in 89% yield as a yellow solid; mp 224–225 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.44 (s, 1H), 8.28 (s, 1H), 8.09 (s, 1H), 7.91 (s, 1H), 7.88–7.78 (m, 6H), 7.42 (d, <i>J</i> = 8.4 Hz, 2H), 6.32 (s, 2H), 3.84 (s, 3H), 2.58 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.98, 157.83, 145.46, 139.50, 138.07, 136.40, 135.34, 134.11, 131.71, 128.68, 128.52, 127.31, 126.82, 125.64, 125.11, 121.86, 118.66, 117.63, 100.95, 92.90, 91.57, 38.60, 20.53. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>20</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 442.1429; found, 442.1428. HPLC analysis: 5.57 min, 100.00% purity.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-methylphenyl)-4-chlorobenzamide (<b>35</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 76%); mp 190–191 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.36 (s, 1H), 8.26 (d, <i>J</i> = 2.3 Hz, 1H), 8.09 (s, 1H), 8.05 (d, <i>J</i> = 2.3 Hz, 1H), 8.00 (d, <i>J</i> = 8.5 Hz, 2H), 7.85 (d, <i>J</i> = 2.3 Hz, 1H), 7.83 (s, 1H), 7.65–7.61 (m, 3H), 7.31 (d, <i>J</i> = 8.4 Hz, 1H), 6.20 (s, 2H), 3.84 (s, 3H), 2.46 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>): δ 164.36, 157.77, 145.03, 136.71, 136.50, 136.20, 135.39, 134.93, 133.42, 129.83, 129.62, 128.54, 126.87, 123.51, 122.33, 121.10, 118.73, 117.72, 109.53, 101.43, 93.49, 89.02, 39.94, 39.80, 39.66, 39.52, 39.38, 39.24, 39.10, 38.64, 20.00. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>20</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 442.1429; found, 442.1429. HPLC analysis: 14.72 min, 95.77% purity.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-<i>N</i>-(4-chlorophenyl)-<i>N</i>,4-dimethylbenzamide (<b>36</b>)</h4><div class="NLM_p last">It is obtained as a deep yellow solid (yield 80%); mp 109–111 °C. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.25 (d, <i>J</i> = 2.4 Hz, 1H), 8.06 (s, 1H), 7.80 (d, <i>J</i> = 0.4 Hz, 1H), 7.79 (d, <i>J</i> = 2.3 Hz, 1H), 7.67 (d, <i>J</i> = 1.3 Hz, 1H), 7.37–7.35 (m, 2H), 7.24 (d, <i>J</i> = 8.7 Hz, 2H), 7.16 (d, <i>J</i> = 8.0 Hz, 1H), 7.06 (d, <i>J</i> = 7.8 Hz, 1H), 6.23 (s, 2H), 3.84 (s, 3H), 3.36 (s, 3H), 2.41 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 168.66, 157.76, 145.20, 143.36, 140.91, 136.29, 135.32, 133.81, 131.73, 130.77, 129.09, 128.89, 128.81, 128.05, 126.80, 122.22, 118.68, 117.57, 101.08, 92.64, 89.76, 38.59, 37.83, 20.29. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>26</sub>H<sub>22</sub>ClN<sub>5</sub>O [M + H]<sup>+</sup>: calcd, 456.1586; found, 456.1583. HPLC analysis: 14.21 min, 98.57% purity.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-((5-(((4-Chlorophenyl)amino)methyl)-2-methylphenyl)ethynyl)-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-2-amine (<b>37</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 70%); mp 230–231 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.24 (s, 1H), 8.07 (s, 1H), 7.82 (s, 2H), 7.60 (s, 1H), 7.27 (s, 2H), 7.06 (d, <i>J</i> = 7.4 Hz, 2H), 6.56 (d, <i>J</i> = 7.8 Hz, 2H), 6.46 (s, 1H), 6.22 (s, 2H), 4.23 (s, 2H), 3.84 (s, 3H), 2.45 (s, 3H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ 157.53, 147.41, 137.83, 137.50, 136.33, 135.37, 130.39, 129.58, 128.54, 127.63, 126.87, 122.17, 119.07, 118.63, 117.68, 113.66, 101.68, 93.75, 88.91, 45.86, 40.02, 39.85, 39.69, 39.52, 39.35, 39.19, 39.02, 38.61, 20.12. HRMS (ESI, <i>m</i>/<i>z</i>) for C<sub>25</sub>H<sub>22</sub>ClN<sub>5</sub> [M + H]<sup>+</sup>: calcd, 428.1637; found, 428.1632. HPLC analysis: 17.79 min, 97.09% purity.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-Amino-5-bromonicotinamide (<b>38f</b>)</h4><div class="NLM_p last">It is obtained as a deep brown solid (1.6 g, yield 80%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.47 (d, <i>J</i> = 2.0 Hz, 1H), 8.15 (d, <i>J</i> = 2.0 Hz, 1H), 7.79 (s, 1H), 7.21 (s, 1H), 6.81 (s, 2H). MS (ESI) <i>m</i>/<i>z</i>: 217.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 6-Amino-5-bromo-<i>N</i>-methylnicotinamide (<b>38g</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (d, <i>J</i> = 2.1 Hz, 1H), 8.26 (q, <i>J</i> = 4.5 Hz, 1H), 8.13 (d, <i>J</i> = 2.1 Hz, 1H), 6.79 (s, 2H), 2.68 (brs, 3H). MS (ESI) <i>m</i>/<i>z</i>: 231.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-((Trimethylsilyl)ethynyl)isoquinoline (<b>39a</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>39a–b</i></b><i>and</i><b><i>39f–h</i></b>. To a solution of 4-bromoisoquinoline (2.0 g, 9.61 mmol) in dry MeCN/Et<sub>3</sub>N (50 mL, 4:1, v/v) were added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (337 mg, 0.48 mmol), CuI (183 mg, 0.96 mmol), and ethynyltrimethylsilane (2.0 mL, 14.42 mmol) at rt under a N<sub>2</sub> atmosphere. After stirring at 80 °C for 4 h under a nitrogen atmosphere, the mixture was diluted with EtOAc and filtered through a pad of Celite. The filtrate was removed by reduced pressure to give the crude material, which was further purified by flash column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 15:1) to give <b>39a</b> as a light brown solid (1.7 g, yield 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.34 (s, 1H), 8.66 (s, 1H), 8.21 (d, <i>J</i> = 8.2 Hz, 1H), 8.14 (dd, <i>J</i> = 1.0, 8.4 Hz, 1H), 7.94 (ddd, <i>J</i> = 1.3, 6.9, 8.3 Hz, 1H), 7.78 (ddd, <i>J</i> = 1.2, 6.9, 8.1 Hz, 1H), 0.32 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 226.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3-((Trimethylsilyl)ethynyl)imidazo[1,2-<i>b</i>]pyridazine (<b>39b</b>)</h4><div class="NLM_p last">It is obtained as a brown solid (yield 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.67 (dd, <i>J</i> = 1.3, 4.4 Hz, 1H), 8.21 (dd, <i>J</i> = 1.4, 9.2 Hz, 1H), 8.12 (s, 1H), 7.36 (dd, <i>J</i> = 4.4, 9.2 Hz, 1H), 0.27 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 216.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 3-((Trimethylsilyl)ethynyl)pyridine (<b>39c</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>39c–e</i></b><i>and</i><b><i>39i</i></b>. To a solution of 3-iodopyridine (2.0 g, 9.76 mmol) in dry Et<sub>3</sub>N (50 mL) were added Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (342 mg, 0.49 mmol), CuI (186 mg, 0.98 mmol), and ethynyltrimethylsilane (2.1 mL, 14.63 mmol) at rt under a N<sub>2</sub> atmosphere. After stirring for 4 h, the mixture was diluted with EtOAc and filtered through a pad of Celite. The filtrate was removed by reduced pressure to give the crude product, which was further purified by column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 15:1) to give <b>39c</b> as a light yellow solid (1.4 g, yield 82%). <sup>1</sup>H NMR (400 MHz, Chloroform-<i>d</i>): δ 8.69 (d, <i>J</i> = 1.1 Hz, 1H), 8.52 (dd, <i>J</i> = 4.8, 1.4 Hz, 1H), 7.77–7.69 (m, 1H), 7.23 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 0.27 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 226.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 3-((Trimethylsilyl)ethynyl)pyridin-2-amine (<b>39d</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 85.0%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.95 (dd, <i>J</i> = 1.9, 4.9 Hz, 1H), 7.50 (dd, <i>J</i> = 1.9, 7.5 Hz, 1H), 6.52 (dd, <i>J</i> = 4.9, 7.5 Hz, 1H), 6.10 (s, 2H). MS (ESI) <i>m</i>/<i>z</i>: 191.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-Chloro-3-((trimethylsilyl)ethynyl)pyridin-2-amine (<b>39e</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.96 (d, <i>J</i> = 2.5 Hz, 1H), 7.60 (d, <i>J</i> = 2.6 Hz, 1H), 6.37 (s, 2H), 0.24 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 225.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-Amino-5-((trimethylsilyl)ethynyl)nicotinamide (<b>39f</b>)</h4><div class="NLM_p last">It is obtained as a gray solid (yield 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.48 (d, <i>J</i> = 2.3 Hz, 1H), 7.99 (d, <i>J</i> = 2.3 Hz, 1H), 7.76 (s, 1H), 7.16 (s, 1H), 6.70 (s, 2H), 0.24 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 234.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6-Amino-<i>N</i>-methyl-5-((trimethylsilyl)ethynyl)nicotinamide (<b>39g</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (92%). <sup>1</sup>H NMR (400 MHz, Chloroform-<i>d</i>): δ 8.43 (d, <i>J</i> = 1.9 Hz, 1H), 7.94 (d, <i>J</i> = 1.8 Hz, 1H), 6.12 (br s, 1H), 5.42 (s, 2H), 2.96 (d, <i>J</i> = 4.7 Hz, 3H), 0.25 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 248.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Methyl 6-Amino-5-((trimethylsilyl)ethynyl)nicotinate (<b>39h</b>)</h4><div class="NLM_p last">It is obtained as a black solid (yield 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.52 (s, 1H), 7.88 (d, <i>J</i> = 2.0 Hz, 1H), 7.06 (s, 2H), 3.77 (s, 3H), 0.24 (s, 8H). MS (ESI) <i>m</i>/<i>z</i>: 249.5 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 5-Bromo-3-((trimethylsilyl)ethynyl)pyridin-2-amine (<b>39i</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 82.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.02 (d, <i>J</i> = 2.4 Hz, 1H), 7.69 (d, <i>J</i> = 2.5 Hz, 1H), 6.37 (s, 2H), 0.24 (s, 9H). MS (ESI) <i>m</i>/<i>z</i>: 269.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 3-Iodo-4-isopropylbenzoic acid (<b>40c</b>)</h4><div class="NLM_p last">Step 1: To a solution of 4-isopropylbenzoic acid (5.0 g, 30.45 mmol) in DMF (60 mL) were added K<sub>2</sub>CO<sub>3</sub> (12.62 g, 91.35 mmol) and MeI (482 μL, 36.54 mmol) at rt, and the mixture was stirred at this temperature for 2 h. After being cooled down to 0 °C, saturated aqueous (sat. aq) Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (10 mL) was poured into the resulting solution and stirred at rt for 20 min. The mixture was poured into water and extracted with EtOAc. The organic layer was washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give methyl 4-isopropylbenzoate as light yellow oil (5.4 g, yield 99%). The crude product was used directly for the next step without further purification. Step 2: To a solution of methyl 4-isopropylbenzoate (4.2 g, 23.60 mmol) in AcOH/Ac<sub>2</sub>O (30 mL, 2:1, v/v) were added NaIO<sub>4</sub> (2.6 g, 12.11 mmol) and I<sub>2</sub> (2.0 g, 8.01 mmol) at 0 °C. Concentrated H<sub>2</sub>SO<sub>4</sub> (10 mL, 184 mmol) was added dropwise into the solution, and the mixture was stirred at 40 °C for 4 h. Water (40 mL) and sat. aq Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution (25 mL) was added into the resulting solution under an ice bath. After stirring at rt for 30 min, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with water and brine and dried with Na<sub>2</sub>SO<sub>4</sub>. The resultant crude material was purified by flash column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 50:1) to give methyl 3-iodo-4-isopropylbenzoate as yellow oil (5.1 g, yield 71.16%). Step 3: To a solution of methyl 3-iodo-4-isopropylbenzoate (3.1 g, 10.19 mmol) in THF/MeOH/H<sub>2</sub>O (35 mL, 4:1:1, v/v/v) was added LiOH·H<sub>2</sub>O (1.1 g, 26.21 mmol) at rt, and the mixture was stirred for 5 h. The resulting solution was cooled down in an ice bath, then the pH was adjusted to 4–5 with diluted hydrochloric acid (1 M), and the product was precipitated. After stirring at 0 °C for 30 min, the mixture was filtrated. The filter cake was rinsed with water (3 × 15 mL) and then dried in a vacuum oven to give <b>40c</b> as a yellow solid (2.8 g, yield 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.99 (s, 1H), 8.32 (s, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.45 (d, <i>J</i> = 8.1 Hz, 1H), 3.24 (hept, <i>J</i> = 6.8 Hz, 1H), 1.19 (d, <i>J</i> = 6.7 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i>: 290.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(3,5-Dimethoxyphenyl)-3-iodo-4-methylbenzamide (<b>41a</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (2.5 g, yield 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.17 (s, 1H), 8.38 (d, <i>J</i> = 1.9 Hz, 1H), 7.88 (dd, <i>J</i> = 1.9, 7.9 Hz, 1H), 7.48 (d, <i>J</i> = 8.2 Hz, 1H), 7.07 (d, <i>J</i> = 2.3 Hz, 2H), 6.27 (t, <i>J</i> = 2.3 Hz, 1H), 3.73 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 398.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-(3,5-Dimethoxyphenyl)-3-iodobenzamide (<b>41b</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 90%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.24 (d, <i>J</i> = 15.2 Hz, 1H), 7.91 (t, <i>J</i> = 8.0 Hz, 2H), 7.28 (t, <i>J</i> = 7.8 Hz, 1H), 6.96 (s, 2H), 6.29 (s, 1H), 3.78 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 384.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-(3,5-Dimethoxyphenyl)-3-iodo-4-isopropylbenzamide (<b>41c</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 85%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.09 (s, 1H), 8.33 (d, <i>J</i> = 2.9 Hz, 1H), 7.88 (dd, <i>J</i> = 15.0, 3.1 Hz, 1H), 7.33 (d, <i>J</i> = 15.0 Hz, 1H), 7.01 (d, <i>J</i> = 3.1 Hz, 2H), 6.23 (t, <i>J</i> = 3.0 Hz, 1H), 3.79 (s, 6H), 3.04–2.69 (m, 1H), 1.17 (d, <i>J</i> = 12.7 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i>: 426.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(3,5-Dimethoxyphenyl)-3-iodo-4-methoxybenzamide (<b>41d</b>)</h4><div class="NLM_p last">It is obtained as a gray solid (yield 84%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.37 (s, 1H), 7.97 (d, <i>J</i> = 8.9 Hz, 1H), 7.05 (d, <i>J</i> = 8.7 Hz, 1H), 6.96 (s, 2H), 6.29 (s, 1H), 3.95 (s, 3H), 3.78 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 414.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 3-Bromo-<i>N</i>-(3,5-dimethoxyphenyl)-4-fluorobenzamide (<b>41e</b>)</h4><div class="NLM_p last">It is obtained as a gray solid (yield 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.27 (s, 1H), 8.30 (d, <i>J</i> = 6.1 Hz, 1H), 8.02 (m, 1H), 7.54 (m, 1H), 7.06 (s, 2H), 6.28 (s, 1H), 3.74 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 402.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 4-Chloro-<i>N</i>-(3,5-dimethoxyphenyl)-3-iodobenzamide (<b>41f</b>)</h4><div class="NLM_p last">It is obtained as a white solid (yield 86%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.43 (s, 1H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 6.95 (s, 2H), 6.28 (s, 1H), 3.77 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 418.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 3-Bromo-<i>N</i>-(3,5-dimethoxyphenyl)-4-(trifluoromethyl)benzamide (<b>41g</b>)</h4><div class="NLM_p last">It is obtained as a white solid (yield 77.8%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.32 (s, 1H), 8.03 (d, <i>J</i> = 7.9 Hz, 1H), 7.91 (d, <i>J</i> = 8.0 Hz, 1H), 6.98 (s, 2H), 6.32 (s, 1H), 3.79 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 452.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-((2-Amino-5-bromopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-2-methylbenz-amide (<b>42a</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 81%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.20 (s, 1H), 8.25 (s, 1H), 8.06 (d, <i>J</i> = 2.3 Hz, 1H), 7.86 (d, <i>J</i> = 5.1 Hz, 1H), 7.85 (s, 1H), 7.47 (d, <i>J</i> = 8.1 Hz, 1H), 7.09 (d, <i>J</i> = 1.9 Hz, 2H), 6.62 (s, 2H), 6.27 (s, 1H), 3.74 (s, 6H), 2.54 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 467.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 3-((2-Amino-5-bromopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)benzamide (<b>42b</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 79.6%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.29 (s, 1H), 8.22 (s, 1H), 8.05 (s, 1H), 7.93 (d, <i>J</i> = 7.2 Hz, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 1H), 7.82 (br s, 1H), 7.59 (t, <i>J</i> = 7.7 Hz, 1H), 7.09 (s, 2H), 6.71 (s, 2H), 6.28 (s, 1H), 3.74 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 453.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-((2-Amino-5-bromopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-isopropylbenzamide (<b>42c</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.23 (s, 1H), 8.31–8.24 (m, 2H), 8.09 (s, 1H), 7.92 (d, <i>J</i> = 8.2 Hz, 1H), 7.85 (s, 1H), 7.55 (m, 1H), 7.12 (d, <i>J</i> = 2.2 Hz, 2H), 6.31 (s, 1H), 6.28 (t, <i>J</i> = 2.1 Hz, 1H), 3.74 (s, 6H), 3.57 (m, <i>J</i> = 13.7, 6.9 Hz, 1H), 1.29 (d, <i>J</i> = 6.8 Hz, 6H). MS (ESI) <i>m</i>/<i>z</i>: 495.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 3-((2-Amino-5-bromopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-methoxybenzamide (<b>42d</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 77%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.13 (s, 1H), 8.22 (s, 1H), 8.07 (d, <i>J</i> = 2.4 Hz, 1H), 8.01 (d, <i>J</i> = 8.6 Hz, 1H), 7.77 (d, <i>J</i> = 2.3 Hz, 1H), 7.62 (s, 1H), 7.26 (d, <i>J</i> = 8.7 Hz, 1H), 7.08 (d, <i>J</i> = 2.1 Hz, 2H), 6.58 (s, 1H), 6.26 (s, 1H), 3.97 (s, 3H), 3.74 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 483.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 3-((2-Amino-5-bromopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-fluorobenzamide (<b>42e</b>)</h4><div class="NLM_p last"><i>General Procedure for Syntheses of</i><b><i>42e–f</i></b>. To a solution of <b>41e</b> (200 mg, 0.56 mmol) in dry MeCN (40 mL) were added <b>39i</b> (205 mg, 0.76 mmol), CsF (214 mg, 1.41 mmol), and Et<sub>3</sub>N (235 μL, 1.69 mmol) at rt under a N<sub>2</sub> atmosphere. The mixture was heated to 80 °C and stirred for 4 h. The resulting solution was poured into water and extracted with EtOAc. The organic layer was washed with brine and dried with Na<sub>2</sub>SO<sub>4</sub>. The crude material was purified by flash column chromatography (SiO<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 25:1) to give <b>42e</b> as a yellow solid (220 mg, yield 82.8%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.29 (s, 1H), 8.39 (d, <i>J</i> = 5.8 Hz, 1H), 8.11–8.06 (m, 1H), 8.04–7.97 (m, 1H), 7.83 (dd, <i>J</i> = 9.3, 1.9 Hz, 1H), 7.51 (t, <i>J</i> = 9.0 Hz, 1H), 7.07 (br s, 2H), 6.78 (s, 1H), 6.70 (s, 2H), 6.28 (s, 1H), 3.74 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 470.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 3-((2-Amino-5-bromopyridin-3-yl)ethynyl)-4-chloro-<i>N</i>-(3,5-dimethoxyphenyl)benzamide (<b>42f</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 76%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.34 (s, 1H), 8.40 (d, <i>J</i> = 2.2 Hz, 1H), 8.10 (d, <i>J</i> = 2.5 Hz, 1H), 7.94 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.83 (d, <i>J</i> = 2.4 Hz, 1H), 7.77 (d, <i>J</i> = 8.4 Hz, 1H), 7.65–7.54 (m, 2H), 7.07 (d, <i>J</i> = 2.2 Hz, 2H), 6.29 (t, <i>J</i> = 2.2 Hz, 1H), 3.74 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 487.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 3-((2-Amino-5-bromopyridin-3-yl)ethynyl)-<i>N</i>-(3,5-dimethoxyphenyl)-4-(trifluoromethyl)benzamide (<b>42g</b>)</h4><div class="NLM_p last">It is obtained as a yellow solid (yield 60%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>): δ 8.34 (s, 1H), 8.06 (s, 2H), 7.92 (d, <i>J</i> = 8.5 Hz, 1H), 7.77 (s, 1H), 7.00 (s, 2H), 6.33 (s, 1H), 5.50 (s, 1H), 3.80 (s, 6H). MS (ESI) <i>m</i>/<i>z</i>: 520.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-methylbenzoate (<b>44</b>)</h4><div class="NLM_p last">Step 1: To a solution of <b>43</b> (5.0 g, 18.11 mmol) in dry MeCN (150 mL) were added <b>39i</b> (6.3 g, 23.54 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (636 mg, 0.91 mmol), CuI (345 mg, 1.81 mmol), CsF (6.9 g, 45.28 mmol), and Et<sub>3</sub>N (7.6 mL, 54.3 mmol) at rt under a N<sub>2</sub> atmosphere, and the mixture was stirred for 6 h. The resulting solution was filtered through a pad of Celite, and the solvent was removed by reduced pressure. The resultant crude material was purified by flash column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 8:1) to give methyl 3-((2-amino-5-bromopyridin-3-yl)ethynyl)-4-methylbenzoate (yellow solid, 6.0 g, yield 96%). The product obtained above (6.0 g, 17.38 mmol) was dissolved in THF/H<sub>2</sub>O (150 mL, 4:1, v/v), followed by the addition of 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (5.4 g, 26.07 mmol), Pd(OAc)<sub>2</sub> (0.4 g, 1.74 mmol), X-Phos (1.7 g, 3.48 mmol), and K<sub>2</sub>CO<sub>3</sub> (6.0 g, 43.45 mmol) under a N<sub>2</sub> atmosphere. The mixture was refluxed at 90 °C for 6 h. The resulting solution was filtered through a pad of Celite, and the filtrate was removed by reduced pressure to give the crude material, which was further purified by flash column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 2:1) to give <b>44</b> as a yellow solid (5.9 g, yield 98%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.28–8.23 (m, 2H), 8.08 (s, 1H), 7.88–7.84 (m, 3H), 7.82 (s, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 6.35 (s, 2H), 3.87 (s, 3H), 3.84 (s, 3H), 2.56 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 347.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 3-((2-Amino-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)pyridin-3-yl)ethynyl)-4-methylbenzoic acid (<b>45</b>)</h4><div class="NLM_p last">To a solution of <b>44</b> (5.9 g, 17.03 mmol) in THF/MeOH/H<sub>2</sub>O (90 mL, 4/1/1, v/v/v) was added LiOH·H<sub>2</sub>O (1.8 g, 42.58 mmol) at rt, and the mixture was stirred at this temperature for 12 h. The resulting solution was cooled to 0 °C, and then the pH was adjusted to 4–5 with diluted hydrochloric acid (1 M), and the product was precipitated. After stirring for 30 min at 0 °C, the mixture was filtered, and the filter cake was rinsed with water (3 × 15 mL) and then dried in a vacuum oven to give <b>45</b> as a yellow-green solid (5.2 g, yield 92%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.06 (br s, 1H), 8.26 (s, 1H), 8.22 (s, 1H), 8.08 (s, 1H), 7.88–7.80 (m, 3H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 6.35 (s, 2H), 3.84 (s, 3H), 2.55 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 333.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>N</i>-(4-Chlorophenyl)-4-iodo-3-methylbenzamide (<b>48a</b>)</h4><div class="NLM_p last">It is obtained as a light pink solid (yield 90%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.92 (d, <i>J</i> = 8.3 Hz, 1H), 7.81 (s, 1H), 7.71 (s, 1H), 7.58 (d, <i>J</i> = 8.6 Hz, 2H), 7.33 (d, <i>J</i> = 8.4 Hz, 2H), 2.50 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 371.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-Chloro-<i>N</i>-(3-iodo-4-methylphenyl)benzamide (<b>48b</b>)</h4><div class="NLM_p last">It is obtained as a white solid (yield 88%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.32 (s, 1H), 8.31 (d, <i>J</i> = 2.1 Hz, 1H), 8.07–7.89 (m, 2H), 7.70 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.68–7.56 (m, 2H), 7.30 (d, <i>J</i> = 8.5 Hz, 1H), 2.34 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 371.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>-(4-Chlorophenyl)-3-iodo-4-methylbenzamide (<b>48c</b>)</h4><div class="NLM_p last">It is obtained as a white solid (yield 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.38 (s, 1H), 8.39 (d, <i>J</i> = 1.8 Hz, 1H), 7.89 (dd, <i>J</i> = 7.9, 1.9 Hz, 1H), 7.82 (d, <i>J</i> = 8.9 Hz, 2H), 7.47 (d, <i>J</i> = 7.7 Hz, 1H), 7.41 (d, <i>J</i> = 8.8 Hz, 2H), 2.44 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 371.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-(4-Chlorophenyl)-3-iodo-<i>N</i>,4-dimethylbenzamide (<b>49</b>)</h4><div class="NLM_p last">A solution of <b>48c</b> (1.0 g, 2.69 mmol) in anhydrous THF (25 mL) was added dropwise to a suspension of NaH (60%, 215 mg, 5.38 mmol) in anhydrous THF (20 mL) under stirring at 0 °C. After stirring at 0 °C for 15 min, MeI (335 μL, 5.38 mmol) was added to the reaction solution. The resulting solution was stirred at rt for 5 h and then cooled in an ice bath. After addition of water, the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with sat. aq Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution and brine and dried with Na<sub>2</sub>SO<sub>4</sub>. The crude product was purified by flash chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 5:1) to give <b>49</b> as a light yellow solid (890 mg, 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.72 (d, <i>J</i> = 1.4 Hz, 1H), 7.34 (d, <i>J</i> = 8.8 Hz, 2H), 7.22 (d, <i>J</i> = 8.7 Hz, 2H), 7.16 (d, <i>J</i> = 7.9 Hz, 1H), 7.11 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 3.32 (s, 3H), 2.27 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 385.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4-Chloro-<i>N</i>-(3-iodo-4-methylbenzyl)aniline (<b>50</b>)</h4><div class="NLM_p last">To a solution of <b>48c</b> (1.0 g, 2.69 mmol) in anhydrous THF (20 mL) was added 1.0 M BH<sub>3</sub>·THF (5.4 mL) solution dropwise at rt, and the reaction mixture was stirred at this temperature for 12 h. The resulting solution was diluted with EtOAc (20 mL) and quenched by the careful addition of sat. aq NaHCO<sub>3</sub> solution (5 mL). The organic layer was washed with sat. aq sodium potassium tartrate solution (30 mL), 10% aq. Na<sub>2</sub>CO<sub>3</sub> solution (30 mL), and brine (30 mL), dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The resulting crude product was purified by flash column chromatography (SiO<sub>2</sub>, petroleum ether/EtOAc, 10:1) to give <b>50</b> as a white solid (427 mg, yield 44%). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>): δ 7.90 (s, 1H), 7.35–7.28 (m, 2H), 7.21 (d, <i>J</i> = 8.9 Hz, 2H), 6.63 (d, <i>J</i> = 8.9 Hz, 2H), 4.33 (s, 2H), 4.15 (br s, 1H), 2.52 (s, 3H). MS (ESI) <i>m</i>/<i>z</i>: 357.3 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Reagents and Antibodies</h3><div class="NLM_p last">Compound PLX3397 (batch number: 160823; purity: 98%) was purchased from Yi shiming (Beijing) biological medicine technology co. LTD. Compounds were dissolved in dimethyl sulfoxide (DMSO, Sigma-Aldrich) at a concentration of 50 mmol/L and then diluted with the Dulbecco’s modified Eagle’s medium (DMEM) medium (Hyclone, South Logan, UT, USA) containing 10% fetal bovine serum (FBS, Hyclone). CCK-8 was purchased from Dojindo (Kumamoto, Japan). LPS was purchased from Sigma (St Louis, MO, USA). Primary antibodies against CSF1R (3152), phosphor-CSF1R (Tyr723, 3151), Akt (9272), and phosphor-Akt (Ser473, 4060) were purchased were purchased from Cell Signaling Technology (CST, Boston, MA, USA). Actin was purchased from Abgent (Abgent, San Diego, CA, USA), and anti-rabbit IgG horseradish peroxidase (HRP)-linked secondary antibody was purchased from Bio-Rad (Bio-Rad, Hercules, CA, USA).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Cell Lines</h3><div class="NLM_p last">The murine macrophage RAW 264.7 cells (ATCC, Manassas, VA, USA) were cultured in DMEM containing 10% fetal bovine serum (FBS), 2 mmol/L of <span class="smallcaps smallerCapital">l</span>-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. The cells were maintained at 37 °C in a 5% CO<sub>2</sub> incubator.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> In Vitro Kinase Enzyme Assay</h3><div class="NLM_p last">The kinase inhibitory activity of each compound was determined using an enzyme-linked immunosorbent assay (ELISA). Recombinant proteins, including CSF1R, VEGFRs, PDGFRs, EGFRs, RET, c-Kit, Flt3, Src, Abl, EphA2, IGF1R, IR, FGFRs, BTK, FAK, ITK, and ACK1, were purchased from Millipore (UK, LTD). Briefly, the 96-well ELISA plates were precoated with substrate poly (Glu, Tyr)<sub>4:1</sub> (Sigma, St. Louis, MO, USA). Active kinases were added into the plate and incubated with the compound in reaction buffer containing 5 μM ATP. After incubation at 37 °C for 1 h, the wells were washed and incubated with PY99 antibody (Santa Cruz Biotechnology, Santa Cruz, CA), followed by a HRP-conjugated secondary antibody. The wells were visualized using <i>o</i>-phenylenediamine and read with a multiwell spectrophotometer (SpectraMax Plus384, Molecular Devices) at an absorbance of 490 nM.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Cell Viability Assay</h3><div class="NLM_p last">The cytotoxicity of the compounds was evaluated by the CCK-8. Briefly, the cells (5 × 10<sup>4</sup> cells/well) were seeded into 96-well plates in triplicate with 200 μL of DMEM media for 24 h in the presence or absence of indicated concentrations of compounds. Subsequently, a total of 20 μL CCK-8 was added to each well. After 1 h incubation, the plates were measured at 450 nm (570 nm calibration) using a microplate reader (Molecular Devices, Sunnyvale, CA, USA), and the cell viability was calculated. The cytotoxicity of the compounds was expressed as CC<sub>50</sub>, using the log (inhibitor) versus normalized response nonlinear fit (GraphPad Prism 8.0).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Western Blot Assay</h3><div class="NLM_p last">RAW264.7 cells (1 × 10<sup>6</sup> cells/well) were seeded into six-well plates and incubated overnight and then treated with or without different concentrations of compound <b>29</b> for 6 h and then stimulated with or without CSF-1 (100 ng/mL) for 20 min. Cell samples were then lysed in 1× SDS lysis buffer (Beyotime, Shanghai, China) and uniformed by the Pierce BCA protein assay kit (Thermo Fisher Scientific, Pittsburgh, PA, USA). Equal protein amounts were loaded to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA), which was blocked with SuperBlockTM T20 blocking buffer (Thermo Fisher Scientific, Pittsburgh, PA, USA) and then incubated overnight at 4 °C with primary antibodies. The bands were incubated with HRP-conjugated anti-rabbit IgG (Bio-Rad, Richmond, CA, USA) and further visualized using a SuperSignalTM West Femto Maximum Sensitivity Substrate kit (Thermo Fisher Scientific, Pittsburgh, PA, USA) under the ChemiDocTM MP Imaging System (Bio-Rad, Richmond, CA, USA).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> In Vitro Anti-Inflammatory Activity Assay</h3><div class="NLM_p last">RAW264.7 cells were incubated with compounds or the media (0.125% DMSO in DMEM containing 10% FBS), and then the cells were primed with LPS (1 μg/mL) for 24 h. The supernatants were collected and then measured using the mouse TNF-α and IL-6 ELISA kit. The IC<sub>50</sub> values were estimated using the log (inhibitor) versus normalized response nonlinear fit (Graph Pad Prism 8.0).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Determination of PK Parameters in Rats</h3><div class="NLM_p">Male SD rats (200 ± 20 g) were purchased from B&K Universal Group Co. Ltd. (Shanghai, China). All the animal studies were performed according to the protocols and guidelines of the Institutional Care and Use Committee of the Shanghai Institute of Materia Medica. Rats were housed in a well-lit air-conditioned animal room at 19–23 °C with 50–60% relative humidity under standard environmental conditions (12 h light/dark cycle). Rats were fed with standard rodent chow and water at libitum. After acclimation to the laboratory for at least 1 week, rats were randomly divided into two groups (each group 3) and then fasted for 12 h with free access to water prior to the experiment. One group was injected with intravenously (iv) formulation at doses of 2 mg/kg compound <b>29</b>, and the other group was treated by oral gavage (p.o.) of p.o. formulation at doses of 5 mg/kg compound <b>29</b>. The p.o. formulation was prepared with DMSO/HPMC (5/95, v/v). The iv formulation was made with DMSO/EtOH/PEG300/Saline (5/5/40/50, v/v/v/v). Blood samples (40 μL) from the femoral vein were collected into a heparinized tube at 15, 30, 60, 120, 240, 480, and 1440 min after administration. Blood samples were immediately centrifuged at 4 °C and 12 000<i>g</i> for 5 min to obtain plasma, which was then transferred to a clean vial and subsequently stored at −20 °C until analysis. The plasma sample (20 μL) was precipitated with 200 μL of methanol containing the geniposide (IS) (20 ng/mL) and vigorously vortex-mixed for 1 min. After centrifugation at 12 000<i>g</i> for 5 min at 4 °C, the supernatants from each sample were analyzed using LC–MS/MS with an Acquity ultra performance liquid chromatography system (I-class, Waters, Milford, USA) coupled to a triple quadrupole mass spectrometer (Xevo TQ-S, Waters, Milford, USA).</div><div class="NLM_p last">The chromatographic separation was performed on a Welch Xtimate C18 column (50 × 2.1 mm, 1.7 μm) at a low flow rate (0.35 mL/min). Plasma amples or calibration standards (5 μL) were injected into the system, and the temperature of column and autosampler was maintained at 45 and 10 °C, respectively. Mobile phases: A, H<sub>2</sub>O (5 mM ammonium acetate and 0.1% HCOOH); B, MeCN (0.1% HCOOH). The gradient program was listed as follow: 0.0–0.1 min, 10% (v/v) B; 0.1–0.8 min, 10–95% B; 0.8–1.8 min, 95% B; 1.8–1.81 min, 95–10% B; 1.81–3.0 min, and 10% B. The mass spectrometer equipped with an electrospray ionization probe was operated in a positive ion mode with a capillary voltage 3.0 kV at a temperature of 500 °C, and the desolvation gas flow 1000 L/h. Quantitative analysis was performed by monitoring [M + H]<sup>+</sup> for the compound <b>29</b> and IS in multiple reaction monitoring modes. PK parameters were calculated using a noncompartmental model of Phoenix 1.3 software (US Pharsight Corporation). The peak concentration <i>C</i><sub>max</sub> and the peak time <i>T</i><sub>max</sub> were measured; the area under the concentration time curve of AUC<sub>0–<i>t</i></sub> value was calculated by the trapezoidal method; AUC<sub>0–∞</sub> = AUC<sub>0–<i>t</i></sub> + <i>C</i><sub><i>t</i></sub>/<i>k</i><sub>e</sub>, where <i>C</i><sub><i>t</i></sub> is the last blood concentration that can be measured, <i>k</i><sub>e</sub> is the elimination rate constant; elimination half-life <i>t</i><sub>1/2</sub> = 0.693/<i>k</i><sub>e</sub>; mean residence time MRT = AUMC/AUC; clearance CL = D/AUC<sub>0–∞</sub>; steady-state distribution volume <i>V</i><sub>ss</sub> = CL × MRT; absolute bioavailability <i>F</i> = AUC<sub>0–∞</sub>(oral)/AUC<sub>0–∞</sub>(i.v.) × dose(i.v.)/dose(oral) × 100%.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> In Vivo Anti-Inflammatory Efficacy Investigation</h3><div class="NLM_p last">All the animal studies were performed according to the protocols and guidelines of the institutional care and use committee. Inbred 8-week-old female BALB/c mice were purchased from Shanghai Lingchang Biotechnology Co., Ltd. (Certificate no. 2013-0018, Shanghai, China). All mice were housed under specific pathogen-free conditions and raised in a 12 h light/dark cycle with humidity (60–80%) and temperature (22 ± 1 °C). All mice were fed standard laboratory chow and water at libitum and allowed to acclimatize in our facility for 1 week before any experiments started. Mice were randomly divided into five groups with six mice per group: untreated normal control, vehicle (0.5% sodium carboxymethylcellulose and 0.25% Tween-80), PLX3397 (40 mg/kg), and compound <b>29</b> (20 and 40 mg/kg). Vehicle, PLX3397, and compound <b>29</b> were orally administrated at 4 h before intraperitoneal injection with a dose of 5 mg/kg of LPS. Blood sample (0.1 mL) was collected via orbital sinus puncture at 1.5 and 3 h after LPS application. The blood sample was centrifuged at 4 °C and 12 000 rpm for 10 min, and then the serum was transferred to a clean tube and stored at −80 °C prior to analysis. The serum of each mouse from all groups was determined by using mouse IL-6 and TNF-α ELISA kits, according to the manufacturer instructions. All ELISA quantification kits were purchased from BD Pharmingen (San Diego, CA, USA).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Molecular Modeling</h3><div class="NLM_p last">Ligands were created with ChmBio3D Ultra 14.0 and minimized according to the MMFF94 force field. Molecular docking of compounds (<b>7</b>, <b>8</b>, <b>12</b>, <b>16</b>, and <b>29</b>) into CSF-1R (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a>) and FGFR1 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a>) kinases was performed in AutoDock Vina.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> For preparation of the macromolecule and ligands, water was excluded, and Gasteiger charges were assigned for the protein. Torsional root and the rotatable bonds of the ligand were identified. Prior to the AutoDock, AutoGrid was carried out for the preparation of the grid map using a grid box, which was centered at the original ligand and extended outward the ligand within the 5 Å domain. A scoring grid was calculated from the original ligand structure to minimize the computation time. Finally, AutoDock vina was performed using the Lamarckian Genetic Algorithm with default settings, and the top ranked poses were visually inspected. The docking results were shown as the cartoon model in Pymol.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Statistical Analysis</h3><div class="NLM_p last">All experiment data were presented as mean ± SEM and statistically evaluated by one-way ANOVA followed by Dunnett’s test between different groups. Statistical analyses were evaluated using GraphPad Prism 8.0 software. Differences where <i>p</i> < 0.05 were considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i94"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01912" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56104" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56104" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01912?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01912</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Blockade effect of <b>29</b> on the hERG channel, <sup>1</sup>H NMR, <sup>13</sup>C NMR spectra of compounds <b>7–37</b>, and <sup>19</sup>F NMR spectra of <b>7</b>, <b>20</b>, <b>22</b>, <b>30</b>, and <b>31</b>, and the purity data of all final compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_001.pdf">jm9b01912_si_001.pdf (5.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_002.csv">jm9b01912_si_002.csv (2.57 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a> was used for modeling docking of compound <b>7</b>, <b>8</b>, <b>12</b>, <b>16</b>, and <b>29</b> in CSF-1R; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a> was used for modeling docking of compound <b>7</b> and <b>8</b>; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a> was used for modeling docking of compound <b>7</b> and <b>8</b> in FGFR1.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01912" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua Xie</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#85edfdece0c5f6ece8e8abe4e6abe6eb"><span class="__cf_email__" data-cfemail="e38b9b8a86a3908a8e8ecd8280cd808d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Tang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c2b6a3aca5b5a7ab82b1abafafeca3a1eca1ac"><span class="__cf_email__" data-cfemail="ccb8ada2abbba9a58cbfa5a1a1e2adafe2afa2">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youhong Hu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1770-6272" title="Orcid link">http://orcid.org/0000-0003-1770-6272</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#047d6c6c7144776d69692a65672a676a"><span class="__cf_email__" data-cfemail="e39a8b8b96a3908a8e8ecd8280cd808d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhicheng Xie</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bing Wu</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yingqiang Liu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenming Ren</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linjiang Tong</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caigui Xiang</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aihuan Wei</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuanzhuo Gao</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University
of Chinese Academy of Sciences, 19 Yuquan Road, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Limin Zeng</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zu-Chong-Zhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.X., B.W., and Y.L. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i97">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was financially supported by the National Science and Technology Major Project Key New Drug Creation and Manufacturing of China (2018ZX09711002), Science and Technology Commission of Shanghai Municipality (18431907100), and the State Key Laboratory of Drug Research (SIMM1803ZZ-01).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CSF-1R</td><td class="NLM_def"><p class="first last">colony stimulating factor 1 receptor kinase</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">FLT-3</td><td class="NLM_def"><p class="first last">FMS-like tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">KIT</td><td class="NLM_def"><p class="first last">stem cell factor receptor</p></td></tr><tr><td class="NLM_term">PDGFR</td><td class="NLM_def"><p class="first last">platelet-derived growth factor receptor</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-α</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">PVNS/dt-GCT</td><td class="NLM_def"><p class="first last">pigmented villonodular synovitis</p></td></tr><tr><td class="NLM_term">FGFR</td><td class="NLM_def"><p class="first last">fibroblast growth factor receptor</p></td></tr><tr><td class="NLM_term">DFG</td><td class="NLM_def"><p class="first last">asparticacid-phenylalanine-glycine</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">Phe</td><td class="NLM_def"><p class="first last">phenylalanine</p></td></tr><tr><td class="NLM_term">Ile</td><td class="NLM_def"><p class="first last">isoleucine</p></td></tr><tr><td class="NLM_term">HishistidineCys</td><td class="NLM_def"><p class="first last">histidineCyscysteine</p></td></tr><tr><td class="NLM_term">Trp</td><td class="NLM_def"><p class="first last">tryptophan</p></td></tr><tr><td class="NLM_term">Glu</td><td class="NLM_def"><p class="first last">glutamicacid</p></td></tr><tr><td class="NLM_term">Asp</td><td class="NLM_def"><p class="first last">asparticacid</p></td></tr><tr><td class="NLM_term">JM</td><td class="NLM_def"><p class="first last">juxtamembrane</p></td></tr><tr><td class="NLM_term">Gly</td><td class="NLM_def"><p class="first last">glycine</p></td></tr><tr><td class="NLM_term">Tyr</td><td class="NLM_def"><p class="first last">tyrosine</p></td></tr><tr><td class="NLM_term">Val</td><td class="NLM_def"><p class="first last">valine</p></td></tr><tr><td class="NLM_term">Ala</td><td class="NLM_def"><p class="first last">alanine</p></td></tr><tr><td class="NLM_term">Lys</td><td class="NLM_def"><p class="first last">lysine</p></td></tr><tr><td class="NLM_term">Thr</td><td class="NLM_def"><p class="first last">threonine</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal (50%) inhibitory concentration (IC)</p></td></tr><tr><td class="NLM_term">Het.</td><td class="NLM_def"><p class="first last">aromatic heterocycle</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">hydrogen bond donor</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ErbB2/4</td><td class="NLM_def"><p class="first last">human epidermal growth factor receptor 2/4</p></td></tr><tr><td class="NLM_term">VEGFR</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor</p></td></tr><tr><td class="NLM_term">IGF1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor 1-receptor</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">RET</td><td class="NLM_def"><p class="first last">proto-oncogene tyrosine-protein kinase receptor Ret</p></td></tr><tr><td class="NLM_term">BTK</td><td class="NLM_def"><p class="first last">Bruton’s tyrosine kinase</p></td></tr><tr><td class="NLM_term">Src</td><td class="NLM_def"><p class="first last">tyrosine kinases that encoded by the oncogenic retrovirus, Rous sarcoma virus</p></td></tr><tr><td class="NLM_term">FAK</td><td class="NLM_def"><p class="first last">focal adhesion kinase</p></td></tr><tr><td class="NLM_term">Abl</td><td class="NLM_def"><p class="first last">nonreceptor tyrosine kinase Abelson</p></td></tr><tr><td class="NLM_term">ITK</td><td class="NLM_def"><p class="first last">IL2-inducible T-cell kinase</p></td></tr><tr><td class="NLM_term">EphA2</td><td class="NLM_def"><p class="first last">ephrin type-A receptor 2</p></td></tr><tr><td class="NLM_term">ACK1</td><td class="NLM_def"><p class="first last">activated CDC42 kinase 1</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">median cytotoxic concentration</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">PK</p></td></tr><tr><td class="NLM_term">SD-rats</td><td class="NLM_def"><p class="first last">Sprague-Dawley rats</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous administration</p></td></tr><tr><td class="NLM_term">p.o.</td><td class="NLM_def"><p class="first last">oral gavage</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">the area under the concentration time curve</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">elimination half-life</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">the peak time</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">the peak concentration</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">steady-state distribution volume</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">absolute bioavailability</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">potassium-ion-channel</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">ethyldiisopropylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term">ppm</td><td class="NLM_def"><p class="first last">parts per million</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i99">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 23 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherr, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rettenmier, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, M. F.</span></span> <span> </span><span class="NLM_article-title">Macrophage colony-stimulating factor, CSF1, and its proto-oncogene-encoded receptor</span>. <i>Cold Spring Harbor Symp. Quant. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1101/sqb.1988.053.01.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1101%2Fsqb.1988.053.01.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=2855492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADyaK3cXls12rsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=521-530&author=C.+J.+Sherrauthor=C.+W.+Rettenmierauthor=M.+F.+Roussel&title=Macrophage+colony-stimulating+factor%2C+CSF1%2C+and+its+proto-oncogene-encoded+receptor&doi=10.1101%2Fsqb.1988.053.01.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor</span></div><div class="casAuthors">Sherr, C. J.; Rettenmier, C. W.; Roussel, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Mol. Biol. Signal Transduction, Pt. 1</span>),
    <span class="NLM_cas:pages">521-30</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review with ∼100 refs.  The CSF-1 receptor is the product of the c-fms proto-oncogene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNptdlBxxGtbVg90H21EOLACvtfcHk0lgRQD5QI-P9cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls12rsLs%253D&md5=3bb763b62cd24ff85ea8a88ad046ee95</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fsqb.1988.053.01.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fsqb.1988.053.01.060%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRettenmier%26aufirst%3DC.%2BW.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26atitle%3DMacrophage%2520colony-stimulating%2520factor%252C%2520CSF1%252C%2520and%2520its%2520proto-oncogene-encoded%2520receptor%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1988%26volume%3D53%26spage%3D521%26epage%3D530%26doi%3D10.1101%2Fsqb.1988.053.01.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothwell, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrschneider, L.</span></span> <span> </span><span class="NLM_article-title">Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3458</span>– <span class="NLM_lpage">3466</span>, <span class="refDoi"> DOI: 10.1128/mcb.5.12.3458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1128%2Fmcb.5.12.3458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=3018521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADyaL28XivFOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1985&pages=3458-3466&author=J.+Woolfordauthor=V.+Rothwellauthor=L.+Rohrschneider&title=Characterization+of+the+human+c-fms+gene+product+and+its+expression+in+cells+of+the+monocyte-macrophage+lineage&doi=10.1128%2Fmcb.5.12.3458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage</span></div><div class="casAuthors">Woolford, Joseph; Rothwell, Victoria; Rohrschneider, Larry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3458-66</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The McDonough strain of feline sarcoma virus contains an oncogene called v-fms whose ultimate protein product (gp140v-fms) resembles a cell surface growth factor receptor.  To identify and characterize the protein product of the proto-oncogene c-fms, antisera were prepd. to the viral fms sequences and used to detect specific cross-reacting sequences in human choriocarcinoma cells (BeWo) known to express c-fms mRNA.  Both tumor-bearing rat sera and a rabbit antiserum prepd. to a segment of v-fms expressed in Escherichia coli detected a 140-kilodalton (kDa) glycoprotein in the BeWo cells.  Tryptic fingerprint anal. of [35S]methionine-labeled proteins indicated that the viral fms proteins and the 140-kDa BeWo cell protein were highly related.  This 140-kDa glycoprotein contained an assocd. tyrosine kinase activity in vitro and was labeled principally on serine after 32Pi metabolic labeling.  Thus, the 140-kDa protein in BeWo cells is the protein product of the human c-fms proto-oncogene.  This conclusion is supported by the finding that a similar protein is detectable only in other human cells that express c-fms mRNA.  These other human cells include adherent monocytes and the cell line ML-1, which can be induced to differentiate along the monocyte-macrophage pathway.  This is in agreement with current thought that the c-fms proto-oncogene product functions as the colony-stimulating factor-1 receptor specific to this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyQC6ZdFdrfrVg90H21EOLACvtfcHk0lgRQD5QI-P9cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XivFOhsQ%253D%253D&md5=183f3753f96a5a6165607014a93065d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2Fmcb.5.12.3458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmcb.5.12.3458%26sid%3Dliteratum%253Aachs%26aulast%3DWoolford%26aufirst%3DJ.%26aulast%3DRothwell%26aufirst%3DV.%26aulast%3DRohrschneider%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520the%2520human%2520c-fms%2520gene%2520product%2520and%2520its%2520expression%2520in%2520cells%2520of%2520the%2520monocyte-macrophage%2520lineage%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1985%26volume%3D5%26spage%3D3458%26epage%3D3466%26doi%3D10.1128%2Fmcb.5.12.3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitu, V.</span></span> <span> </span><span class="NLM_article-title">CSF-1 receptor signaling in myeloid cells</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">a021857</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a021857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1101%2Fcshperspect.a021857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=24890514" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=a021857&author=E.+R.+Stanleyauthor=V.+Chitu&title=CSF-1+receptor+signaling+in+myeloid+cells&doi=10.1101%2Fcshperspect.a021857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a021857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a021857%26sid%3Dliteratum%253Aachs%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DChitu%26aufirst%3DV.%26atitle%3DCSF-1%2520receptor%2520signaling%2520in%2520myeloid%2520cells%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2014%26volume%3D6%26spage%3Da021857%26doi%3D10.1101%2Fcshperspect.a021857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourette, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrschneider, L. R.</span></span> <span> </span><span class="NLM_article-title">Early events in M-CSF receptor signaling</span>. <i>Growth Factors</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.3109/08977190009001065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.3109%2F08977190009001065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10705574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A280%3ADC%252BD3c7mvFOmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2000&pages=155-166&author=R.+P.+Bouretteauthor=L.+R.+Rohrschneider&title=Early+events+in+M-CSF+receptor+signaling&doi=10.3109%2F08977190009001065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Early events in M-CSF receptor signaling</span></div><div class="casAuthors">Bourette R P; Rohrschneider L R</div><div class="citationInfo"><span class="NLM_cas:title">Growth factors (Chur, Switzerland)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-66</span>
        ISSN:<span class="NLM_cas:issn">0897-7194</span>.
    </div><div class="casAbstract">The M-CSF receptor (M-CSFR) is expressed in monocytes-macrophages and their progenitors, and drives growth and development of this blood cell lineage.  The M-CSFR is a member of a small family of growth factor receptors exhibiting related structures but distinct tissue-specific functions.  This review discusses the early molecular events in the M-CSF signaling mechanisms, positive signals, negative signals, the possible organization of individual signaling pathways, and the problem of achieving specificity in the signal transduction mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQoZ6EG8k4AFv3jf77P2BG3fW6udTcc2earPTEh8_c-nLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7mvFOmsA%253D%253D&md5=09f6171000dcd2d1dc7a36292e79ab5b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3109%2F08977190009001065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08977190009001065%26sid%3Dliteratum%253Aachs%26aulast%3DBourette%26aufirst%3DR.%2BP.%26aulast%3DRohrschneider%26aufirst%3DL.%2BR.%26atitle%3DEarly%2520events%2520in%2520M-CSF%2520receptor%2520signaling%26jtitle%3DGrowth%2520Factors%26date%3D2000%26volume%3D17%26spage%3D155%26epage%3D166%26doi%3D10.3109%2F08977190009001065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silakari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. K.</span></span> <span> </span><span class="NLM_article-title">Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.04.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1016%2Fj.biopha.2018.04.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=29679908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFOqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2018&pages=662-679&author=A.+Kumariauthor=O.+Silakariauthor=R.+K.+Singh&title=Recent+advances+in+colony+stimulating+factor-1+receptor%2Fc-FMS+as+an+emerging+target+for+various+therapeutic+implications&doi=10.1016%2Fj.biopha.2018.04.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications</span></div><div class="casAuthors">Kumari, Archana; Silakari, Om; Singh, Rajesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">662-679</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Colony stimulating factor-1 (CSF-1) is one of the most common proinflammatory cytokine responsible for various inflammatory disorders.  It has a remarkable role in the development and progression of osteoarthritis, cancer and other autoimmune disease conditions.  The CSF-1 acts by binding to the receptor, called colony stimulating factor-1 receptor (CSF-1R) also known as c-FMS resulting in the cascade of signalling pathway causing cell proliferation and differentiation.  Interleukin-34 (IL-34), recently identified as another ligand for CSF-IR, is a cytokine protein.  Both, CSF-1 and IL-34, although two distinct cytokines, follow the similar signalling pathway on binding to the same receptor, CSF-1R.  Like CSF-1, IL-34 promotes the differentiation and survival of monocyte, macrophages and osteoclasts.  This CSF-1R/c-FMS is over expressed in many cancers and on tumor assocd. macrophages, consequently, have been exploited as a drug target for promising treatment for cancer and inflammatory diseases.  Some CSF-1R/c-FMS inhibitors such as ABT-869, Imatinib, AG013736, JNJ-40346527, PLX3397, DCC-3014 and Ki20227 have been successfully used in these disease conditions.  Many c-FMS inhibitors have been the candidates of clin. trials, but suffer from some side effects like cardiotoxicity, vomiting, swollen eyes, diarrhoea, etc.  If selectivity of cFMS inhibition is achieved successfully, side effects can be overruled and this approach may become a novel therapy for treatment of various therapeutic interventions.  Thus, successful targeting of c-FMS may result in multifunctional therapy.  With this background of information, the present review focuses on the recent developments in the area of CSF-1R/c-FMS inhibitors with emphasis on crystal structure, mechanism of action and various therapeutic implications in which c-FMS plays a pivotal role.  The review on structure activity relationship of various compds. acting as the inhibitors of c-FMS which gives the selection criteria for the development of novel mols. is also being presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCRQaIDZJ9obVg90H21EOLACvtfcHk0ljRwaRNoMh4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFOqsrw%253D&md5=72c2ccefc7ef777cf87bffdb5f929170</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.04.046%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DA.%26aulast%3DSilakari%26aufirst%3DO.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26atitle%3DRecent%2520advances%2520in%2520colony%2520stimulating%2520factor-1%2520receptor%252Fc-FMS%2520as%2520an%2520emerging%2520target%2520for%2520various%2520therapeutic%2520implications%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D103%26spage%3D662%26epage%3D679%26doi%3D10.1016%2Fj.biopha.2018.04.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chockalingam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S. S.</span></span> <span> </span><span class="NLM_article-title">Macrophage colony-stimulating factor and cancer: a review</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">10635</span>– <span class="NLM_lpage">10644</span>, <span class="refDoi"> DOI: 10.1007/s13277-014-2627-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1007%2Fs13277-014-2627-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=10635-10644&author=S.+Chockalingamauthor=S.+S.+Ghosh&title=Macrophage+colony-stimulating+factor+and+cancer%3A+a+review&doi=10.1007%2Fs13277-014-2627-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage colony-stimulating factor and cancer: a review</span></div><div class="casAuthors">Chockalingam, S.; Ghosh, Siddhartha Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10635-10644</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor growth is influenced by a wide variety of external and internal factors.  One of the most important mediators of tumor development is our immune system.  The nonstop surveillance of the immune system was originally expected to clear the transformed cells from the body and guard against the development of tumor.  But contradictory evidences are reported to show the involvement of immune system in supporting the growth and spread of tumor.  Tumor infiltrating immune cells, in addn. to harboring immunosuppressive activities, also promote angiogenesis and metastasis of tumor.  Many growth factors and cytokines are involved in shaping this complex immune microenvironment of the tumor.  Macrophage colony-stimulating factor (MCSF) is one such growth factor which is overexpressed in many tumors.  In this review, we summarize the basic biol. of MCSF, its role in cancer and discuss the involvement of tumor-assocd. macrophages (TAMs) in tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonrRt-ocMfhrVg90H21EOLACvtfcHk0ljRwaRNoMh4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM&md5=01055b227ccf55ef96e8d9a4a3ec1277</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs13277-014-2627-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-014-2627-0%26sid%3Dliteratum%253Aachs%26aulast%3DChockalingam%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DS.%2BS.%26atitle%3DMacrophage%2520colony-stimulating%2520factor%2520and%2520cancer%253A%2520a%2520review%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D10635%26epage%3D10644%26doi%3D10.1007%2Fs13277-014-2627-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutta, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DesJarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span> <span> </span><span class="NLM_article-title">Pyrido 2,3-d pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1021/jm801406h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801406h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1081-1099&author=H.+Huangauthor=D.+A.+Huttaauthor=J.+M.+Rinkerauthor=H.+Huauthor=W.+H.+Parsonsauthor=C.+Schubertauthor=R.+L.+DesJarlaisauthor=C.+S.+Cryslerauthor=M.+A.+Chaikinauthor=R.+R.+Donatelliauthor=Y.+Chenauthor=D.+Chengauthor=Z.+Zhouauthor=E.+Yurkowauthor=C.+L.+Mantheyauthor=M.+R.+Player&title=Pyrido+2%2C3-d+pyrimidin-5-ones%3A+a+novel+class+of+antiinflammatory+macrophage+colony-stimulating+factor-1+receptor+inhibitors&doi=10.1021%2Fjm801406h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[2,3-d]pyrimidin-5-ones: A novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors</span></div><div class="casAuthors">Huang, Hui; Hutta, Daniel A.; Rinker, James M.; Hu, Huaping; Parsons, William H.; Schubert, Carsten; DesJarlais, Renee L.; Crysler, Carl S.; Chaikin, Margery A.; Donatelli, Robert R.; Chen, Yanmin; Cheng, Deping; Zhou, Zhao; Yurkow, Edward; Manthey, Carl L.; Player, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1081-1099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrido[2,3-d]pyrimidin-5-ones, e.g., I has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS).  FMS inhibitors may be useful in treating rheumatoid arthritis and other chronic inflammatory diseases.  Structure-based optimization of the lead amide analog II (R = H)led to hydroxamate analog II (R = OMe), which possessed excellent potency and an improved pharmacokinetic profile.  During the chronic phase of streptococcal cell wall-induced arthritis in rats, compd. II (R = OMe) (10, 3, and 1 mg/kg) was highly effective at reversing established joint swelling.  In an adjuvant-induced arthritis model in rats, II prevented joint swelling partially at 10 mg/kg.  In this model, osteoclastogenesis and bone erosion were prevented by low doses (1 or 0.33 mg/kg) that had minimal impact on inflammation.  These data underscore the potential of FMS inhibitors to prevent erosions and reduce symptoms in rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXwgHd8k1p7Vg90H21EOLACvtfcHk0ljRwaRNoMh4xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWgtLk%253D&md5=ca6f70b21bce3263161a60a28e4af4ce</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm801406h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801406h%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHutta%26aufirst%3DD.%2BA.%26aulast%3DRinker%26aufirst%3DJ.%2BM.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DR.%2BR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DYurkow%26aufirst%3DE.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26atitle%3DPyrido%25202%252C3-d%2520pyrimidin-5-ones%253A%2520a%2520novel%2520class%2520of%2520antiinflammatory%2520macrophage%2520colony-stimulating%2520factor-1%2520receptor%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1081%26epage%3D1099%26doi%3D10.1021%2Fjm801406h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Illig, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meegalla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballentine, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DesJarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomczuk, B. E.</span></span> <span> </span><span class="NLM_article-title">Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N- 2-(1-cyclohexen-1-yl)-4- 1- (dimethylamino)acetyl -4-piperidi nyl phenyl -1H-imidazole-2-carboxamide (JNJ-28312141)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7860</span>– <span class="NLM_lpage">7883</span>, <span class="refDoi"> DOI: 10.1021/jm200900q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200900q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7860-7883&author=C.+R.+Illigauthor=C.+L.+Mantheyauthor=M.+J.+Wallauthor=S.+K.+Meegallaauthor=J.+Chenauthor=K.+J.+Wilsonauthor=S.+K.+Ballentineauthor=R.+L.+DesJarlaisauthor=C.+Schubertauthor=C.+S.+Cryslerauthor=Y.+Chenauthor=C.+J.+Molloyauthor=M.+A.+Chaikinauthor=R.+R.+Donatelliauthor=E.+Yurkowauthor=Z.+Zhouauthor=M.+R.+Playerauthor=B.+E.+Tomczuk&title=Optimization+of+a+potent+class+of+arylamide+colony-stimulating+factor-1+receptor+inhibitors+leading+to+anti-inflammatory+clinical+candidate+4-cyano-N-+2-%281-cyclohexen-1-yl%29-4-+1-+%28dimethylamino%29acetyl+-4-piperidi+nyl+phenyl+-1H-imidazole-2-carboxamide+%28JNJ-28312141%29&doi=10.1021%2Fjm200900q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Potent Class of Arylamide Colony-Stimulating Factor-1 Receptor Inhibitors Leading to Anti-inflammatory Clinical Candidate 4-Cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)</span></div><div class="casAuthors">Illig, Carl R.; Manthey, Carl L.; Wall, Mark J.; Meegalla, Sanath K.; Chen, Jinsheng; Wilson, Kenneth J.; Ballentine, Shelley K.; DesJarlais, Renee L.; Schubert, Carsten; Crysler, Carl S.; Chen, Yanmin; Molloy, Christopher J.; Chaikin, Margery A.; Donatelli, Robert R.; Yurkow, Edward; Zhou, Zhao; Player, Mark R.; Tomczuk, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7860-7883</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A class of potent inhibitors of colony-stimulating factor-1 receptor (CSF-1R or FMS) was optimized to improve pharmacokinetic and pharmacodynamic properties and potential toxicol. liabilities.  Early stage absorption, distribution, metab., and excretion assays were employed to ensure the incorporation of druglike properties resulting in the selection of several compds. with good activity in a pharmacodynamic screening assay in mice.  Further investigation, utilizing the type II collagen-induced arthritis model in mice, culminated in the selection of anti-inflammatory development candidate JNJ-28312141 (23, I, FMS IC50 = 0.69 nM, cell assay IC50 = 2.6 nM).  Compd. 23 also demonstrated efficacy in rat adjuvant and streptococcal cell wall-induced models of arthritis and has entered phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE9cLVtgUGRbVg90H21EOLACvtfcHk0lhiHsvaItZ2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqs7bO&md5=a2d8b6a468f917dd1abbddc704f0f0ec</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm200900q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200900q%26sid%3Dliteratum%253Aachs%26aulast%3DIllig%26aufirst%3DC.%2BR.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DMeegalla%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DK.%2BJ.%26aulast%3DBallentine%26aufirst%3DS.%2BK.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DR.%2BR.%26aulast%3DYurkow%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26atitle%3DOptimization%2520of%2520a%2520potent%2520class%2520of%2520arylamide%2520colony-stimulating%2520factor-1%2520receptor%2520inhibitors%2520leading%2520to%2520anti-inflammatory%2520clinical%2520candidate%25204-cyano-N-%25202-%25281-cyclohexen-1-yl%2529-4-%25201-%2520%2528dimethylamino%2529acetyl%2520-4-piperidi%2520nyl%2520phenyl%2520-1H-imidazole-2-carboxamide%2520%2528JNJ-28312141%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7860%26epage%3D7883%26doi%3D10.1021%2Fjm200900q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carias, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesch, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5689</span>– <span class="NLM_lpage">5694</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219457110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1073%2Fpnas.1219457110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=23493555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5689-5694&author=C.+Zhangauthor=P.+N.+Ibrahimauthor=J.+Zhangauthor=E.+A.+Burtonauthor=G.+Habetsauthor=Y.+Zhangauthor=B.+Powellauthor=B.+L.+Westauthor=B.+Matusowauthor=G.+Tsangauthor=R.+Shellooeauthor=H.+Cariasauthor=H.+Nguyenauthor=A.+Marimuthuauthor=K.+Y.+J.+Zhangauthor=A.+Ohauthor=R.+Bremerauthor=C.+R.+Hurtauthor=D.+R.+Artisauthor=G.+Wuauthor=M.+Nespiauthor=W.+Spevakauthor=P.+Linauthor=K.+Nolopauthor=P.+Hirthauthor=G.+H.+Teschauthor=G.+Bollag&title=Design+and+pharmacology+of+a+highly+specific+dual+FMS+and+KIT+kinase+inhibitor&doi=10.1073%2Fpnas.1219457110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span></div><div class="casAuthors">Zhang, Chao; Ibrahim, Prabha N.; Zhang, Jiazhong; Burton, Elizabeth A.; Habets, Gaston; Zhang, Ying; Powell, Ben; West, Brian L.; Matusow, Bernice; Tsang, Garson; Shellooe, Rafe; Carias, Heidi; Nguyen, Hoa; Marimuthu, Adhirai; Zhang, Kam Y. J.; Oh, Angela; Bremer, Ryan; Hurt, Clarence R.; Artis, Dean R.; Wu, Guoxian; Nespi, Marika; Spevak, Wayne; Lin, Paul; Nolop, Keith; Hirth, Peter; Tesch, Greg H.; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5689-5694, S5689/1-S5689/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inflammation and cancer, two therapeutic areas historically addressed by sep. drug discovery efforts, are now coupled in treatment approaches by a growing understanding of the dynamic mol. dialogues between immune and cancer cells.  Agents that target specific compartments of the immune system, therefore, not only bring new disease modifying modalities to inflammatory diseases, but also offer a new avenue to cancer therapy by disrupting immune components of the microenvironment that foster tumor growth, progression, immune evasion, and treatment resistance.  McDonough feline sarcoma viral (v-fms) oncogene homolog (FMS) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) are two hematopoietic cell surface receptors that regulate the development and function of macrophages and mast cells, resp.  The authors disclose a highly specific dual FMS and KIT kinase inhibitor developed from a multifaceted chem. scaffold.  As expected, this inhibitor blocks the activation of macrophages, osteoclasts, and mast cells controlled by these two receptors.  More importantly, the dual FMS and KIT inhibition profile has translated into a combination of benefits in preclin. disease models of inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofECnjzEONuLVg90H21EOLACvtfcHk0lhiHsvaItZ2lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D&md5=e4fbca9d41f95718a5119a08a54f5acc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219457110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219457110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCarias%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DHurt%26aufirst%3DC.%2BR.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTesch%26aufirst%3DG.%2BH.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDesign%2520and%2520pharmacology%2520of%2520a%2520highly%2520specific%2520dual%2520FMS%2520and%2520KIT%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D5689%26epage%3D5694%26doi%3D10.1073%2Fpnas.1219457110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Muriana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francos-Quijorna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmos-Alonso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Nicola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Vales, R.</span></span> <span> </span><span class="NLM_article-title">CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral Nerves</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">25663</span>, <span class="refDoi"> DOI: 10.1038/srep25663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1038%2Fsrep25663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=27174644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFKqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=25663&author=A.+Martinez-Murianaauthor=R.+Mancusoauthor=I.+Francos-Quijornaauthor=A.+Olmos-Alonsoauthor=R.+Ostaauthor=V.+H.+Perryauthor=X.+Navarroauthor=D.+Gomez-Nicolaauthor=R.+Lopez-Vales&title=CSF1R+blockade+slows+the+progression+of+amyotrophic+lateral+sclerosis+by+reducing+microgliosis+and+invasion+of+macrophages+into+peripheral+Nerves&doi=10.1038%2Fsrep25663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves</span></div><div class="casAuthors">Martinez-Muriana, Anna; Mancuso, Renzo; Francos-Quijorna, Isaac; Olmos-Alonso, Adrian; Osta, Rosario; Perry, V. Hugh; Navarro, Xavier; Gomez-Nicola, Diego; Lopez-Vales, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25663</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammation is a common neuropathol. feature in several neurol. disorders, including amyotrophic lateral sclerosis (ALS).  We have studied the contribution of CSF1R signalling to inflammation in ALS, as a pathway previously reported to control the expansion and activation of microglial cells.  We found that microglial cell proliferation in the spinal cord of SOD1G93A transgenic mice correlates with the expression of CSF1R and its ligand CSF1.  Administration of GW2580, a selective CSF1R inhibitor, reduced microglial cell proliferation in SOD1G93A mice, indicating the importance of CSF1-CSF1R signalling in microgliosis in ALS.  Moreover, GW2580 treatment slowed disease progression, attenuated motoneuron cell death and extended survival of SOD1G93A mice.  Electrophysiol. assessment revealed that GW2580 treatment protected skeletal muscle from denervation prior to its effects on microglial cells.  We found that macrophages invaded the peripheral nerve of ALS mice before CSF1R-induced microgliosis occurred.  Interestingly, treatment with GW2580 attenuated the influx of macrophages into the nerve, which was partly caused by the monocytopenia induced by CSF1R inhibition.  Overall, our findings provide evidence that CSF1R signalling regulates inflammation in the central and peripheral nervous system in ALS, supporting therapeutic targeting of CSF1R in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSmPgguZQ4qbVg90H21EOLACvtfcHk0ljc1w-GD5N1Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFKqt74%253D&md5=993a80391dfac008405738f4926b587c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsrep25663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep25663%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Muriana%26aufirst%3DA.%26aulast%3DMancuso%26aufirst%3DR.%26aulast%3DFrancos-Quijorna%26aufirst%3DI.%26aulast%3DOlmos-Alonso%26aufirst%3DA.%26aulast%3DOsta%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DV.%2BH.%26aulast%3DNavarro%26aufirst%3DX.%26aulast%3DGomez-Nicola%26aufirst%3DD.%26aulast%3DLopez-Vales%26aufirst%3DR.%26atitle%3DCSF1R%2520blockade%2520slows%2520the%2520progression%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520by%2520reducing%2520microgliosis%2520and%2520invasion%2520of%2520macrophages%2520into%2520peripheral%2520Nerves%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D25663%26doi%3D10.1038%2Fsrep25663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohsfield, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rymar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broome, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span> <span> </span><span class="NLM_article-title">Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3758</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-11674-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1038%2Fs41467-019-11674-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=31434879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A280%3ADC%252BB3MrgtFOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3758&author=E.+Spangenbergauthor=P.+L.+Seversonauthor=L.+A.+Hohsfieldauthor=J.+Crapserauthor=J.+Zhangauthor=E.+A.+Burtonauthor=Y.+Zhangauthor=W.+Spevakauthor=J.+Linauthor=N.+Y.+Phanauthor=G.+Habetsauthor=A.+Rymarauthor=G.+Tsangauthor=J.+Waltersauthor=M.+Nespiauthor=P.+Singhauthor=S.+Broomeauthor=P.+Ibrahimauthor=C.+Zhangauthor=G.+Bollagauthor=B.+L.+Westauthor=K.+N.+Green&title=Sustained+microglial+depletion+with+CSF1R+inhibitor+impairs+parenchymal+plaque+development+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1038%2Fs41467-019-11674-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model</span></div><div class="casAuthors">Spangenberg Elizabeth; Hohsfield Lindsay A; Crapser Joshua; Phan Nicole Y; Green Kim N; Severson Paul L; Zhang Jiazhong; Burton Elizabeth A; Zhang Ying; Spevak Wayne; Lin Jack; Habets Gaston; Rymar Andrey; Tsang Garson; Walters Jason; Nespi Marika; Singh Parmveer; Broome Stephanie; Ibrahim Prabha; Zhang Chao; Bollag Gideon; West Brian L</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3758</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many risk genes for the development of Alzheimer's disease (AD) are exclusively or highly expressed in myeloid cells.  Microglia are dependent on colony-stimulating factor 1 receptor (CSF1R) signaling for their survival.  We designed and synthesized a highly selective brain-penetrant CSF1R inhibitor (PLX5622) allowing for extended and specific microglial elimination, preceding and during pathology development.  We find that in the 5xFAD mouse model of AD, plaques fail to form in the parenchymal space following microglial depletion, except in areas containing surviving microglia.  Instead, Aβ deposits in cortical blood vessels reminiscent of cerebral amyloid angiopathy.  Altered gene expression in the 5xFAD hippocampus is also reversed by the absence of microglia.  Transcriptional analyses of the residual plaque-forming microglia show they exhibit a disease-associated microglia profile.  Collectively, we describe the structure, formulation, and efficacy of PLX5622, which allows for sustained microglial depletion and identify roles of microglia in initiating plaque pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZsPEWZPmRRMNIRw0GKUoEfW6udTcc2ebRmLZFDLthObntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrgtFOruw%253D%253D&md5=ec6089949cf49ffec6faefe983cb3beb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-11674-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-11674-z%26sid%3Dliteratum%253Aachs%26aulast%3DSpangenberg%26aufirst%3DE.%26aulast%3DSeverson%26aufirst%3DP.%2BL.%26aulast%3DHohsfield%26aufirst%3DL.%2BA.%26aulast%3DCrapser%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DPhan%26aufirst%3DN.%2BY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DRymar%26aufirst%3DA.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWalters%26aufirst%3DJ.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DBroome%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26atitle%3DSustained%2520microglial%2520depletion%2520with%2520CSF1R%2520inhibitor%2520impairs%2520parenchymal%2520plaque%2520development%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D3758%26doi%3D10.1038%2Fs41467-019-11674-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Gamal, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ameen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Koumi, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamad, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalal, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.-H.</span></span> <span> </span><span class="NLM_article-title">Recent advances of colony-stimulating factor-1 receptor (CSF-1R) kinase and its inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5450</span>– <span class="NLM_lpage">5466</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00873</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00873" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5450-5466&author=M.+I.+El-Gamalauthor=S.+K.+Al-Ameenauthor=D.+M.+Al-Koumiauthor=M.+G.+Hamadauthor=N.+A.+Jalalauthor=C.-H.+Oh&title=Recent+advances+of+colony-stimulating+factor-1+receptor+%28CSF-1R%29+kinase+and+its+inhibitors&doi=10.1021%2Facs.jmedchem.7b00873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors</span></div><div class="casAuthors">El-Gamal, Mohammed I.; Al-Ameen, Shahad K.; Al-Koumi, Dania M.; Hamad, Mawadda G.; Jalal, Nouran A.; Oh, Chang-Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5450-5466</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is over-stimulated by its ligand, CSF-1.  Innate immunity, as well as macrophage differentiation and survival, are regulated by the stimulation of the CSF-1R.  Another ligand, interleukin-34 (IL-34), was recently reported to activate the CSF-1R receptor in a different manner.  The relationship between CSF-1R and microglia has been reviewed.  Both CSF-1 antibodies and small mol. CSF-1R kinase inhibitors have now been tested in animal models and in humans.  In this Perspective, the authors discuss the role of CSF-1 and IL-34 in producing cancer, bone disorders, and inflammation.  The authors also review the newly discovered and improved small mol. kinase inhibitors and monoclonal antibodies that have shown potent activity toward CSF-1R, reported from 2012 until 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov4GIYJSVtGbVg90H21EOLACvtfcHk0ljc1w-GD5N1Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWgtg%253D%253D&md5=9fa615ecf2f532f1a2f1bac1e4c48932</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00873%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Gamal%26aufirst%3DM.%2BI.%26aulast%3DAl-Ameen%26aufirst%3DS.%2BK.%26aulast%3DAl-Koumi%26aufirst%3DD.%2BM.%26aulast%3DHamad%26aufirst%3DM.%2BG.%26aulast%3DJalal%26aufirst%3DN.%2BA.%26aulast%3DOh%26aufirst%3DC.-H.%26atitle%3DRecent%2520advances%2520of%2520colony-stimulating%2520factor-1%2520receptor%2520%2528CSF-1R%2529%2520kinase%2520and%2520its%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5450%26epage%3D5466%26doi%3D10.1021%2Facs.jmedchem.7b00873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tap, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainberg, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healey, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmielowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staddon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanftner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterfy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong-Starksen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1411366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1056%2Fnejmoa1411366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=26222558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=428-437&author=W.+D.+Tapauthor=Z.+A.+Wainbergauthor=S.+P.+Anthonyauthor=P.+N.+Ibrahimauthor=C.+Zhangauthor=J.+H.+Healeyauthor=B.+Chmielowskiauthor=A.+P.+Staddonauthor=A.+L.+Cohnauthor=G.+I.+Shapiroauthor=V.+L.+Keedyauthor=A.+S.+Singhauthor=I.+Puzanovauthor=E.+L.+Kwakauthor=A.+J.+Wagnerauthor=D.+D.+Von+Hoffauthor=G.+J.+Weissauthor=R.+K.+Ramanathanauthor=J.+Zhangauthor=G.+Habetsauthor=Y.+Zhangauthor=E.+A.+Burtonauthor=G.+Visorauthor=L.+Sanftnerauthor=P.+Seversonauthor=H.+Nguyenauthor=M.+J.+Kimauthor=A.+Marimuthuauthor=G.+Tsangauthor=R.+Shellooeauthor=C.+Geeauthor=B.+L.+Westauthor=P.+Hirthauthor=K.+Nolopauthor=M.+van+de+Rijnauthor=H.+H.+Hsuauthor=C.+Peterfyauthor=P.+S.+Linauthor=S.+Tong-Starksenauthor=G.+Bollag&title=Structure-guided+blockade+of+CSF1R+kinase+in+tenosynovial+giant-cell+tumor&doi=10.1056%2Fnejmoa1411366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span></div><div class="casAuthors">Tap, W. D.; Wainberg, Z. A.; Anthony, S. P.; Ibrahim, P. N.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Staddon, A. P.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; Singh, A. S.; Puzanov, I.; Kwak, E. L.; Wagner, A. J.; Von Hoff, D. D.; Weiss, G. J.; Ramanathan, R. K.; Zhang, J.; Habets, G.; Zhang, Y.; Burton, E. A.; Visor, G.; Sanftner, L.; Severson, P.; Nguyen, H.; Kim, M. J.; Marimuthu, A.; Tsang, G.; Shellooe, R.; Gee, C.; West, B. L.; Hirth, P.; Nolop, K.; van de Rijn, M.; Hsu, H. H.; Peterfy, C.; Lin, P. S.; Tong-Starksen, S.; Bollag, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-437</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Expression of the colony-stimulating factor 1 (CSF1) gene is elevated in most tenosynovial giant-cell tumors.  This observation has led to the discovery and clin. development of therapy targeting the CSF1 receptor (CSF1R).  METHODS Using x-ray co-crystallog. to guide our drug-discovery research, we generated a potent, selective CSF1R inhibitor, PLX3397, that traps the kinase in the autoinhibited conformation.  We then conducted a multicenter, phase 1 trial in two parts to analyze this compd.  In the first part, we evaluated escalations in the dose of PLX3397 that was administered orally in patients with solid tumors (doseescalation study).  In the second part, we evaluated PLX3397 at the chosen phase 2 dose in an extension cohort of patients with tenosynovial giant-cell tumors (extension study).  Pharmacokinetic and tumor responses in the enrolled patients were assessed, and CSF1 in situ hybridization was performed to confirm the mechanism of action of PLX3397 and that the pattern of CSF1 expression was consistent with the pathol. features of tenosynovial giant-cell tumor.  RESULTS A total of 41 patients were enrolled in the dose-escalation study, and an addnl. 23 patients were enrolled in the extension study.  The chosen phase 2 dose of PLX3397 was 1000 mg per day.  In the extension study, 12 patients with tenosynovial giant-cell tumors had a partial response and 7 patients had stable disease.  Responses usually occurred within the first 4 mo of treatment, and the median duration of response exceeded 8 mo.  The most common adverse events included fatigue, change in hair color, nausea, dysgeusia, and periorbital edema; adverse events rarely led to discontinuation of treatment.  CONCLUSIONS Treatment of tenosynovial giant-cell tumors with PLX3397 resulted in a prolonged regression in tumor vol. in most patients. (Funded by Plexxikon; ClinicalTrials.gov no., NCT01004861.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgftPP4lKlQrVg90H21EOLACvtfcHk0lhGqyePwKRKAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN&md5=5e822a87786aca7495222e3d18f82bdb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1411366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1411366%26sid%3Dliteratum%253Aachs%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DChmielowski%26aufirst%3DB.%26aulast%3DStaddon%26aufirst%3DA.%2BP.%26aulast%3DCohn%26aufirst%3DA.%2BL.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DKeedy%26aufirst%3DV.%2BL.%26aulast%3DSingh%26aufirst%3DA.%2BS.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DVisor%26aufirst%3DG.%26aulast%3DSanftner%26aufirst%3DL.%26aulast%3DSeverson%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DGee%26aufirst%3DC.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DH.%2BH.%26aulast%3DPeterfy%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DTong-Starksen%26aufirst%3DS.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DStructure-guided%2520blockade%2520of%2520CSF1R%2520kinase%2520in%2520tenosynovial%2520giant-cell%2520tumor%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D428%26epage%3D437%26doi%3D10.1056%2Fnejmoa1411366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyonteck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijeiro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1038/nm.3337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1038%2Fnm.3337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=24056773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1264-1272&author=S.+M.+Pyonteckauthor=L.+Akkariauthor=A.+J.+Schuhmacherauthor=R.+L.+Bowmanauthor=L.+Sevenichauthor=D.+F.+Quailauthor=O.+C.+Olsonauthor=M.+L.+Quickauthor=J.+T.+Huseauthor=V.+Teijeiroauthor=M.+Settyauthor=C.+S.+Leslieauthor=Y.+Oeiauthor=A.+Pedrazaauthor=J.+Zhangauthor=C.+W.+Brennanauthor=J.+C.+Suttonauthor=E.+C.+Hollandauthor=D.+Danielauthor=J.+A.+Joyce&title=CSF-1R+inhibition+alters+macrophage+polarization+and+blocks+glioma+progression&doi=10.1038%2Fnm.3337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span></div><div class="casAuthors">Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Huse, Jason T.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Oei, Yoko; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.; Sutton, James C.; Holland, Eric C.; Daniel, Dylan; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1272</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) comprises several mol. subtypes, including proneural GBM.  Most therapeutic approaches targeting glioma cells have failed.  An alternative strategy is to target cells in the glioma microenvironment, such as tumor-assocd. macrophages and microglia (TAMs).  Macrophages depend on colony stimulating factor-1 (CSF-1) for differentiation and survival.  We used an inhibitor of the CSF-1 receptor (CSF-1R) to target TAMs in a mouse proneural GBM model, which significantly increased survival and regressed established tumors.  CSF-1R blockade addnl. slowed intracranial growth of patient-derived glioma xenografts.  Surprisingly, TAMs were not depleted in treated mice.  Instead, glioma-secreted factors, including granulocyte-macrophage CSF (GM-CSF) and interferon-γ (IFN-γ), facilitated TAM survival in the context of CSF-1R inhibition.  Expression of alternatively activated M2 markers decreased in surviving TAMs, which is consistent with impaired tumor-promoting functions.  These gene signatures were assocd. with enhanced survival in patients with proneural GBM.  Our results identify TAMs as a promising therapeutic target for proneural gliomas and establish the translational potential of CSF-1R inhibition for GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirwpRVIWUELVg90H21EOLACvtfcHk0liVwrpOTUg3ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N&md5=9b908e86c4a7da35a009bf322d492214</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnm.3337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3337%26sid%3Dliteratum%253Aachs%26aulast%3DPyonteck%26aufirst%3DS.%2BM.%26aulast%3DAkkari%26aufirst%3DL.%26aulast%3DSchuhmacher%26aufirst%3DA.%2BJ.%26aulast%3DBowman%26aufirst%3DR.%2BL.%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DQuail%26aufirst%3DD.%2BF.%26aulast%3DOlson%26aufirst%3DO.%2BC.%26aulast%3DQuick%26aufirst%3DM.%2BL.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DTeijeiro%26aufirst%3DV.%26aulast%3DSetty%26aufirst%3DM.%26aulast%3DLeslie%26aufirst%3DC.%2BS.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DHolland%26aufirst%3DE.%2BC.%26aulast%3DDaniel%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DCSF-1R%2520inhibition%2520alters%2520macrophage%2520polarization%2520and%2520blocks%2520glioma%2520progression%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1264%26epage%3D1272%26doi%3D10.1038%2Fnm.3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolcher, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrus, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cable, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, A.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">A252</span>, <span class="refDoi"> DOI: 10.1158/1535-7163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1158%2F1535-7163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=A252&author=J.+C.+Bendellauthor=A.+W.+Tolcherauthor=S.+F.+Jonesauthor=M.+Beeramauthor=J.+R.+Infanteauthor=P.+Larsenauthor=K.+Rasorauthor=J.+E.+Garrusauthor=J.+F.+Liauthor=P.+L.+Cableauthor=C.+Eberhardtauthor=J.+Schreiberauthor=S.+Rushauthor=K.+W.+Woodauthor=E.+Barretauthor=A.+Patnaik&title=A+phase+1+study+of+ARRY-382%2C+an+oral+inhibitor+of+colony-stimulating+factor-1+receptor+%28CSF1R%29%2C+in+patients+with+advanced+or+metastatic+cancers&doi=10.1158%2F1535-7163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163%26sid%3Dliteratum%253Aachs%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DTolcher%26aufirst%3DA.%2BW.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DBeeram%26aufirst%3DM.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DLarsen%26aufirst%3DP.%26aulast%3DRasor%26aufirst%3DK.%26aulast%3DGarrus%26aufirst%3DJ.%2BE.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DCable%26aufirst%3DP.%2BL.%26aulast%3DEberhardt%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DJ.%26aulast%3DRush%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DBarret%26aufirst%3DE.%26aulast%3DPatnaik%26aufirst%3DA.%26atitle%3DA%2520phase%25201%2520study%2520of%2520ARRY-382%252C%2520an%2520oral%2520inhibitor%2520of%2520colony-stimulating%2520factor-1%2520receptor%2520%2528CSF1R%2529%252C%2520in%2520patients%2520with%2520advanced%2520or%2520metastatic%2520cancers%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3DA252%26doi%3D10.1158%2F1535-7163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Von
Tresckow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribrag, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetharam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoulek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engert, A.</span></span> <span> </span><span class="NLM_article-title">An open-label, multicenter, phase I/II study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1850</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-14-1845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1158%2F1078-0432.ccr-14-1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=25628399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1843-1850&author=B.+Von%0ATresckowauthor=F.+Morschhauserauthor=V.+Ribragauthor=M.+S.+Toppauthor=C.+Chienauthor=S.+Seetharamauthor=R.+Aquinoauthor=S.+Kotoulekauthor=C.+J.+de+Boerauthor=A.+Engert&title=An+open-label%2C+multicenter%2C+phase+I%2FII+study+of+JNJ-40346527%2C+a+CSF-1R+inhibitor%2C+in+patients+with+relapsed+or+refractory+hodgkin+lymphoma&doi=10.1158%2F1078-0432.ccr-14-1845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma</span></div><div class="casAuthors">von Tresckow, Bastian; Morschhauser, Franck; Ribrag, Vincent; Topp, Max S.; Chien, Caly; Seetharam, Shobha; Aquino, Regina; Kotoulek, Sonja; de Boer, Carla J.; Engert, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1843-1850</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This phase I/II study investigated JNJ-40346527, a selective inhibitor of the colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase as treatment for relapsed or refractory classical Hodgkin lymphoma (cHL).  Patients ≥18 years with histopathol. confirmed initial diagnosis of cHL that had relapsed or was refractory after ≥1 appropriate therapies were assigned to sequential cohorts of oral daily doses of JNJ-40346527 (150, 300, 450, 600 mg every day, and 150 mg twice a day).  For the dose-escalation phase, the primary endpoint was to establish the recommended phase II dose.  Secondary endpoints included safety, pharmacokinetics, and pharmacodynamics.  Twenty-one patients [(150 mg: 3; 300 mg: 5; 450 mg: 3, 600 mg: 3) every day, and 150 mg twice a day: 7] were enrolled, 10 men, median age 40 (range, 19-75) years, median no. of prior systemic therapies 6 (range, 3-14).  No dose-limiting toxicities were obsd.; max.-tolerated dose was not established.  Best overall response was complete remission in 1 patient (duration, +352 days) and stable disease in 11 patients: (duration, 1.5-8 mo).  Median no. of cycles: 4 (range, 1-16).  Most common (≥20% patients) possibly drug-related adverse events (per investigator assessment) were nausea (n = 6), headache, and pyrexia (n = 5 each).  JNJ-40346527 exposure increased in near dose-proportional manner over a dose range of 150 to 450 mg every day, but plateaued at 600 mg every day.  Target engagement was confirmed (>80% inhibition of CSF-1R phosphorylation, 4 h after dosing).  JNJ-40346527, a selective inhibitor of CSF-1R was well tolerated, and preliminary antitumor results suggested limited activity in monotherapy for the treatment of cHL.  Clin Cancer Res; 21(8); 1843-50. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZuUy9-7MhLVg90H21EOLACvtfcHk0liVwrpOTUg3ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D&md5=e3d4f2b2937078f85ef0ead51e093f82</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-14-1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-14-1845%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BTresckow%26aufirst%3DB.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DRibrag%26aufirst%3DV.%26aulast%3DTopp%26aufirst%3DM.%2BS.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DSeetharam%26aufirst%3DS.%26aulast%3DAquino%26aufirst%3DR.%26aulast%3DKotoulek%26aufirst%3DS.%26aulast%3Dde%2BBoer%26aufirst%3DC.%2BJ.%26aulast%3DEngert%26aufirst%3DA.%26atitle%3DAn%2520open-label%252C%2520multicenter%252C%2520phase%2520I%252FII%2520study%2520of%2520JNJ-40346527%252C%2520a%2520CSF-1R%2520inhibitor%252C%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520hodgkin%2520lymphoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D1843%26epage%3D1850%26doi%3D10.1158%2F1078-0432.ccr-14-1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, J. P.</span></span> <span> </span><span class="NLM_article-title">Blocking colony stimulating factor 1 receptor (CSF-1R) and tropomyosin receptor kinase (Trk) improves antitumor efficacy of immunotherapy</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">PR01</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=PR01&author=S.+Mokauthor=C.+Duffyauthor=R.+Duauthor=J.+P.+Allison&title=Blocking+colony+stimulating+factor+1+receptor+%28CSF-1R%29+and+tropomyosin+receptor+kinase+%28Trk%29+improves+antitumor+efficacy+of+immunotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMok%26aufirst%3DS.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26atitle%3DBlocking%2520colony%2520stimulating%2520factor%25201%2520receptor%2520%2528CSF-1R%2529%2520and%2520tropomyosin%2520receptor%2520kinase%2520%2528Trk%2529%2520improves%2520antitumor%2520efficacy%2520of%2520immunotherapy%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2017%26volume%3D5%26spage%3DPR01" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osipov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saung, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A. G.</span></span> <span> </span><span class="NLM_article-title">Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">224</span>, <span class="refDoi"> DOI: 10.1186/s40425-019-0667-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1186%2Fs40425-019-0667-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=31439034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A280%3ADC%252BB3MrgsF2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=224&author=A.+Osipovauthor=M.+T.+Saungauthor=L.+Zhengauthor=A.+G.+Murphy&title=Small+molecule+immunomodulation%3A+the+tumor+microenvironment+and+overcoming+immune+escape&doi=10.1186%2Fs40425-019-0667-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape</span></div><div class="casAuthors">Osipov Arsen; Saung May Tun; Zheng Lei; Murphy Adrian G; Murphy Adrian G</div><div class="citationInfo"><span class="NLM_cas:title">Journal for immunotherapy of cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Immunotherapy has led to a paradigm shift in the treatment of many advanced malignancies.  Despite the success in treatment of tumors like non-small cell lung cancer (NSCLC) and melanoma, checkpoint inhibition-based immunotherapy has limitations.  Many tumors, such as pancreatic cancer, are less responsive to checkpoint inhibitors, where patients tend to have a limited duration of benefit and where clinical responses are more robust in patients who are positive for predictive biomarkers.  One of the critical factors that influence the efficacy of immunotherapy is the tumor microenvironment (TME), which contains a heterogeneous composition of immunosuppressive cells.  Myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) alter the immune landscape of the TME and serve as facilitators of tumor proliferation, metastatic growth and immunotherapy resistance.  Small molecule inhibitors that target these components of the TME have been developed.  This special issue review focuses on two promising classes of immunomodulatory small molecule inhibitors: colony stimulating factor-1 receptor (CSF-1R) and focal adhesion kinase (FAK).  Small molecule inhibitors of CSF-1R reprogram the TME and TAMs, and lead to enhanced T-cell-mediated tumor eradication.  FAK small molecule inhibitors decrease the infiltration MDSCs, TAMs and regulatory T-cells.  Additionally, FAK inhibitors are implicated as modulators of stromal density and cancer stem cells, leading to a TME more conducive to an anti-tumor immune response.  Immunomodulatory small molecule inhibitors present a unique opportunity to attenuate immune escape of tumors and potentiate the effectiveness of immunotherapy and traditional cytotoxic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMtQEKH7hnxRFwe7cAcrfPfW6udTcc2eaNyM-Uaf6pGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrgsF2nsw%253D%253D&md5=f38c986988b001c3d272f4cace19e295</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs40425-019-0667-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40425-019-0667-0%26sid%3Dliteratum%253Aachs%26aulast%3DOsipov%26aufirst%3DA.%26aulast%3DSaung%26aufirst%3DM.%2BT.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DA.%2BG.%26atitle%3DSmall%2520molecule%2520immunomodulation%253A%2520the%2520tumor%2520microenvironment%2520and%2520overcoming%2520immune%2520escape%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2019%26volume%3D7%26spage%3D224%26doi%3D10.1186%2Fs40425-019-0667-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levis, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of c-Kit by tyrosine kinase inhibitors</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">e77</span>– <span class="NLM_lpage">e79</span>, <span class="refDoi"> DOI: 10.3324/haematol.2014.117028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.3324%2Fhaematol.2014.117028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=25425690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=e77-e79&author=A.+Galanisauthor=M.+Levis&title=Inhibition+of+c-Kit+by+tyrosine+kinase+inhibitors&doi=10.3324%2Fhaematol.2014.117028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2014.117028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2014.117028%26sid%3Dliteratum%253Aachs%26aulast%3DGalanis%26aufirst%3DA.%26aulast%3DLevis%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520c-Kit%2520by%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3De77%26epage%3De79%26doi%3D10.3324%2Fhaematol.2014.117028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1016%2Fj.ejmech.2016.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=27750146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslShsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=122-132&author=Y.+Liuauthor=X.+Pengauthor=X.+Guanauthor=D.+Luauthor=Y.+Xiauthor=S.+Jinauthor=H.+Chenauthor=L.+Zengauthor=J.+Aiauthor=M.+Gengauthor=Y.+Hu&title=Discovery+of+novel+ponatinib+analogues+for+reducing+KDR+activity+as+potent+FGFRs+inhibitors&doi=10.1016%2Fj.ejmech.2016.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors</span></div><div class="casAuthors">Liu, Yang; Peng, Xia; Guan, Xiaocong; Lu, Dong; Xi, Yong; Jin, Shiyu; Chen, Hui; Zeng, Limin; Ai, Jing; Geng, Meiyu; Hu, Youhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">122-132</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">FGF receptors (FGFRs) are tyrosine kinases that are overexpressed in diverse tumors by genetic alterations such as gene amplifications, somatic mutations and translocations.  Owing to this characteristic, FGFRs are attractive targets for cancer treatment.  It has been demonstrated that most multi-targeted, ATP competitive tyrosine kinase inhibitors are active against FGFRs as well as other kinases.  The design of new and more selective inhibitors of FGFRs, which might be reduced off-target and side effects, is a difficult yet significant challenge.  The results of the current investigation, show that novel Ponatinib analogs are highly active as FGFR inhibitors and that they possess reduced kinase insert domain receptor (KDR) activities.  Observations made in a structure and activity relationship (SAR) investigation led to the development of a promising, orally available lead compd. 4-chloro-N-(4-((4-methylpiperazin-1-yl) methyl)-3-(trifluoromethyl) phenyl)-3-((5-morpholinopyridin-3-yl) ethynyl) benzamide (compd. 4, I), which displays a 50-100-fold in vitro selectivity for inhibition of FGFR1-3 over KDR.  In addn., biol. evaluation of I showed that it displays significant antitumor activities in FGFR1-amplificated H1581 and FGFR2-amplificated SNU-16 xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMqkDLJD5jOLVg90H21EOLACvtfcHk0lhcnuf3hyp3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslShsbbK&md5=020229eec1c8a365516b752219a50368</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DXi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520novel%2520ponatinib%2520analogues%2520for%2520reducing%2520KDR%2520activity%2520as%2520potent%2520FGFRs%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D122%26epage%3D132%26doi%3D10.1016%2Fj.ejmech.2016.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1241</span>, <span class="refDoi"> DOI: 10.1021/cb500129t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500129t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1230-1241&author=Z.+Zhaoauthor=H.+Wuauthor=L.+Wangauthor=Y.+Liuauthor=S.+Knappauthor=Q.+Liuauthor=N.+S.+Gray&title=Exploration+of+type+II+binding+mode%3A+a+privileged+approach+for+kinase+inhibitor+focused+drug+discovery%3F&doi=10.1021%2Fcb500129t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?</span></div><div class="casAuthors">Zhao, Zheng; Wu, Hong; Wang, Li; Liu, Yi; Knapp, Stefan; Liu, Qingsong; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1230-1241</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The ATP site of kinases displays remarkable conformational flexibility when accommodating chem. diverse small mol. inhibitors.  The so-called activation segment, whose conformation controls catalytic activity and access to the substrate binding pocket, can undergo a large conformational change with the active state assuming a 'DFG-in' and an inactive state assuming a 'DFG-out' conformation.  Compds. that preferentially bind to the DFG-out conformation are typically called 'type II' inhibitors in contrast to 'type I' inhibitors that bind to the DFG-in conformation.  This review surveys the large no. of type II inhibitors that have been developed and provides an anal. of their crystallog. detd. binding modes.  Using a small library of type II inhibitors, we demonstrate that more than 200 kinases can be targeted, suggesting that type II inhibitors may not be intrinsically more selective than type I inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jYt6Db3Ap7Vg90H21EOLACvtfcHk0lhcnuf3hyp3kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D&md5=95bf185ff7f973eda5a65f4096bfaa82</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500129t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520of%2520type%2520II%2520binding%2520mode%253A%2520a%2520privileged%2520approach%2520for%2520kinase%2520inhibitor%2520focused%2520drug%2520discovery%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1230%26epage%3D1241%26doi%3D10.1021%2Fcb500129t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanqué, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meakin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, C. R.</span></span> <span> </span><span class="NLM_article-title">Selective enhancement of LPS-induced serum TNF-alpha production by carrageenan pretreatment in mice</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/s0306-3623(97)00434-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1016%2Fs0306-3623%2897%2900434-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=9688477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADyaK1cXjs1Orsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1998&pages=301-306&author=R.+Blanqu%C3%A9author=C.+Meakinauthor=S.+Milletauthor=C.+R.+Gardner&title=Selective+enhancement+of+LPS-induced+serum+TNF-alpha+production+by+carrageenan+pretreatment+in+mice&doi=10.1016%2Fs0306-3623%2897%2900434-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selective enhancement of LPS-induced serum TNF-α production by carrageenan pretreatment in mice</span></div><div class="casAuthors">Blanque, R.; Meakin, C.; Millet, S.; Gardner, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-306</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Bacterial lipopolysaccharide (LPS)-induced increases in serum cytokines (TNF-α, IL-1 and IL-6) and hypothermia were studied in mice sensitized by carrageenan pretreatment and compared with mice sensitized with heat-killed P. acnes or IFN-γ, all given i.p. at appropriate intervals (24 h, 7 days and 12-18 h, resp.) before LPS.  In mice with localized peritoneal inflammation induced by carrageenan, peak TNF-α levels (1.5-2 h after LPS) were markedly enhanced after both doses of LPS tested (50 and 200 μg/mouse i.p.).  However, IL-1β levels were not changed and IL-6 levels were decreased only after the higher dose of LPS.  Hypothermia showed weak and inconsistent changes in carrageenan-sensitized mice.  IL-1β levels in spleen lysates were higher but paralleled those in the serum, being increased in IFN-γ-sensitized but not in carrageenan-sensitized mice.  The levels of both TNF-α and IL-1β were high in the peritoneum of carrageenan-sensitized mice, suggesting that the increased serum TNF-α did not emanate from the peritoneum.  In mice sensitized with the other two agents, as expected, the levels of all three cytokines increased, but peak levels were attained at the same times post-LPS (TNF-α: 1-1.5 h; IL-1: 3-4 h; IL-6: 3-4 h).  In addn., hypothermia was increased with both of these methods of sensitization.  The lack of consistent correlation of the levels of cytokines studied, particularly TNF-α, with the degree of hypothermia, raises questions as to their causative role in its induction in these models.  The mechanisms underlying these models of sensitization are clearly different, and further understanding of these mechanisms would aid in the interpretation of the effects of drugs in the models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLv7osrglM2rVg90H21EOLACvtfcHk0likG4EQZ83l4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjs1Orsb8%253D&md5=06e9708a3fc8def9e4eee54d57ad3dcd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fs0306-3623%2897%2900434-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0306-3623%252897%252900434-5%26sid%3Dliteratum%253Aachs%26aulast%3DBlanqu%25C3%25A9%26aufirst%3DR.%26aulast%3DMeakin%26aufirst%3DC.%26aulast%3DMillet%26aufirst%3DS.%26aulast%3DGardner%26aufirst%3DC.%2BR.%26atitle%3DSelective%2520enhancement%2520of%2520LPS-induced%2520serum%2520TNF-alpha%2520production%2520by%2520carrageenan%2520pretreatment%2520in%2520mice%26jtitle%3DGen.%2520Pharmacol.%26date%3D1998%26volume%3D31%26spage%3D301%26epage%3D306%26doi%3D10.1016%2Fs0306-3623%2897%2900434-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0likG4EQZ83l4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao‐Tun  Cao</span>, <span class="hlFld-ContribAuthor ">Lu  Yan</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">Determination and application of the excited‐state substituent constants of pyridyl and substituted phenyl groups. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physical Organic Chemistry</span><span> <strong>2021,</strong> <em>310 </em><a href="https://doi.org/10.1002/poc.4246" title="DOI URL">https://doi.org/10.1002/poc.4246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/poc.4246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpoc.4246%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physical%2520Organic%2520Chemistry%26atitle%3DDetermination%252Band%252Bapplication%252Bof%252Bthe%252Bexcited%2525E2%252580%252590state%252Bsubstituent%252Bconstants%252Bof%252Bpyridyl%252Band%252Bsubstituted%252Bphenyl%252Bgroups%26aulast%3DCao%26aufirst%3DChao%25E2%2580%2590Tun%26date%3D2021%26date%3D2021%26volume%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuela  Berrino</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Carta</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Cecilia  Coletti</span>, <span class="hlFld-ContribAuthor ">Roberto  Paciotti</span>, <span class="hlFld-ContribAuthor ">Helmut  Schweikl</span>, <span class="hlFld-ContribAuthor ">Francesca  Maestrelli</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Cerbai</span>, <span class="hlFld-ContribAuthor ">Marialucia  Gallorini</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (1)
                                     , 56. <a href="https://doi.org/10.3390/antiox10010056" title="DOI URL">https://doi.org/10.3390/antiox10010056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10010056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10010056%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DDual%252BCarbonic%252BAnhydrase%252BIX%25252FXII%252BInhibitors%252Band%252BCarbon%252BMonoxide%252BReleasing%252BMolecules%252BModulate%252BLPS-Mediated%252BInflammation%252Bin%252BMouse%252BMacrophages%26aulast%3DBerrino%26aufirst%3DEmanuela%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D1%26spage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sifeng  Li</span>, <span class="hlFld-ContribAuthor ">Zihao  Wang</span>, <span class="hlFld-ContribAuthor ">Haitao  Xiao</span>, <span class="hlFld-ContribAuthor ">Zhaoxiang  Bian</span>, <span class="hlFld-ContribAuthor ">Jun (Joelle)  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective synthesis of indole derivatives by Rh/Pd relay catalysis and their anti-inflammatory evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (55)
                                     , 7573-7576. <a href="https://doi.org/10.1039/D0CC03158E" title="DOI URL">https://doi.org/10.1039/D0CC03158E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC03158E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC03158E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DEnantioselective%252Bsynthesis%252Bof%252Bindole%252Bderivatives%252Bby%252BRh%25252FPd%252Brelay%252Bcatalysis%252Band%252Btheir%252Banti-inflammatory%252Bevaluation%26aulast%3DLi%26aufirst%3DSifeng%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D55%26spage%3D7573%26epage%3D7576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative chemical structure of CSF-1R kinase inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>8–22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagent and conditions: (a) X = Br: trimethylsilylacetylene, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, MeCN/Et<sub>3</sub>N (4:1, v/v), 80 °C, 4 h; X = I: ethynyltrimethyl-silane, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, rt, 6 h; (b) HATU, DIPEA, DMF, rt, 4 h; (c) X = Br: Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, 80 °C, 4 h; X = I: Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, rt, 4 h; (d) 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, toulene/EtOH/H<sub>2</sub>O (2/1/1, v/v/v), microwave irradiation, 100 °C, 20 min.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>23–33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagent and conditions: (a) <b>39i</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, rt, 5 h; (b) 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, Pd(OAc)<sub>2</sub>, X-phos, K<sub>2</sub>CO<sub>3</sub>, THF/H<sub>2</sub>O (4/1, v/v), 90 °C, 6 h; (c) LiOH·H<sub>2</sub>O, THF/MeOH/H<sub>2</sub>O (4/1/1, v/v/v), rt, 12 h; (d) the substituted phenylamines, HATU, DIPEA, DMF, rt, 4 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>34–37</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagent and conditions: (a) HATU, DIPEA, DMF, rt, 4 h; (b) MeI, NaH, THF, 0 °C to rt, 5 h; (c) BF<sub>3</sub>·THF (1 M), THF, rt, 12 h; (d) <b>39i</b>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, CsF, Et<sub>3</sub>N, MeCN, rt, 4 h; (e) 1-methyl-4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)-1<i>H</i>-pyrazole, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, THF/EtOH/H<sub>2</sub>O (2/1/1, v/v/v), microwave irradiation, 100 °C, 20 min.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Development schematic of novel <i>o</i>-aminopyridylene scaffold-based CSF-1R selective inhibitor <b>29</b> by structural modification of the previously designed FGFR inhibitor <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding mode analysis of compounds <b>7</b> and <b>8</b> to FGFR and CSF-1R kinases. (A) Crystal structure of CSF-1R kinase domain with PLX3397 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>). (B) Molecular docking of compound <b>7</b> into FGFR1 kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a>). (C) Molecular docking of compound <b>8</b> into FGFR1 kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a>). (D) Molecular docking of compound <b>7</b> into CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a>). (E) Structure illustration of compound <b>7</b> displaces the JM domain of CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a>). (F) Structure illustration of compound <b>8</b> recruits the JM domain of CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic illustration of the SAR exploration rationale. (A) Binding mode study of compound <b>12</b> in CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>); (B) binding mode study of compound <b>16</b> in CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Molecular modeling analysis of the binding mode of compound <b>16</b> in CSF-1R kinase. (A) Binding mode study of <b>16</b> in CSF-1R kinase (generated from PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>); (B) Approximate orthogonal conformation of the diarylethyne system was controlled by the methyl group in the middle benzene ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Binding mode study of inhibitor <b>29</b> in CSF1R kinase (generated from PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cellular effects of compound <b>29</b> in the RAW264.7 cell line. (A) Compound <b>29</b> inhibited phosphorylation of CSF-1R and its downstream signaling pathway in RAW264.7 cells as determined by Western blot analysis. (B) Compound <b>29</b> exhibited potent activity on LPS-induced TNF-α and IL-6 release in RAW264.7 cells. Blk: Blank. Data are given as the mean ± standard error of the mean (SEM). Statistical analysis is performed by one-way analysis of variance (ANOVA). *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to LPS. #<i>P</i> < 0.05, ##<i>P</i> < 0.01, and ###<i>P</i> < 0.001 compared to Blk. (C) Cytotoxicity of compound <b>29</b> (CC<sub>50</sub> = 66.01 μM) and PLX3397 (CC<sub>50</sub> = 20.52 μM) over RAW264.7 macrophages was determined by Cell Counting Kit-8 (CCK-8).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/medium/jm9b01912_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Inflammation cytokine concentrations in serum of the LPS-induced mice model. The mice were orally administrated with PLX3397 (40 mg/kg), compound <b>29</b> (20 and 40 mg/kg) at 4 h before intraperitoneal injection with LPS (<i>n</i> = 6, female). The concentration of cytokines in serum was detected at 1.5 h for TNF-α and 3 h for IL-6 by ELISA assay. Data are given as mean ± SEM. Statistical analysis is performed by one-way analysis of variance (ANOVA). *<i>P</i> < 0.05, **<i>P</i> < 0.01, and ***<i>P</i> < 0.001 compared to vehicle. #<i>P</i> < 0.05, ##<i>P</i> < 0.01, and ###<i>P</i> < 0.001 compared to normal.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-3/acs.jmedchem.9b01912/20200207/images/large/jm9b01912_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01912&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i99">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17580" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17580" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 23 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sherr, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rettenmier, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roussel, M. F.</span></span> <span> </span><span class="NLM_article-title">Macrophage colony-stimulating factor, CSF1, and its proto-oncogene-encoded receptor</span>. <i>Cold Spring Harbor Symp. Quant. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">530</span>, <span class="refDoi"> DOI: 10.1101/sqb.1988.053.01.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1101%2Fsqb.1988.053.01.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=2855492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADyaK3cXls12rsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=521-530&author=C.+J.+Sherrauthor=C.+W.+Rettenmierauthor=M.+F.+Roussel&title=Macrophage+colony-stimulating+factor%2C+CSF1%2C+and+its+proto-oncogene-encoded+receptor&doi=10.1101%2Fsqb.1988.053.01.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage colony-stimulating factor, CSF-1, and its proto-oncogene-encoded receptor</span></div><div class="casAuthors">Sherr, C. J.; Rettenmier, C. W.; Roussel, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Mol. Biol. Signal Transduction, Pt. 1</span>),
    <span class="NLM_cas:pages">521-30</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review with ∼100 refs.  The CSF-1 receptor is the product of the c-fms proto-oncogene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNptdlBxxGtbVg90H21EOLACvtfcHk0ljuzsUI2PJ0nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls12rsLs%253D&md5=3bb763b62cd24ff85ea8a88ad046ee95</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1101%2Fsqb.1988.053.01.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fsqb.1988.053.01.060%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DRettenmier%26aufirst%3DC.%2BW.%26aulast%3DRoussel%26aufirst%3DM.%2BF.%26atitle%3DMacrophage%2520colony-stimulating%2520factor%252C%2520CSF1%252C%2520and%2520its%2520proto-oncogene-encoded%2520receptor%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1988%26volume%3D53%26spage%3D521%26epage%3D530%26doi%3D10.1101%2Fsqb.1988.053.01.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woolford, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothwell, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrschneider, L.</span></span> <span> </span><span class="NLM_article-title">Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">3458</span>– <span class="NLM_lpage">3466</span>, <span class="refDoi"> DOI: 10.1128/mcb.5.12.3458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1128%2Fmcb.5.12.3458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=3018521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADyaL28XivFOhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1985&pages=3458-3466&author=J.+Woolfordauthor=V.+Rothwellauthor=L.+Rohrschneider&title=Characterization+of+the+human+c-fms+gene+product+and+its+expression+in+cells+of+the+monocyte-macrophage+lineage&doi=10.1128%2Fmcb.5.12.3458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage</span></div><div class="casAuthors">Woolford, Joseph; Rothwell, Victoria; Rohrschneider, Larry</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3458-66</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The McDonough strain of feline sarcoma virus contains an oncogene called v-fms whose ultimate protein product (gp140v-fms) resembles a cell surface growth factor receptor.  To identify and characterize the protein product of the proto-oncogene c-fms, antisera were prepd. to the viral fms sequences and used to detect specific cross-reacting sequences in human choriocarcinoma cells (BeWo) known to express c-fms mRNA.  Both tumor-bearing rat sera and a rabbit antiserum prepd. to a segment of v-fms expressed in Escherichia coli detected a 140-kilodalton (kDa) glycoprotein in the BeWo cells.  Tryptic fingerprint anal. of [35S]methionine-labeled proteins indicated that the viral fms proteins and the 140-kDa BeWo cell protein were highly related.  This 140-kDa glycoprotein contained an assocd. tyrosine kinase activity in vitro and was labeled principally on serine after 32Pi metabolic labeling.  Thus, the 140-kDa protein in BeWo cells is the protein product of the human c-fms proto-oncogene.  This conclusion is supported by the finding that a similar protein is detectable only in other human cells that express c-fms mRNA.  These other human cells include adherent monocytes and the cell line ML-1, which can be induced to differentiate along the monocyte-macrophage pathway.  This is in agreement with current thought that the c-fms proto-oncogene product functions as the colony-stimulating factor-1 receptor specific to this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyQC6ZdFdrfrVg90H21EOLACvtfcHk0ljuzsUI2PJ0nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XivFOhsQ%253D%253D&md5=183f3753f96a5a6165607014a93065d6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1128%2Fmcb.5.12.3458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fmcb.5.12.3458%26sid%3Dliteratum%253Aachs%26aulast%3DWoolford%26aufirst%3DJ.%26aulast%3DRothwell%26aufirst%3DV.%26aulast%3DRohrschneider%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520the%2520human%2520c-fms%2520gene%2520product%2520and%2520its%2520expression%2520in%2520cells%2520of%2520the%2520monocyte-macrophage%2520lineage%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1985%26volume%3D5%26spage%3D3458%26epage%3D3466%26doi%3D10.1128%2Fmcb.5.12.3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanley, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitu, V.</span></span> <span> </span><span class="NLM_article-title">CSF-1 receptor signaling in myeloid cells</span>. <i>Cold Spring Harbor Perspect. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">a021857</span>, <span class="refDoi"> DOI: 10.1101/cshperspect.a021857</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1101%2Fcshperspect.a021857" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=24890514" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=a021857&author=E.+R.+Stanleyauthor=V.+Chitu&title=CSF-1+receptor+signaling+in+myeloid+cells&doi=10.1101%2Fcshperspect.a021857"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a021857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a021857%26sid%3Dliteratum%253Aachs%26aulast%3DStanley%26aufirst%3DE.%2BR.%26aulast%3DChitu%26aufirst%3DV.%26atitle%3DCSF-1%2520receptor%2520signaling%2520in%2520myeloid%2520cells%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2014%26volume%3D6%26spage%3Da021857%26doi%3D10.1101%2Fcshperspect.a021857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourette, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrschneider, L. R.</span></span> <span> </span><span class="NLM_article-title">Early events in M-CSF receptor signaling</span>. <i>Growth Factors</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.3109/08977190009001065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.3109%2F08977190009001065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10705574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A280%3ADC%252BD3c7mvFOmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2000&pages=155-166&author=R.+P.+Bouretteauthor=L.+R.+Rohrschneider&title=Early+events+in+M-CSF+receptor+signaling&doi=10.3109%2F08977190009001065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Early events in M-CSF receptor signaling</span></div><div class="casAuthors">Bourette R P; Rohrschneider L R</div><div class="citationInfo"><span class="NLM_cas:title">Growth factors (Chur, Switzerland)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">155-66</span>
        ISSN:<span class="NLM_cas:issn">0897-7194</span>.
    </div><div class="casAbstract">The M-CSF receptor (M-CSFR) is expressed in monocytes-macrophages and their progenitors, and drives growth and development of this blood cell lineage.  The M-CSFR is a member of a small family of growth factor receptors exhibiting related structures but distinct tissue-specific functions.  This review discusses the early molecular events in the M-CSF signaling mechanisms, positive signals, negative signals, the possible organization of individual signaling pathways, and the problem of achieving specificity in the signal transduction mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQoZ6EG8k4AFv3jf77P2BG3fW6udTcc2eZB4GtY-QJPu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7mvFOmsA%253D%253D&md5=09f6171000dcd2d1dc7a36292e79ab5b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3109%2F08977190009001065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08977190009001065%26sid%3Dliteratum%253Aachs%26aulast%3DBourette%26aufirst%3DR.%2BP.%26aulast%3DRohrschneider%26aufirst%3DL.%2BR.%26atitle%3DEarly%2520events%2520in%2520M-CSF%2520receptor%2520signaling%26jtitle%3DGrowth%2520Factors%26date%3D2000%26volume%3D17%26spage%3D155%26epage%3D166%26doi%3D10.3109%2F08977190009001065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silakari, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. K.</span></span> <span> </span><span class="NLM_article-title">Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications</span>. <i>Biomed. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">662</span>– <span class="NLM_lpage">679</span>, <span class="refDoi"> DOI: 10.1016/j.biopha.2018.04.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1016%2Fj.biopha.2018.04.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=29679908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosFOqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2018&pages=662-679&author=A.+Kumariauthor=O.+Silakariauthor=R.+K.+Singh&title=Recent+advances+in+colony+stimulating+factor-1+receptor%2Fc-FMS+as+an+emerging+target+for+various+therapeutic+implications&doi=10.1016%2Fj.biopha.2018.04.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in colony stimulating factor-1 receptor/c-FMS as an emerging target for various therapeutic implications</span></div><div class="casAuthors">Kumari, Archana; Silakari, Om; Singh, Rajesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Biomedicine & Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">662-679</span>CODEN:
                <span class="NLM_cas:coden">BIPHEX</span>;
        ISSN:<span class="NLM_cas:issn">0753-3322</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Colony stimulating factor-1 (CSF-1) is one of the most common proinflammatory cytokine responsible for various inflammatory disorders.  It has a remarkable role in the development and progression of osteoarthritis, cancer and other autoimmune disease conditions.  The CSF-1 acts by binding to the receptor, called colony stimulating factor-1 receptor (CSF-1R) also known as c-FMS resulting in the cascade of signalling pathway causing cell proliferation and differentiation.  Interleukin-34 (IL-34), recently identified as another ligand for CSF-IR, is a cytokine protein.  Both, CSF-1 and IL-34, although two distinct cytokines, follow the similar signalling pathway on binding to the same receptor, CSF-1R.  Like CSF-1, IL-34 promotes the differentiation and survival of monocyte, macrophages and osteoclasts.  This CSF-1R/c-FMS is over expressed in many cancers and on tumor assocd. macrophages, consequently, have been exploited as a drug target for promising treatment for cancer and inflammatory diseases.  Some CSF-1R/c-FMS inhibitors such as ABT-869, Imatinib, AG013736, JNJ-40346527, PLX3397, DCC-3014 and Ki20227 have been successfully used in these disease conditions.  Many c-FMS inhibitors have been the candidates of clin. trials, but suffer from some side effects like cardiotoxicity, vomiting, swollen eyes, diarrhoea, etc.  If selectivity of cFMS inhibition is achieved successfully, side effects can be overruled and this approach may become a novel therapy for treatment of various therapeutic interventions.  Thus, successful targeting of c-FMS may result in multifunctional therapy.  With this background of information, the present review focuses on the recent developments in the area of CSF-1R/c-FMS inhibitors with emphasis on crystal structure, mechanism of action and various therapeutic implications in which c-FMS plays a pivotal role.  The review on structure activity relationship of various compds. acting as the inhibitors of c-FMS which gives the selection criteria for the development of novel mols. is also being presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCRQaIDZJ9obVg90H21EOLACvtfcHk0lgdfildr6eRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosFOqsrw%253D&md5=72c2ccefc7ef777cf87bffdb5f929170</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.biopha.2018.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopha.2018.04.046%26sid%3Dliteratum%253Aachs%26aulast%3DKumari%26aufirst%3DA.%26aulast%3DSilakari%26aufirst%3DO.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26atitle%3DRecent%2520advances%2520in%2520colony%2520stimulating%2520factor-1%2520receptor%252Fc-FMS%2520as%2520an%2520emerging%2520target%2520for%2520various%2520therapeutic%2520implications%26jtitle%3DBiomed.%2520Pharmacother.%26date%3D2018%26volume%3D103%26spage%3D662%26epage%3D679%26doi%3D10.1016%2Fj.biopha.2018.04.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chockalingam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, S. S.</span></span> <span> </span><span class="NLM_article-title">Macrophage colony-stimulating factor and cancer: a review</span>. <i>Tumor Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">10635</span>– <span class="NLM_lpage">10644</span>, <span class="refDoi"> DOI: 10.1007/s13277-014-2627-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1007%2Fs13277-014-2627-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=10635-10644&author=S.+Chockalingamauthor=S.+S.+Ghosh&title=Macrophage+colony-stimulating+factor+and+cancer%3A+a+review&doi=10.1007%2Fs13277-014-2627-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage colony-stimulating factor and cancer: a review</span></div><div class="casAuthors">Chockalingam, S.; Ghosh, Siddhartha Sankar</div><div class="citationInfo"><span class="NLM_cas:title">Tumor Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">10635-10644</span>CODEN:
                <span class="NLM_cas:coden">TUMBEA</span>;
        ISSN:<span class="NLM_cas:issn">1010-4283</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Tumor growth is influenced by a wide variety of external and internal factors.  One of the most important mediators of tumor development is our immune system.  The nonstop surveillance of the immune system was originally expected to clear the transformed cells from the body and guard against the development of tumor.  But contradictory evidences are reported to show the involvement of immune system in supporting the growth and spread of tumor.  Tumor infiltrating immune cells, in addn. to harboring immunosuppressive activities, also promote angiogenesis and metastasis of tumor.  Many growth factors and cytokines are involved in shaping this complex immune microenvironment of the tumor.  Macrophage colony-stimulating factor (MCSF) is one such growth factor which is overexpressed in many tumors.  In this review, we summarize the basic biol. of MCSF, its role in cancer and discuss the involvement of tumor-assocd. macrophages (TAMs) in tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonrRt-ocMfhrVg90H21EOLACvtfcHk0lgdfildr6eRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsLfM&md5=01055b227ccf55ef96e8d9a4a3ec1277</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs13277-014-2627-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13277-014-2627-0%26sid%3Dliteratum%253Aachs%26aulast%3DChockalingam%26aufirst%3DS.%26aulast%3DGhosh%26aufirst%3DS.%2BS.%26atitle%3DMacrophage%2520colony-stimulating%2520factor%2520and%2520cancer%253A%2520a%2520review%26jtitle%3DTumor%2520Biol.%26date%3D2014%26volume%3D35%26spage%3D10635%26epage%3D10644%26doi%3D10.1007%2Fs13277-014-2627-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutta, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DesJarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span> <span> </span><span class="NLM_article-title">Pyrido 2,3-d pyrimidin-5-ones: a novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1099</span>, <span class="refDoi"> DOI: 10.1021/jm801406h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801406h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1081-1099&author=H.+Huangauthor=D.+A.+Huttaauthor=J.+M.+Rinkerauthor=H.+Huauthor=W.+H.+Parsonsauthor=C.+Schubertauthor=R.+L.+DesJarlaisauthor=C.+S.+Cryslerauthor=M.+A.+Chaikinauthor=R.+R.+Donatelliauthor=Y.+Chenauthor=D.+Chengauthor=Z.+Zhouauthor=E.+Yurkowauthor=C.+L.+Mantheyauthor=M.+R.+Player&title=Pyrido+2%2C3-d+pyrimidin-5-ones%3A+a+novel+class+of+antiinflammatory+macrophage+colony-stimulating+factor-1+receptor+inhibitors&doi=10.1021%2Fjm801406h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrido[2,3-d]pyrimidin-5-ones: A novel class of antiinflammatory macrophage colony-stimulating factor-1 receptor inhibitors</span></div><div class="casAuthors">Huang, Hui; Hutta, Daniel A.; Rinker, James M.; Hu, Huaping; Parsons, William H.; Schubert, Carsten; DesJarlais, Renee L.; Crysler, Carl S.; Chaikin, Margery A.; Donatelli, Robert R.; Chen, Yanmin; Cheng, Deping; Zhou, Zhao; Yurkow, Edward; Manthey, Carl L.; Player, Mark R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1081-1099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of pyrido[2,3-d]pyrimidin-5-ones, e.g., I has been synthesized and evaluated as inhibitors of the kinase domain of macrophage colony-stimulating factor-1 receptor (FMS).  FMS inhibitors may be useful in treating rheumatoid arthritis and other chronic inflammatory diseases.  Structure-based optimization of the lead amide analog II (R = H)led to hydroxamate analog II (R = OMe), which possessed excellent potency and an improved pharmacokinetic profile.  During the chronic phase of streptococcal cell wall-induced arthritis in rats, compd. II (R = OMe) (10, 3, and 1 mg/kg) was highly effective at reversing established joint swelling.  In an adjuvant-induced arthritis model in rats, II prevented joint swelling partially at 10 mg/kg.  In this model, osteoclastogenesis and bone erosion were prevented by low doses (1 or 0.33 mg/kg) that had minimal impact on inflammation.  These data underscore the potential of FMS inhibitors to prevent erosions and reduce symptoms in rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXXwgHd8k1p7Vg90H21EOLACvtfcHk0lgX2fOy2K9JPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWgtLk%253D&md5=ca6f70b21bce3263161a60a28e4af4ce</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm801406h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801406h%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHutta%26aufirst%3DD.%2BA.%26aulast%3DRinker%26aufirst%3DJ.%2BM.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DParsons%26aufirst%3DW.%2BH.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DR.%2BR.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DYurkow%26aufirst%3DE.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26atitle%3DPyrido%25202%252C3-d%2520pyrimidin-5-ones%253A%2520a%2520novel%2520class%2520of%2520antiinflammatory%2520macrophage%2520colony-stimulating%2520factor-1%2520receptor%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1081%26epage%3D1099%26doi%3D10.1021%2Fjm801406h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Illig, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthey, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meegalla, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballentine, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DesJarlais, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crysler, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molloy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donatelli, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yurkow, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Player, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomczuk, B. E.</span></span> <span> </span><span class="NLM_article-title">Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N- 2-(1-cyclohexen-1-yl)-4- 1- (dimethylamino)acetyl -4-piperidi nyl phenyl -1H-imidazole-2-carboxamide (JNJ-28312141)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7860</span>– <span class="NLM_lpage">7883</span>, <span class="refDoi"> DOI: 10.1021/jm200900q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200900q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqs7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7860-7883&author=C.+R.+Illigauthor=C.+L.+Mantheyauthor=M.+J.+Wallauthor=S.+K.+Meegallaauthor=J.+Chenauthor=K.+J.+Wilsonauthor=S.+K.+Ballentineauthor=R.+L.+DesJarlaisauthor=C.+Schubertauthor=C.+S.+Cryslerauthor=Y.+Chenauthor=C.+J.+Molloyauthor=M.+A.+Chaikinauthor=R.+R.+Donatelliauthor=E.+Yurkowauthor=Z.+Zhouauthor=M.+R.+Playerauthor=B.+E.+Tomczuk&title=Optimization+of+a+potent+class+of+arylamide+colony-stimulating+factor-1+receptor+inhibitors+leading+to+anti-inflammatory+clinical+candidate+4-cyano-N-+2-%281-cyclohexen-1-yl%29-4-+1-+%28dimethylamino%29acetyl+-4-piperidi+nyl+phenyl+-1H-imidazole-2-carboxamide+%28JNJ-28312141%29&doi=10.1021%2Fjm200900q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Potent Class of Arylamide Colony-Stimulating Factor-1 Receptor Inhibitors Leading to Anti-inflammatory Clinical Candidate 4-Cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)</span></div><div class="casAuthors">Illig, Carl R.; Manthey, Carl L.; Wall, Mark J.; Meegalla, Sanath K.; Chen, Jinsheng; Wilson, Kenneth J.; Ballentine, Shelley K.; DesJarlais, Renee L.; Schubert, Carsten; Crysler, Carl S.; Chen, Yanmin; Molloy, Christopher J.; Chaikin, Margery A.; Donatelli, Robert R.; Yurkow, Edward; Zhou, Zhao; Player, Mark R.; Tomczuk, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7860-7883</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A class of potent inhibitors of colony-stimulating factor-1 receptor (CSF-1R or FMS) was optimized to improve pharmacokinetic and pharmacodynamic properties and potential toxicol. liabilities.  Early stage absorption, distribution, metab., and excretion assays were employed to ensure the incorporation of druglike properties resulting in the selection of several compds. with good activity in a pharmacodynamic screening assay in mice.  Further investigation, utilizing the type II collagen-induced arthritis model in mice, culminated in the selection of anti-inflammatory development candidate JNJ-28312141 (23, I, FMS IC50 = 0.69 nM, cell assay IC50 = 2.6 nM).  Compd. 23 also demonstrated efficacy in rat adjuvant and streptococcal cell wall-induced models of arthritis and has entered phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE9cLVtgUGRbVg90H21EOLACvtfcHk0lgX2fOy2K9JPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqs7bO&md5=a2d8b6a468f917dd1abbddc704f0f0ec</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm200900q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200900q%26sid%3Dliteratum%253Aachs%26aulast%3DIllig%26aufirst%3DC.%2BR.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DWall%26aufirst%3DM.%2BJ.%26aulast%3DMeegalla%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DK.%2BJ.%26aulast%3DBallentine%26aufirst%3DS.%2BK.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DSchubert%26aufirst%3DC.%26aulast%3DCrysler%26aufirst%3DC.%2BS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMolloy%26aufirst%3DC.%2BJ.%26aulast%3DChaikin%26aufirst%3DM.%2BA.%26aulast%3DDonatelli%26aufirst%3DR.%2BR.%26aulast%3DYurkow%26aufirst%3DE.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26atitle%3DOptimization%2520of%2520a%2520potent%2520class%2520of%2520arylamide%2520colony-stimulating%2520factor-1%2520receptor%2520inhibitors%2520leading%2520to%2520anti-inflammatory%2520clinical%2520candidate%25204-cyano-N-%25202-%25281-cyclohexen-1-yl%2529-4-%25201-%2520%2528dimethylamino%2529acetyl%2520-4-piperidi%2520nyl%2520phenyl%2520-1H-imidazole-2-carboxamide%2520%2528JNJ-28312141%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7860%26epage%3D7883%26doi%3D10.1021%2Fjm200900q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matusow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carias, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurt, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesch, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">5689</span>– <span class="NLM_lpage">5694</span>, <span class="refDoi"> DOI: 10.1073/pnas.1219457110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1073%2Fpnas.1219457110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=23493555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=5689-5694&author=C.+Zhangauthor=P.+N.+Ibrahimauthor=J.+Zhangauthor=E.+A.+Burtonauthor=G.+Habetsauthor=Y.+Zhangauthor=B.+Powellauthor=B.+L.+Westauthor=B.+Matusowauthor=G.+Tsangauthor=R.+Shellooeauthor=H.+Cariasauthor=H.+Nguyenauthor=A.+Marimuthuauthor=K.+Y.+J.+Zhangauthor=A.+Ohauthor=R.+Bremerauthor=C.+R.+Hurtauthor=D.+R.+Artisauthor=G.+Wuauthor=M.+Nespiauthor=W.+Spevakauthor=P.+Linauthor=K.+Nolopauthor=P.+Hirthauthor=G.+H.+Teschauthor=G.+Bollag&title=Design+and+pharmacology+of+a+highly+specific+dual+FMS+and+KIT+kinase+inhibitor&doi=10.1073%2Fpnas.1219457110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Design and pharmacology of a highly specific dual FMS and KIT kinase inhibitor</span></div><div class="casAuthors">Zhang, Chao; Ibrahim, Prabha N.; Zhang, Jiazhong; Burton, Elizabeth A.; Habets, Gaston; Zhang, Ying; Powell, Ben; West, Brian L.; Matusow, Bernice; Tsang, Garson; Shellooe, Rafe; Carias, Heidi; Nguyen, Hoa; Marimuthu, Adhirai; Zhang, Kam Y. J.; Oh, Angela; Bremer, Ryan; Hurt, Clarence R.; Artis, Dean R.; Wu, Guoxian; Nespi, Marika; Spevak, Wayne; Lin, Paul; Nolop, Keith; Hirth, Peter; Tesch, Greg H.; Bollag, Gideon</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5689-5694, S5689/1-S5689/11</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Inflammation and cancer, two therapeutic areas historically addressed by sep. drug discovery efforts, are now coupled in treatment approaches by a growing understanding of the dynamic mol. dialogues between immune and cancer cells.  Agents that target specific compartments of the immune system, therefore, not only bring new disease modifying modalities to inflammatory diseases, but also offer a new avenue to cancer therapy by disrupting immune components of the microenvironment that foster tumor growth, progression, immune evasion, and treatment resistance.  McDonough feline sarcoma viral (v-fms) oncogene homolog (FMS) and v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) are two hematopoietic cell surface receptors that regulate the development and function of macrophages and mast cells, resp.  The authors disclose a highly specific dual FMS and KIT kinase inhibitor developed from a multifaceted chem. scaffold.  As expected, this inhibitor blocks the activation of macrophages, osteoclasts, and mast cells controlled by these two receptors.  More importantly, the dual FMS and KIT inhibition profile has translated into a combination of benefits in preclin. disease models of inflammation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofECnjzEONuLVg90H21EOLACvtfcHk0ljU1vrfLOXoZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVWksLk%253D&md5=e4fbca9d41f95718a5119a08a54f5acc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1219457110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1219457110%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DMatusow%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DCarias%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26aulast%3DOh%26aufirst%3DA.%26aulast%3DBremer%26aufirst%3DR.%26aulast%3DHurt%26aufirst%3DC.%2BR.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DTesch%26aufirst%3DG.%2BH.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DDesign%2520and%2520pharmacology%2520of%2520a%2520highly%2520specific%2520dual%2520FMS%2520and%2520KIT%2520kinase%2520inhibitor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3D5689%26epage%3D5694%26doi%3D10.1073%2Fpnas.1219457110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Muriana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francos-Quijorna, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmos-Alonso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Nicola, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Vales, R.</span></span> <span> </span><span class="NLM_article-title">CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral Nerves</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">25663</span>, <span class="refDoi"> DOI: 10.1038/srep25663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1038%2Fsrep25663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=27174644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC28XotFKqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=25663&author=A.+Martinez-Murianaauthor=R.+Mancusoauthor=I.+Francos-Quijornaauthor=A.+Olmos-Alonsoauthor=R.+Ostaauthor=V.+H.+Perryauthor=X.+Navarroauthor=D.+Gomez-Nicolaauthor=R.+Lopez-Vales&title=CSF1R+blockade+slows+the+progression+of+amyotrophic+lateral+sclerosis+by+reducing+microgliosis+and+invasion+of+macrophages+into+peripheral+Nerves&doi=10.1038%2Fsrep25663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">CSF1R blockade slows the progression of amyotrophic lateral sclerosis by reducing microgliosis and invasion of macrophages into peripheral nerves</span></div><div class="casAuthors">Martinez-Muriana, Anna; Mancuso, Renzo; Francos-Quijorna, Isaac; Olmos-Alonso, Adrian; Osta, Rosario; Perry, V. Hugh; Navarro, Xavier; Gomez-Nicola, Diego; Lopez-Vales, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25663</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inflammation is a common neuropathol. feature in several neurol. disorders, including amyotrophic lateral sclerosis (ALS).  We have studied the contribution of CSF1R signalling to inflammation in ALS, as a pathway previously reported to control the expansion and activation of microglial cells.  We found that microglial cell proliferation in the spinal cord of SOD1G93A transgenic mice correlates with the expression of CSF1R and its ligand CSF1.  Administration of GW2580, a selective CSF1R inhibitor, reduced microglial cell proliferation in SOD1G93A mice, indicating the importance of CSF1-CSF1R signalling in microgliosis in ALS.  Moreover, GW2580 treatment slowed disease progression, attenuated motoneuron cell death and extended survival of SOD1G93A mice.  Electrophysiol. assessment revealed that GW2580 treatment protected skeletal muscle from denervation prior to its effects on microglial cells.  We found that macrophages invaded the peripheral nerve of ALS mice before CSF1R-induced microgliosis occurred.  Interestingly, treatment with GW2580 attenuated the influx of macrophages into the nerve, which was partly caused by the monocytopenia induced by CSF1R inhibition.  Overall, our findings provide evidence that CSF1R signalling regulates inflammation in the central and peripheral nervous system in ALS, supporting therapeutic targeting of CSF1R in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSmPgguZQ4qbVg90H21EOLACvtfcHk0ljU1vrfLOXoZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotFKqt74%253D&md5=993a80391dfac008405738f4926b587c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fsrep25663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep25663%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Muriana%26aufirst%3DA.%26aulast%3DMancuso%26aufirst%3DR.%26aulast%3DFrancos-Quijorna%26aufirst%3DI.%26aulast%3DOlmos-Alonso%26aufirst%3DA.%26aulast%3DOsta%26aufirst%3DR.%26aulast%3DPerry%26aufirst%3DV.%2BH.%26aulast%3DNavarro%26aufirst%3DX.%26aulast%3DGomez-Nicola%26aufirst%3DD.%26aulast%3DLopez-Vales%26aufirst%3DR.%26atitle%3DCSF1R%2520blockade%2520slows%2520the%2520progression%2520of%2520amyotrophic%2520lateral%2520sclerosis%2520by%2520reducing%2520microgliosis%2520and%2520invasion%2520of%2520macrophages%2520into%2520peripheral%2520Nerves%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D25663%26doi%3D10.1038%2Fsrep25663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spangenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohsfield, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crapser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spevak, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, N. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rymar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nespi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broome, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span> <span> </span><span class="NLM_article-title">Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3758</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-11674-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1038%2Fs41467-019-11674-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=31434879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A280%3ADC%252BB3MrgtFOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3758&author=E.+Spangenbergauthor=P.+L.+Seversonauthor=L.+A.+Hohsfieldauthor=J.+Crapserauthor=J.+Zhangauthor=E.+A.+Burtonauthor=Y.+Zhangauthor=W.+Spevakauthor=J.+Linauthor=N.+Y.+Phanauthor=G.+Habetsauthor=A.+Rymarauthor=G.+Tsangauthor=J.+Waltersauthor=M.+Nespiauthor=P.+Singhauthor=S.+Broomeauthor=P.+Ibrahimauthor=C.+Zhangauthor=G.+Bollagauthor=B.+L.+Westauthor=K.+N.+Green&title=Sustained+microglial+depletion+with+CSF1R+inhibitor+impairs+parenchymal+plaque+development+in+an+Alzheimer%E2%80%99s+disease+model&doi=10.1038%2Fs41467-019-11674-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model</span></div><div class="casAuthors">Spangenberg Elizabeth; Hohsfield Lindsay A; Crapser Joshua; Phan Nicole Y; Green Kim N; Severson Paul L; Zhang Jiazhong; Burton Elizabeth A; Zhang Ying; Spevak Wayne; Lin Jack; Habets Gaston; Rymar Andrey; Tsang Garson; Walters Jason; Nespi Marika; Singh Parmveer; Broome Stephanie; Ibrahim Prabha; Zhang Chao; Bollag Gideon; West Brian L</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3758</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many risk genes for the development of Alzheimer's disease (AD) are exclusively or highly expressed in myeloid cells.  Microglia are dependent on colony-stimulating factor 1 receptor (CSF1R) signaling for their survival.  We designed and synthesized a highly selective brain-penetrant CSF1R inhibitor (PLX5622) allowing for extended and specific microglial elimination, preceding and during pathology development.  We find that in the 5xFAD mouse model of AD, plaques fail to form in the parenchymal space following microglial depletion, except in areas containing surviving microglia.  Instead, Aβ deposits in cortical blood vessels reminiscent of cerebral amyloid angiopathy.  Altered gene expression in the 5xFAD hippocampus is also reversed by the absence of microglia.  Transcriptional analyses of the residual plaque-forming microglia show they exhibit a disease-associated microglia profile.  Collectively, we describe the structure, formulation, and efficacy of PLX5622, which allows for sustained microglial depletion and identify roles of microglia in initiating plaque pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZsPEWZPmRRMNIRw0GKUoEfW6udTcc2eadEwqvao7f8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrgtFOruw%253D%253D&md5=ec6089949cf49ffec6faefe983cb3beb</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-11674-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-11674-z%26sid%3Dliteratum%253Aachs%26aulast%3DSpangenberg%26aufirst%3DE.%26aulast%3DSeverson%26aufirst%3DP.%2BL.%26aulast%3DHohsfield%26aufirst%3DL.%2BA.%26aulast%3DCrapser%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DSpevak%26aufirst%3DW.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DPhan%26aufirst%3DN.%2BY.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DRymar%26aufirst%3DA.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DWalters%26aufirst%3DJ.%26aulast%3DNespi%26aufirst%3DM.%26aulast%3DSingh%26aufirst%3DP.%26aulast%3DBroome%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DK.%2BN.%26atitle%3DSustained%2520microglial%2520depletion%2520with%2520CSF1R%2520inhibitor%2520impairs%2520parenchymal%2520plaque%2520development%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520model%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D3758%26doi%3D10.1038%2Fs41467-019-11674-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Gamal, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ameen, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Koumi, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamad, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalal, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, C.-H.</span></span> <span> </span><span class="NLM_article-title">Recent advances of colony-stimulating factor-1 receptor (CSF-1R) kinase and its inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5450</span>– <span class="NLM_lpage">5466</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00873</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00873" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5450-5466&author=M.+I.+El-Gamalauthor=S.+K.+Al-Ameenauthor=D.+M.+Al-Koumiauthor=M.+G.+Hamadauthor=N.+A.+Jalalauthor=C.-H.+Oh&title=Recent+advances+of+colony-stimulating+factor-1+receptor+%28CSF-1R%29+kinase+and+its+inhibitors&doi=10.1021%2Facs.jmedchem.7b00873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors</span></div><div class="casAuthors">El-Gamal, Mohammed I.; Al-Ameen, Shahad K.; Al-Koumi, Dania M.; Hamad, Mawadda G.; Jalal, Nouran A.; Oh, Chang-Hyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5450-5466</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Colony stimulation factor-1 receptor (CSF-1R), which is also known as FMS kinase, plays an important role in initiating inflammatory, cancer, and bone disorders when it is over-stimulated by its ligand, CSF-1.  Innate immunity, as well as macrophage differentiation and survival, are regulated by the stimulation of the CSF-1R.  Another ligand, interleukin-34 (IL-34), was recently reported to activate the CSF-1R receptor in a different manner.  The relationship between CSF-1R and microglia has been reviewed.  Both CSF-1 antibodies and small mol. CSF-1R kinase inhibitors have now been tested in animal models and in humans.  In this Perspective, the authors discuss the role of CSF-1 and IL-34 in producing cancer, bone disorders, and inflammation.  The authors also review the newly discovered and improved small mol. kinase inhibitors and monoclonal antibodies that have shown potent activity toward CSF-1R, reported from 2012 until 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov4GIYJSVtGbVg90H21EOLACvtfcHk0ljigLiX6HjHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWgtg%253D%253D&md5=9fa615ecf2f532f1a2f1bac1e4c48932</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00873%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Gamal%26aufirst%3DM.%2BI.%26aulast%3DAl-Ameen%26aufirst%3DS.%2BK.%26aulast%3DAl-Koumi%26aufirst%3DD.%2BM.%26aulast%3DHamad%26aufirst%3DM.%2BG.%26aulast%3DJalal%26aufirst%3DN.%2BA.%26aulast%3DOh%26aufirst%3DC.-H.%26atitle%3DRecent%2520advances%2520of%2520colony-stimulating%2520factor-1%2520receptor%2520%2528CSF-1R%2529%2520kinase%2520and%2520its%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5450%26epage%3D5466%26doi%3D10.1021%2Facs.jmedchem.7b00873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tap, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainberg, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Healey, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chmielowski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staddon, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohn, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puzanov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramanathan, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habets, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visor, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanftner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Severson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marimuthu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shellooe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Rijn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterfy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong-Starksen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span> <span> </span><span class="NLM_article-title">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">437</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1411366</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1056%2Fnejmoa1411366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=26222558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=428-437&author=W.+D.+Tapauthor=Z.+A.+Wainbergauthor=S.+P.+Anthonyauthor=P.+N.+Ibrahimauthor=C.+Zhangauthor=J.+H.+Healeyauthor=B.+Chmielowskiauthor=A.+P.+Staddonauthor=A.+L.+Cohnauthor=G.+I.+Shapiroauthor=V.+L.+Keedyauthor=A.+S.+Singhauthor=I.+Puzanovauthor=E.+L.+Kwakauthor=A.+J.+Wagnerauthor=D.+D.+Von+Hoffauthor=G.+J.+Weissauthor=R.+K.+Ramanathanauthor=J.+Zhangauthor=G.+Habetsauthor=Y.+Zhangauthor=E.+A.+Burtonauthor=G.+Visorauthor=L.+Sanftnerauthor=P.+Seversonauthor=H.+Nguyenauthor=M.+J.+Kimauthor=A.+Marimuthuauthor=G.+Tsangauthor=R.+Shellooeauthor=C.+Geeauthor=B.+L.+Westauthor=P.+Hirthauthor=K.+Nolopauthor=M.+van+de+Rijnauthor=H.+H.+Hsuauthor=C.+Peterfyauthor=P.+S.+Linauthor=S.+Tong-Starksenauthor=G.+Bollag&title=Structure-guided+blockade+of+CSF1R+kinase+in+tenosynovial+giant-cell+tumor&doi=10.1056%2Fnejmoa1411366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor</span></div><div class="casAuthors">Tap, W. D.; Wainberg, Z. A.; Anthony, S. P.; Ibrahim, P. N.; Zhang, C.; Healey, J. H.; Chmielowski, B.; Staddon, A. P.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; Singh, A. S.; Puzanov, I.; Kwak, E. L.; Wagner, A. J.; Von Hoff, D. D.; Weiss, G. J.; Ramanathan, R. K.; Zhang, J.; Habets, G.; Zhang, Y.; Burton, E. A.; Visor, G.; Sanftner, L.; Severson, P.; Nguyen, H.; Kim, M. J.; Marimuthu, A.; Tsang, G.; Shellooe, R.; Gee, C.; West, B. L.; Hirth, P.; Nolop, K.; van de Rijn, M.; Hsu, H. H.; Peterfy, C.; Lin, P. S.; Tong-Starksen, S.; Bollag, G.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">428-437</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND Expression of the colony-stimulating factor 1 (CSF1) gene is elevated in most tenosynovial giant-cell tumors.  This observation has led to the discovery and clin. development of therapy targeting the CSF1 receptor (CSF1R).  METHODS Using x-ray co-crystallog. to guide our drug-discovery research, we generated a potent, selective CSF1R inhibitor, PLX3397, that traps the kinase in the autoinhibited conformation.  We then conducted a multicenter, phase 1 trial in two parts to analyze this compd.  In the first part, we evaluated escalations in the dose of PLX3397 that was administered orally in patients with solid tumors (doseescalation study).  In the second part, we evaluated PLX3397 at the chosen phase 2 dose in an extension cohort of patients with tenosynovial giant-cell tumors (extension study).  Pharmacokinetic and tumor responses in the enrolled patients were assessed, and CSF1 in situ hybridization was performed to confirm the mechanism of action of PLX3397 and that the pattern of CSF1 expression was consistent with the pathol. features of tenosynovial giant-cell tumor.  RESULTS A total of 41 patients were enrolled in the dose-escalation study, and an addnl. 23 patients were enrolled in the extension study.  The chosen phase 2 dose of PLX3397 was 1000 mg per day.  In the extension study, 12 patients with tenosynovial giant-cell tumors had a partial response and 7 patients had stable disease.  Responses usually occurred within the first 4 mo of treatment, and the median duration of response exceeded 8 mo.  The most common adverse events included fatigue, change in hair color, nausea, dysgeusia, and periorbital edema; adverse events rarely led to discontinuation of treatment.  CONCLUSIONS Treatment of tenosynovial giant-cell tumors with PLX3397 resulted in a prolonged regression in tumor vol. in most patients. (Funded by Plexxikon; ClinicalTrials.gov no., NCT01004861.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgftPP4lKlQrVg90H21EOLACvtfcHk0ljigLiX6HjHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLjN&md5=5e822a87786aca7495222e3d18f82bdb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1411366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1411366%26sid%3Dliteratum%253Aachs%26aulast%3DTap%26aufirst%3DW.%2BD.%26aulast%3DWainberg%26aufirst%3DZ.%2BA.%26aulast%3DAnthony%26aufirst%3DS.%2BP.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DHealey%26aufirst%3DJ.%2BH.%26aulast%3DChmielowski%26aufirst%3DB.%26aulast%3DStaddon%26aufirst%3DA.%2BP.%26aulast%3DCohn%26aufirst%3DA.%2BL.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DKeedy%26aufirst%3DV.%2BL.%26aulast%3DSingh%26aufirst%3DA.%2BS.%26aulast%3DPuzanov%26aufirst%3DI.%26aulast%3DKwak%26aufirst%3DE.%2BL.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DWeiss%26aufirst%3DG.%2BJ.%26aulast%3DRamanathan%26aufirst%3DR.%2BK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHabets%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBurton%26aufirst%3DE.%2BA.%26aulast%3DVisor%26aufirst%3DG.%26aulast%3DSanftner%26aufirst%3DL.%26aulast%3DSeverson%26aufirst%3DP.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DM.%2BJ.%26aulast%3DMarimuthu%26aufirst%3DA.%26aulast%3DTsang%26aufirst%3DG.%26aulast%3DShellooe%26aufirst%3DR.%26aulast%3DGee%26aufirst%3DC.%26aulast%3DWest%26aufirst%3DB.%2BL.%26aulast%3DHirth%26aufirst%3DP.%26aulast%3DNolop%26aufirst%3DK.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DHsu%26aufirst%3DH.%2BH.%26aulast%3DPeterfy%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DP.%2BS.%26aulast%3DTong-Starksen%26aufirst%3DS.%26aulast%3DBollag%26aufirst%3DG.%26atitle%3DStructure-guided%2520blockade%2520of%2520CSF1R%2520kinase%2520in%2520tenosynovial%2520giant-cell%2520tumor%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D428%26epage%3D437%26doi%3D10.1056%2Fnejmoa1411366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pyonteck, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkari, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevenich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quick, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huse, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teijeiro, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setty, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holland, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, J. A.</span></span> <span> </span><span class="NLM_article-title">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1264</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1038/nm.3337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1038%2Fnm.3337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=24056773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1264-1272&author=S.+M.+Pyonteckauthor=L.+Akkariauthor=A.+J.+Schuhmacherauthor=R.+L.+Bowmanauthor=L.+Sevenichauthor=D.+F.+Quailauthor=O.+C.+Olsonauthor=M.+L.+Quickauthor=J.+T.+Huseauthor=V.+Teijeiroauthor=M.+Settyauthor=C.+S.+Leslieauthor=Y.+Oeiauthor=A.+Pedrazaauthor=J.+Zhangauthor=C.+W.+Brennanauthor=J.+C.+Suttonauthor=E.+C.+Hollandauthor=D.+Danielauthor=J.+A.+Joyce&title=CSF-1R+inhibition+alters+macrophage+polarization+and+blocks+glioma+progression&doi=10.1038%2Fnm.3337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">CSF-1R inhibition alters macrophage polarization and blocks glioma progression</span></div><div class="casAuthors">Pyonteck, Stephanie M.; Akkari, Leila; Schuhmacher, Alberto J.; Bowman, Robert L.; Sevenich, Lisa; Quail, Daniela F.; Olson, Oakley C.; Quick, Marsha L.; Huse, Jason T.; Teijeiro, Virginia; Setty, Manu; Leslie, Christina S.; Oei, Yoko; Pedraza, Alicia; Zhang, Jianan; Brennan, Cameron W.; Sutton, James C.; Holland, Eric C.; Daniel, Dylan; Joyce, Johanna A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1272</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Glioblastoma multiforme (GBM) comprises several mol. subtypes, including proneural GBM.  Most therapeutic approaches targeting glioma cells have failed.  An alternative strategy is to target cells in the glioma microenvironment, such as tumor-assocd. macrophages and microglia (TAMs).  Macrophages depend on colony stimulating factor-1 (CSF-1) for differentiation and survival.  We used an inhibitor of the CSF-1 receptor (CSF-1R) to target TAMs in a mouse proneural GBM model, which significantly increased survival and regressed established tumors.  CSF-1R blockade addnl. slowed intracranial growth of patient-derived glioma xenografts.  Surprisingly, TAMs were not depleted in treated mice.  Instead, glioma-secreted factors, including granulocyte-macrophage CSF (GM-CSF) and interferon-γ (IFN-γ), facilitated TAM survival in the context of CSF-1R inhibition.  Expression of alternatively activated M2 markers decreased in surviving TAMs, which is consistent with impaired tumor-promoting functions.  These gene signatures were assocd. with enhanced survival in patients with proneural GBM.  Our results identify TAMs as a promising therapeutic target for proneural gliomas and establish the translational potential of CSF-1R inhibition for GBM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrirwpRVIWUELVg90H21EOLACvtfcHk0liszL15_CfFqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2jsr3N&md5=9b908e86c4a7da35a009bf322d492214</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnm.3337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3337%26sid%3Dliteratum%253Aachs%26aulast%3DPyonteck%26aufirst%3DS.%2BM.%26aulast%3DAkkari%26aufirst%3DL.%26aulast%3DSchuhmacher%26aufirst%3DA.%2BJ.%26aulast%3DBowman%26aufirst%3DR.%2BL.%26aulast%3DSevenich%26aufirst%3DL.%26aulast%3DQuail%26aufirst%3DD.%2BF.%26aulast%3DOlson%26aufirst%3DO.%2BC.%26aulast%3DQuick%26aufirst%3DM.%2BL.%26aulast%3DHuse%26aufirst%3DJ.%2BT.%26aulast%3DTeijeiro%26aufirst%3DV.%26aulast%3DSetty%26aufirst%3DM.%26aulast%3DLeslie%26aufirst%3DC.%2BS.%26aulast%3DOei%26aufirst%3DY.%26aulast%3DPedraza%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBrennan%26aufirst%3DC.%2BW.%26aulast%3DSutton%26aufirst%3DJ.%2BC.%26aulast%3DHolland%26aufirst%3DE.%2BC.%26aulast%3DDaniel%26aufirst%3DD.%26aulast%3DJoyce%26aufirst%3DJ.%2BA.%26atitle%3DCSF-1R%2520inhibition%2520alters%2520macrophage%2520polarization%2520and%2520blocks%2520glioma%2520progression%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1264%26epage%3D1272%26doi%3D10.1038%2Fnm.3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bendell, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolcher, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beeram, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrus, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cable, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhardt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rush, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patnaik, A.</span></span> <span> </span><span class="NLM_article-title">A phase 1 study of ARRY-382, an oral inhibitor of colony-stimulating factor-1 receptor (CSF1R), in patients with advanced or metastatic cancers</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">A252</span>, <span class="refDoi"> DOI: 10.1158/1535-7163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1158%2F1535-7163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=A252&author=J.+C.+Bendellauthor=A.+W.+Tolcherauthor=S.+F.+Jonesauthor=M.+Beeramauthor=J.+R.+Infanteauthor=P.+Larsenauthor=K.+Rasorauthor=J.+E.+Garrusauthor=J.+F.+Liauthor=P.+L.+Cableauthor=C.+Eberhardtauthor=J.+Schreiberauthor=S.+Rushauthor=K.+W.+Woodauthor=E.+Barretauthor=A.+Patnaik&title=A+phase+1+study+of+ARRY-382%2C+an+oral+inhibitor+of+colony-stimulating+factor-1+receptor+%28CSF1R%29%2C+in+patients+with+advanced+or+metastatic+cancers&doi=10.1158%2F1535-7163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1535-7163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163%26sid%3Dliteratum%253Aachs%26aulast%3DBendell%26aufirst%3DJ.%2BC.%26aulast%3DTolcher%26aufirst%3DA.%2BW.%26aulast%3DJones%26aufirst%3DS.%2BF.%26aulast%3DBeeram%26aufirst%3DM.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DLarsen%26aufirst%3DP.%26aulast%3DRasor%26aufirst%3DK.%26aulast%3DGarrus%26aufirst%3DJ.%2BE.%26aulast%3DLi%26aufirst%3DJ.%2BF.%26aulast%3DCable%26aufirst%3DP.%2BL.%26aulast%3DEberhardt%26aufirst%3DC.%26aulast%3DSchreiber%26aufirst%3DJ.%26aulast%3DRush%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DK.%2BW.%26aulast%3DBarret%26aufirst%3DE.%26aulast%3DPatnaik%26aufirst%3DA.%26atitle%3DA%2520phase%25201%2520study%2520of%2520ARRY-382%252C%2520an%2520oral%2520inhibitor%2520of%2520colony-stimulating%2520factor-1%2520receptor%2520%2528CSF1R%2529%252C%2520in%2520patients%2520with%2520advanced%2520or%2520metastatic%2520cancers%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3DA252%26doi%3D10.1158%2F1535-7163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Von
Tresckow, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morschhauser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribrag, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topp, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seetharam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aquino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotoulek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engert, A.</span></span> <span> </span><span class="NLM_article-title">An open-label, multicenter, phase I/II study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory hodgkin lymphoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1850</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.ccr-14-1845</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1158%2F1078-0432.ccr-14-1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=25628399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1843-1850&author=B.+Von%0ATresckowauthor=F.+Morschhauserauthor=V.+Ribragauthor=M.+S.+Toppauthor=C.+Chienauthor=S.+Seetharamauthor=R.+Aquinoauthor=S.+Kotoulekauthor=C.+J.+de+Boerauthor=A.+Engert&title=An+open-label%2C+multicenter%2C+phase+I%2FII+study+of+JNJ-40346527%2C+a+CSF-1R+inhibitor%2C+in+patients+with+relapsed+or+refractory+hodgkin+lymphoma&doi=10.1158%2F1078-0432.ccr-14-1845"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma</span></div><div class="casAuthors">von Tresckow, Bastian; Morschhauser, Franck; Ribrag, Vincent; Topp, Max S.; Chien, Caly; Seetharam, Shobha; Aquino, Regina; Kotoulek, Sonja; de Boer, Carla J.; Engert, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1843-1850</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This phase I/II study investigated JNJ-40346527, a selective inhibitor of the colony-stimulating factor-1 receptor (CSF-1R) tyrosine kinase as treatment for relapsed or refractory classical Hodgkin lymphoma (cHL).  Patients ≥18 years with histopathol. confirmed initial diagnosis of cHL that had relapsed or was refractory after ≥1 appropriate therapies were assigned to sequential cohorts of oral daily doses of JNJ-40346527 (150, 300, 450, 600 mg every day, and 150 mg twice a day).  For the dose-escalation phase, the primary endpoint was to establish the recommended phase II dose.  Secondary endpoints included safety, pharmacokinetics, and pharmacodynamics.  Twenty-one patients [(150 mg: 3; 300 mg: 5; 450 mg: 3, 600 mg: 3) every day, and 150 mg twice a day: 7] were enrolled, 10 men, median age 40 (range, 19-75) years, median no. of prior systemic therapies 6 (range, 3-14).  No dose-limiting toxicities were obsd.; max.-tolerated dose was not established.  Best overall response was complete remission in 1 patient (duration, +352 days) and stable disease in 11 patients: (duration, 1.5-8 mo).  Median no. of cycles: 4 (range, 1-16).  Most common (≥20% patients) possibly drug-related adverse events (per investigator assessment) were nausea (n = 6), headache, and pyrexia (n = 5 each).  JNJ-40346527 exposure increased in near dose-proportional manner over a dose range of 150 to 450 mg every day, but plateaued at 600 mg every day.  Target engagement was confirmed (>80% inhibition of CSF-1R phosphorylation, 4 h after dosing).  JNJ-40346527, a selective inhibitor of CSF-1R was well tolerated, and preliminary antitumor results suggested limited activity in monotherapy for the treatment of cHL.  Clin Cancer Res; 21(8); 1843-50. cpr2015 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwZuUy9-7MhLVg90H21EOLACvtfcHk0liszL15_CfFqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsl2gt7g%253D&md5=e3d4f2b2937078f85ef0ead51e093f82</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.ccr-14-1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.ccr-14-1845%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BTresckow%26aufirst%3DB.%26aulast%3DMorschhauser%26aufirst%3DF.%26aulast%3DRibrag%26aufirst%3DV.%26aulast%3DTopp%26aufirst%3DM.%2BS.%26aulast%3DChien%26aufirst%3DC.%26aulast%3DSeetharam%26aufirst%3DS.%26aulast%3DAquino%26aufirst%3DR.%26aulast%3DKotoulek%26aufirst%3DS.%26aulast%3Dde%2BBoer%26aufirst%3DC.%2BJ.%26aulast%3DEngert%26aufirst%3DA.%26atitle%3DAn%2520open-label%252C%2520multicenter%252C%2520phase%2520I%252FII%2520study%2520of%2520JNJ-40346527%252C%2520a%2520CSF-1R%2520inhibitor%252C%2520in%2520patients%2520with%2520relapsed%2520or%2520refractory%2520hodgkin%2520lymphoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2015%26volume%3D21%26spage%3D1843%26epage%3D1850%26doi%3D10.1158%2F1078-0432.ccr-14-1845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mok, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, J. P.</span></span> <span> </span><span class="NLM_article-title">Blocking colony stimulating factor 1 receptor (CSF-1R) and tropomyosin receptor kinase (Trk) improves antitumor efficacy of immunotherapy</span>. <i>Cancer Immunol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">PR01</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=PR01&author=S.+Mokauthor=C.+Duffyauthor=R.+Duauthor=J.+P.+Allison&title=Blocking+colony+stimulating+factor+1+receptor+%28CSF-1R%29+and+tropomyosin+receptor+kinase+%28Trk%29+improves+antitumor+efficacy+of+immunotherapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMok%26aufirst%3DS.%26aulast%3DDuffy%26aufirst%3DC.%26aulast%3DDu%26aufirst%3DR.%26aulast%3DAllison%26aufirst%3DJ.%2BP.%26atitle%3DBlocking%2520colony%2520stimulating%2520factor%25201%2520receptor%2520%2528CSF-1R%2529%2520and%2520tropomyosin%2520receptor%2520kinase%2520%2528Trk%2529%2520improves%2520antitumor%2520efficacy%2520of%2520immunotherapy%26jtitle%3DCancer%2520Immunol.%2520Res.%26date%3D2017%26volume%3D5%26spage%3DPR01" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Osipov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saung, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, A. G.</span></span> <span> </span><span class="NLM_article-title">Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape</span>. <i>J. Immunother. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">224</span>, <span class="refDoi"> DOI: 10.1186/s40425-019-0667-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1186%2Fs40425-019-0667-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=31439034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A280%3ADC%252BB3MrgsF2nsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2019&pages=224&author=A.+Osipovauthor=M.+T.+Saungauthor=L.+Zhengauthor=A.+G.+Murphy&title=Small+molecule+immunomodulation%3A+the+tumor+microenvironment+and+overcoming+immune+escape&doi=10.1186%2Fs40425-019-0667-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape</span></div><div class="casAuthors">Osipov Arsen; Saung May Tun; Zheng Lei; Murphy Adrian G; Murphy Adrian G</div><div class="citationInfo"><span class="NLM_cas:title">Journal for immunotherapy of cancer</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">224</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Immunotherapy has led to a paradigm shift in the treatment of many advanced malignancies.  Despite the success in treatment of tumors like non-small cell lung cancer (NSCLC) and melanoma, checkpoint inhibition-based immunotherapy has limitations.  Many tumors, such as pancreatic cancer, are less responsive to checkpoint inhibitors, where patients tend to have a limited duration of benefit and where clinical responses are more robust in patients who are positive for predictive biomarkers.  One of the critical factors that influence the efficacy of immunotherapy is the tumor microenvironment (TME), which contains a heterogeneous composition of immunosuppressive cells.  Myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs) alter the immune landscape of the TME and serve as facilitators of tumor proliferation, metastatic growth and immunotherapy resistance.  Small molecule inhibitors that target these components of the TME have been developed.  This special issue review focuses on two promising classes of immunomodulatory small molecule inhibitors: colony stimulating factor-1 receptor (CSF-1R) and focal adhesion kinase (FAK).  Small molecule inhibitors of CSF-1R reprogram the TME and TAMs, and lead to enhanced T-cell-mediated tumor eradication.  FAK small molecule inhibitors decrease the infiltration MDSCs, TAMs and regulatory T-cells.  Additionally, FAK inhibitors are implicated as modulators of stromal density and cancer stem cells, leading to a TME more conducive to an anti-tumor immune response.  Immunomodulatory small molecule inhibitors present a unique opportunity to attenuate immune escape of tumors and potentiate the effectiveness of immunotherapy and traditional cytotoxic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMtQEKH7hnxRFwe7cAcrfPfW6udTcc2eYU4vOILtQ5cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrgsF2nsw%253D%253D&md5=f38c986988b001c3d272f4cace19e295</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs40425-019-0667-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40425-019-0667-0%26sid%3Dliteratum%253Aachs%26aulast%3DOsipov%26aufirst%3DA.%26aulast%3DSaung%26aufirst%3DM.%2BT.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DMurphy%26aufirst%3DA.%2BG.%26atitle%3DSmall%2520molecule%2520immunomodulation%253A%2520the%2520tumor%2520microenvironment%2520and%2520overcoming%2520immune%2520escape%26jtitle%3DJ.%2520Immunother.%2520Cancer%26date%3D2019%26volume%3D7%26spage%3D224%26doi%3D10.1186%2Fs40425-019-0667-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levis, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of c-Kit by tyrosine kinase inhibitors</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">e77</span>– <span class="NLM_lpage">e79</span>, <span class="refDoi"> DOI: 10.3324/haematol.2014.117028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.3324%2Fhaematol.2014.117028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=25425690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2015&pages=e77-e79&author=A.+Galanisauthor=M.+Levis&title=Inhibition+of+c-Kit+by+tyrosine+kinase+inhibitors&doi=10.3324%2Fhaematol.2014.117028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.3324%2Fhaematol.2014.117028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3324%252Fhaematol.2014.117028%26sid%3Dliteratum%253Aachs%26aulast%3DGalanis%26aufirst%3DA.%26aulast%3DLevis%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520c-Kit%2520by%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DHaematologica%26date%3D2015%26volume%3D100%26spage%3De77%26epage%3De79%26doi%3D10.3324%2Fhaematol.2014.117028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1016%2Fj.ejmech.2016.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=27750146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslShsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2017&pages=122-132&author=Y.+Liuauthor=X.+Pengauthor=X.+Guanauthor=D.+Luauthor=Y.+Xiauthor=S.+Jinauthor=H.+Chenauthor=L.+Zengauthor=J.+Aiauthor=M.+Gengauthor=Y.+Hu&title=Discovery+of+novel+ponatinib+analogues+for+reducing+KDR+activity+as+potent+FGFRs+inhibitors&doi=10.1016%2Fj.ejmech.2016.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors</span></div><div class="casAuthors">Liu, Yang; Peng, Xia; Guan, Xiaocong; Lu, Dong; Xi, Yong; Jin, Shiyu; Chen, Hui; Zeng, Limin; Ai, Jing; Geng, Meiyu; Hu, Youhong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">122-132</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">FGF receptors (FGFRs) are tyrosine kinases that are overexpressed in diverse tumors by genetic alterations such as gene amplifications, somatic mutations and translocations.  Owing to this characteristic, FGFRs are attractive targets for cancer treatment.  It has been demonstrated that most multi-targeted, ATP competitive tyrosine kinase inhibitors are active against FGFRs as well as other kinases.  The design of new and more selective inhibitors of FGFRs, which might be reduced off-target and side effects, is a difficult yet significant challenge.  The results of the current investigation, show that novel Ponatinib analogs are highly active as FGFR inhibitors and that they possess reduced kinase insert domain receptor (KDR) activities.  Observations made in a structure and activity relationship (SAR) investigation led to the development of a promising, orally available lead compd. 4-chloro-N-(4-((4-methylpiperazin-1-yl) methyl)-3-(trifluoromethyl) phenyl)-3-((5-morpholinopyridin-3-yl) ethynyl) benzamide (compd. 4, I), which displays a 50-100-fold in vitro selectivity for inhibition of FGFR1-3 over KDR.  In addn., biol. evaluation of I showed that it displays significant antitumor activities in FGFR1-amplificated H1581 and FGFR2-amplificated SNU-16 xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMqkDLJD5jOLVg90H21EOLACvtfcHk0lgRM2ISdO2qVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslShsbbK&md5=020229eec1c8a365516b752219a50368</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DD.%26aulast%3DXi%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAi%26aufirst%3DJ.%26aulast%3DGeng%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520novel%2520ponatinib%2520analogues%2520for%2520reducing%2520KDR%2520activity%2520as%2520potent%2520FGFRs%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D126%26spage%3D122%26epage%3D132%26doi%3D10.1016%2Fj.ejmech.2016.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N. S.</span></span> <span> </span><span class="NLM_article-title">Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1230</span>– <span class="NLM_lpage">1241</span>, <span class="refDoi"> DOI: 10.1021/cb500129t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500129t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1230-1241&author=Z.+Zhaoauthor=H.+Wuauthor=L.+Wangauthor=Y.+Liuauthor=S.+Knappauthor=Q.+Liuauthor=N.+S.+Gray&title=Exploration+of+type+II+binding+mode%3A+a+privileged+approach+for+kinase+inhibitor+focused+drug+discovery%3F&doi=10.1021%2Fcb500129t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?</span></div><div class="casAuthors">Zhao, Zheng; Wu, Hong; Wang, Li; Liu, Yi; Knapp, Stefan; Liu, Qingsong; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1230-1241</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The ATP site of kinases displays remarkable conformational flexibility when accommodating chem. diverse small mol. inhibitors.  The so-called activation segment, whose conformation controls catalytic activity and access to the substrate binding pocket, can undergo a large conformational change with the active state assuming a 'DFG-in' and an inactive state assuming a 'DFG-out' conformation.  Compds. that preferentially bind to the DFG-out conformation are typically called 'type II' inhibitors in contrast to 'type I' inhibitors that bind to the DFG-in conformation.  This review surveys the large no. of type II inhibitors that have been developed and provides an anal. of their crystallog. detd. binding modes.  Using a small library of type II inhibitors, we demonstrate that more than 200 kinases can be targeted, suggesting that type II inhibitors may not be intrinsically more selective than type I inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4jYt6Db3Ap7Vg90H21EOLACvtfcHk0lh0SakAxXpv0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtV2nt7s%253D&md5=95bf185ff7f973eda5a65f4096bfaa82</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500129t%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DExploration%2520of%2520type%2520II%2520binding%2520mode%253A%2520a%2520privileged%2520approach%2520for%2520kinase%2520inhibitor%2520focused%2520drug%2520discovery%253F%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1230%26epage%3D1241%26doi%3D10.1021%2Fcb500129t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanqué, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meakin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, C. R.</span></span> <span> </span><span class="NLM_article-title">Selective enhancement of LPS-induced serum TNF-alpha production by carrageenan pretreatment in mice</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">301</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/s0306-3623(97)00434-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1016%2Fs0306-3623%2897%2900434-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=9688477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADyaK1cXjs1Orsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1998&pages=301-306&author=R.+Blanqu%C3%A9author=C.+Meakinauthor=S.+Milletauthor=C.+R.+Gardner&title=Selective+enhancement+of+LPS-induced+serum+TNF-alpha+production+by+carrageenan+pretreatment+in+mice&doi=10.1016%2Fs0306-3623%2897%2900434-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Selective enhancement of LPS-induced serum TNF-α production by carrageenan pretreatment in mice</span></div><div class="casAuthors">Blanque, R.; Meakin, C.; Millet, S.; Gardner, C. R.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">301-306</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Bacterial lipopolysaccharide (LPS)-induced increases in serum cytokines (TNF-α, IL-1 and IL-6) and hypothermia were studied in mice sensitized by carrageenan pretreatment and compared with mice sensitized with heat-killed P. acnes or IFN-γ, all given i.p. at appropriate intervals (24 h, 7 days and 12-18 h, resp.) before LPS.  In mice with localized peritoneal inflammation induced by carrageenan, peak TNF-α levels (1.5-2 h after LPS) were markedly enhanced after both doses of LPS tested (50 and 200 μg/mouse i.p.).  However, IL-1β levels were not changed and IL-6 levels were decreased only after the higher dose of LPS.  Hypothermia showed weak and inconsistent changes in carrageenan-sensitized mice.  IL-1β levels in spleen lysates were higher but paralleled those in the serum, being increased in IFN-γ-sensitized but not in carrageenan-sensitized mice.  The levels of both TNF-α and IL-1β were high in the peritoneum of carrageenan-sensitized mice, suggesting that the increased serum TNF-α did not emanate from the peritoneum.  In mice sensitized with the other two agents, as expected, the levels of all three cytokines increased, but peak levels were attained at the same times post-LPS (TNF-α: 1-1.5 h; IL-1: 3-4 h; IL-6: 3-4 h).  In addn., hypothermia was increased with both of these methods of sensitization.  The lack of consistent correlation of the levels of cytokines studied, particularly TNF-α, with the degree of hypothermia, raises questions as to their causative role in its induction in these models.  The mechanisms underlying these models of sensitization are clearly different, and further understanding of these mechanisms would aid in the interpretation of the effects of drugs in the models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLv7osrglM2rVg90H21EOLACvtfcHk0lh0SakAxXpv0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjs1Orsb8%253D&md5=06e9708a3fc8def9e4eee54d57ad3dcd</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fs0306-3623%2897%2900434-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0306-3623%252897%252900434-5%26sid%3Dliteratum%253Aachs%26aulast%3DBlanqu%25C3%25A9%26aufirst%3DR.%26aulast%3DMeakin%26aufirst%3DC.%26aulast%3DMillet%26aufirst%3DS.%26aulast%3DGardner%26aufirst%3DC.%2BR.%26atitle%3DSelective%2520enhancement%2520of%2520LPS-induced%2520serum%2520TNF-alpha%2520production%2520by%2520carrageenan%2520pretreatment%2520in%2520mice%26jtitle%3DGen.%2520Pharmacol.%26date%3D1998%26volume%3D31%26spage%3D301%26epage%3D306%26doi%3D10.1016%2Fs0306-3623%2897%2900434-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trott, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">455</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1002/jcc.21334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-461&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading&doi=10.1002%2Fjcc.21334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lh0SakAxXpv0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D461%26doi%3D10.1002%2Fjcc.21334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04','PDB','4V04'); return false;">PDB: 4V04</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H','PDB','4R7H'); return false;">PDB: 4R7H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I','PDB','4R7I'); return false;">PDB: 4R7I</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i94"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01912">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_21722"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01912?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01912</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Blockade effect of <b>29</b> on the hERG channel, <sup>1</sup>H NMR, <sup>13</sup>C NMR spectra of compounds <b>7–37</b>, and <sup>19</sup>F NMR spectra of <b>7</b>, <b>20</b>, <b>22</b>, <b>30</b>, and <b>31</b>, and the purity data of all final compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_001.pdf">jm9b01912_si_001.pdf (5.83 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01912/suppl_file/jm9b01912_si_002.csv">jm9b01912_si_002.csv (2.57 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7H">4R7H</a> was used for modeling docking of compound <b>7</b>, <b>8</b>, <b>12</b>, <b>16</b>, and <b>29</b> in CSF-1R; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4R7I">4R7I</a> was used for modeling docking of compound <b>7</b> and <b>8</b>; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4V04">4V04</a> was used for modeling docking of compound <b>7</b> and <b>8</b> in FGFR1.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01912&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01912%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-3%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01912" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677afb96ccb83c2e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
